9

Cancer Incidence Data: Sri Lanka Year 2001-2005
National Cancer Control Programme 555, Elvitigala Mawatha Colombo 05 Sri Lanka
Cancer Registry
National Cancer Control Programe - 2009 7th Publication
Data collection and analysis: Dr K G Nirmala Jayanthi Dr Lahiruwan Somaratne Dr Nayomi Walpola Dr Chaminda Wickramasinghe Mr Mahinda Sirikumara Dr D Pradeep Randil Dr Derrick Wijesuriya Dr V Kalhara Batuwana Dr Pramod C Chandrasinghe The statistical analysis of this publication was primarily done by Dr Anuradhani Kasturiratne of the Faculty of Medicine, University of Kelaniya under the supervision of Dr M A Y Ariyaratne, Director/ NCCP. Support Staff: Saman Kumara Mahalekam U K Sumanasiri I W Suneetha Thushari Dhammika Indika Lakmal K A Hemasiri
ISBN: 978-955-9099-07-9
Printed By: Gunaratne Offset Ltd Wellampitiya
ii
Cancer Incidence Data - 2005
Message by the Minister of Healthcare & Nutrition
It gives me great pleasure to release this short message at the occasion of the publication of the 7th edition of the Sri Lanka Cancer Registry. As Sri Lanka develops, the pattern of disease in Sri Lanka is becoming increasingly similar to that of developed countries, with the incidence and prevalence of non-communicable diseases (NCDs) increasing rapidly. Among these NCDs, cancers are an especially grave problem as they give rise to a significant amount of morbidity and mortality. In the Health Master Plan initiated by me, the Ministry of Healthcare & Nutrition has clearly identified the importance of developing timely interventions to combat this NCD epidemic and it is in the process of developing facilities for early detection of malignancy and improved cancer therapy. The cancer registry is an important tool in this process that will help us to identify areas that we need to concentrate our resources on. It will also provide valuable information to Professionals engaged in cancer research. The aim of the Ministry of Healthcare & Nutrition is to convert the current hospital based publication into a population based cancer registry and I am confident that this can be achieved in the near future. I would like to thank the WHO for supporting the printing of this publication and I would also like to take this opportunity to congratulate and thank the Director and the staff of the National Cancer Control Programme for their hard work in making this registry a reality. Hon Nimal Siripala de Silva Minister of Healthcare & Nutrition
iii
Message by the Secretary/ Ministry of Healthcare & Nutrition
I am pleased to release this message at the occasion in which the National Cancer Control Program is to publish the Sri Lanka Cancer Registry. This registry contains cancer incidence data from all cancer units in the country for the period 2001 to 2005. This data will be invaluable to professionals engaged in cancer research in order to analyse genetic, environmental, geographic, ethnic and other differences that provide clues to causative and other associated risk factors. This data will also aid the Ministry of Healthcare & Nutrition in planning the future expansion of cancer therapy in Sri Lanka as well as helping to identify priority areas where specific interventional programs need to be instituted. At a time when Sri Lanka is striving to achieve international standards in healthcare, this publication of the countrys cancer data will put us on par with the practices of the developed world. The ultimate goal would be to create a population based cancer registry in Sri Lanka which I hope the National Cancer Control Program can achieve by the time the next edition is published. I wish to express my appreciation to the World Health Organization for supporting us in the efforts to create a Sri Lanka Cancer Registry and I also wish to thank all the officials who have worked tirelessly to successfully complete this important publication.
Dr. H.A.P.Kahandaliyanage Secretary Ministry of Healthcare & Nutrition
vi
Message by the Director General of Health Services
I am happy to provide this message for the publication of National Cancer Registry data for the period, 2001 to 2005. The National Cancer Control Programme is involved in various aspects of cancer prevention and control in Sri Lanka and the National Cancer Registry is one such activity. The NCCP has published hospital based cancer incidence data since 1985. This is the only such publication in Sri Lanka covering the entire island. I am confident this publication will be an invaluable resource for policy makers and clinicians alike in making decisions regarding policy and patient care. I hope the NCCP will be able to carry on the good work and continue to publish the National Cancer Registry in the future too. I would like to express my sincere gratitude for the World Health Organisation who have provided the necessary funds for printing the registry.
Dr U A Mendis Director General of Health Services
vii
viii
FOREWORD
The data with regard to incidence and prevalence of a disease condition is very important to take decisions pertaining to making available facilities for treatment as well as for preventive work. In fact, any decision made without this basic factual knowledge stands to loose its usefulness as the cost-effectiveness and benefit will be minimal and wastage will be high. The basis of any research is epidemiological analysis and the database of the NCCP is the only countrywide database on cancers in Sri Lanka. The whole team of the NCCP including myself is very pleased and takes pride in making this publication of cancer incidence data 2001-2005. Prior to this, we had to collect, analyse and publish data, only once in 5 years. Therefore, this publication of data for five consecutive years is a great step toward improvement of the cancer registry in Sri Lanka. This publication gives the data of cancer patients registered during the period 2001-2005 in Sri Lanka. There are statistics on cancers in general and on individual types of cancer. I am grateful to Drs. Nirmala Jayanthi, Lahiruwan Somaratne, Nayomi Walpola and Chaminda Wickramasinghe, Mr Mahinda Sirikumara, Mrs. Sriya Walisundara and staff members Indika Lakmal, K A Hemasiri, I W Suneetha, Thushari Dhammika, Saman Kumara Mahalekam and U K Sumanasiri for their excellent teamwork in collecting the data. The computer work done by Nayomi Kanchana and Ashani Hettiarachchi is highly commendable. Japan International Cooperation Agency (JICA) helped us with providing the research assistants for data collection and their contribution to this publication is very much appreciated. The assistance given by the staff of the Department of Public Health, Faculty of Medicine, University of Kelaniya with Prof. Rajitha Wickramasinghe and Dr. Anuradhani Kasturiratne was a main factor which enabled us to publish this data on time. The usefulness of a database is measured by the amount of usage, the same is being put to. Therefore, it is my privilege to invite all researchers and officials involved in the health sector planning and implementation and academics to make the best use of this publication.
Dr M A Y Ariyaratne MBBS, MD Director/ NCCP
ix
Table of contents
Foreword Message from Hon. Minister of Healthcare and Nutrition Message from Secretary to the Ministry of Healthcare and Nutrition Message from Director General of Health Services Message from the current Director/ National Cancer Control Programme Part Ia: Cancer Incidence Data: 2005 Graph Table Table Table Graph Table Table Table Graph Table Graph Graph Graph 01 01 02 03 02 04 05 06 03 07 04 05 06 General population of Sri Lanka by age group General population: Sex distribution Statistics on doctors, hospitals and beds Cancer mortality data: 1985 - 2003 Crude hospital death rates: 1996 - 2003 Cancer mortality rates: 2001 Cancer incidence in Sri Lanka: 1985 - 2005 Overall cancer incidence 2005, by age and sex Cancer vs. age: 2005 Leading cancer sites: 2005 Leading cancer sites: 2005 Leading cancers by age groups: 0 - 14: 2005 Leading cancers by age groups: 15 -34: 2005 Leading cancers by age groups: 35 -49: 2005 Leading cancers by age groups: 50 -64: 2005 Leading cancers by age groups: 65 and above: 2005 Age standardised rate: male and female: 1985 - 2005 Percentage changes in ASR for selected cancer: 1995 - 2005 Number of cancer cases by ethnicity, sex and sub site Number of cancer cases by age group, male: 2005 Number of cancer cases by age group, female: 2005 Number of cancer cases by histological type and sub site
Graph Graph Table Table Table
07 08 08 09 10
Part Ib Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table
11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
Lip, oral cavity and pharynx Lip and anterior part of oral cavity Posterior part of oral cavity and pharynx Tongue Esophagus Stomach Colon, rectum and rectosigmoid junction Colon Rectum, anal canal and anus Larynx Trachea, bronchus and lung Haematopoietic and reticuloendothelial system Skin Breast Cervix uteri Ovary and other female genital organs Prostate Bladder Brain Thyroid gland
xi
Cancer Incidence Data - 2005 Part Ic Table Table Table 31 32 33 Cancer treatment: 2005 Cancer survival status by age group, ethnicity and sub site Cancer incidence by geography: 2005
Part IIa : Cancer Incidence Data: 2001 - 2005 Table xx Table xx Table xx Table xx Table xx Part IIb Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Lip, oral cavity and pharynx Lip and anterior part of oral cavity Posterior part of oral cavity and pharynx Tongue Esophagus Stomach Colon, rectum and rectosigmoid junction Colon Rectum, anal canal and anus Larynx Trachea, bronchus and lung Haematopoietic and reticuloendothelial system Skin Breast Cervix uteri Ovary and other female genital organs Prostate Bladder Brain Thyroid gland Cancer incidence by reporting year, sex and sub-site: 2001 2005 Cancer incidence by ethnicity, sex and sub-site: 2001 2005 Cancer incidence by age group and sub-site, males: 2001 - 2005 Cancer incidence by age group and sub-site, females: 2001 2005 Cancer incidence by histological type and sub-site: 2001 2005
Appendices Appendix i : Statistical Terminology Appendix ii : List of References
xii
Cancer Incidence Data
2005
Graph 01 General population of Sri Lanka by 5-year age groups 2001

75+ 70-74 65-69 60-64 55-59 50-54 45-49 Age Group 40-44 35-39 30-34 25-29 20-24 15-19 5-9 0-4
1000 800
Male
600
400
200
200
400
Populaton in thousands
Female
600
800
1000
Source: Census of Population and Housing 2001- enumerated population in 18 districts (excludes Jaffna, Mannar, Vavuniya, Mullaitivu, Kilinochchi, Trincomalee and Batticaloa districts)
2005
75+ 70-74 65-69 60-64 55-59 50-54 45-49 Age Group 40-44 35-39 30-34 25-29 20-24 15-19 10-14 5-9 0-4
1500 1000 500 0 500 1000 1500
Male
Populaton in thousands
Female
Source: Department of Census and Statistics Sri Lanka Estimated population 2005
Table 1 General Population: Sex Distribution

Population (000) Male Female Sex ratio1
1
1981 6,497 6,265 103.7
1991 8,792 8,455 104.0
Year
2001 9,267 9,465 97.9
2005 9,718 9,950 97.7
Number of males per 100 females
Source: Department of Census and Statistics
Denominators used for calculations in Cancer Registry

Population (000) Male Female Total Year 1995 9,246 8,890 18,136
1985 8,076 7,766 15,842
1990 8,661 8,332 6,993
2000 9,870 9,489 19,359
2005 9,718 9,950 19,668
Source: Registrar Generals Department and Department of Census and Statistics
Table 2 Statistics on doctors, hospitals and hospital beds

(Government institutions -1980-2005) 1980 2,273 6,573 480 43,389 NA NA NA NA NA 2.9 1985 2,353 6,733 490 44,861 NA NA NA NA NA 2.8 1990 2,757 5,258 422 42,079 509 NA NA NA NA 2.9 Year 1995 5,048 3,593 467 47,665 533 NA NA NA NA 2.9 2000 8,600 2,251 558 57,027 637 82 79 29 NA 2.9 2005 11,152 1,764 608 61,594 701 95 149 29 54 3.2
Doctors Population per doctor Hospitals Beds Cancer Unit beds Maharagama Kandy Galle Anuradhapura Badulla Beds per 1000 population
1 1 2
Includes dental surgeons and medical officers in curative, administrative and preventive services Excludes North and Eastern provinces
Source: Medical Statistics Unit, Ministry of Health
Table 3 - Cancer mortality data 1985-2003

Year Population at risk (000) 15,842 16,993 18,136 18,732 19,014 19,252 Cancer deaths 4,416 4,479 5,710 8,063 7,986 8,393 Crude annual cancer death rate per 100 000 27.9 26.4 31.5 42.9 42.0 43.6 Proportionate mortality rate 4.5 4.6 5.5 7.1 7.1 7.3
1985 1990 1995 2001 2002 2003
Sources: Department of Census and Statistics Registrar Generals Department
Graph 2 - Crude hospital death rates 1996-2003

1000
Crude Rate per 100 000 population
100
Ischaemic heart disease Pulmonary heart disease and disease of the pul. circulation Disease of the G1 tract Neoplasms
10
Cerebrovascular disease All causes
1 1996 1997
1998
1999
Year
2000 2001
2002 2003
Source: Medical Statistics Unit, Ministry of Health

Cause of death 1-027 1-028 1-029
Table 04 - Cancer mortality rates, 2001

ICD No 579 236 CDR Male ASR 8.7 3.6 No 203 210
Female CDR
Malignant neoplasm of lip, oral cavity and pharynx Malignant neoplasm of oesophagus
ASR 3.4 3.5
C00-C14 C15
5.9 2.4
2.1 2.2
1-030 1-031 1-032
Malignant neoplasm of stomach Malignant neoplasm of colon, rectum and anus Malignant neoplasm of liver and intrahepatic bile ducts
C16
218 53 146
2.2 0.5 1.5
3.2 0.8 2.2
219 50 86
2.3 0.5 0.9
3.6 0.8 1.4
C18-C21 C22
1-033
Malignant neoplasm of pancreas Malignant neoplasm of larynx Malignant neoplasm of trachea bronchus and lung
C25
1-034 1-035
C32
22
32
0.2
0.3 4.2
0.3
0.5 6.2
12
0.1
0.0 1.3
0.2
0.0 2.0
1-036
Malignant neoplasm of skin
C33-C34
1-037
Malignant neoplasm of breast Malignant neoplasm of other and unspecified parts of female genital tract Malignant neoplasm of ovary
C43
414
1-038 1-039
Malignant neoplasm of cervix uteri
C50
C53
21
0.0
0.2
0.0
122
0.3
308
0.0
75
3.2
0.0
0.8 1.9
4.7
1.2 3.0
C54-C55
1-040
1-041
Malignant neoplasm of prostate Malignant neoplasm of bladder Malignant neoplasm of meninges, brain and Multiple myeloma and malignant plasma cell Leukaemia
C56
C61
1-042 1-043
C67
55
61 96
0.6
0.6 1.0
0.8
182
86
0.9 1.3
15 71
0.9
0.0
1.3
0.2 0.7
0.3 0.9
1-044 1-045
Non-Hodgkin lymphoma
C70-C72
C82-C85 C90
83 41
0.8 0.4
1.1 0.6
50 27
0.5 0.3
0.8 0.5
1-046
Remainder of malignant neoplasm
1-047
1-026
Remainder of neoplasm Neoplasm
C17, C23-C24, C26-C31, C37-C41, C44-C49, C51-C52, C57-C60, C62-C66, C68-C69, C73-C81, C88, C96-C97
C91-C95
275
2.8
3.3
197
2.1
2.6
C00-D48
D0-D48
1996
4375
43
20.2
44.3
0.4
29.3
63.8
0.5
1730
3688
40
18.2
38.9
0.4
28.0
58.9
0.6
Cancer Incidence Data - 2005 Year 1985
Table 5 - Cancer incidence in Sri Lanka, 1985-2005

Sex Number 2 564 2 448 5 012 2 979 3 084 6 063 3 450 3 875 7 325 5 130 5 795 10 925 6 058 7 314 13 372 % CR ASR 34.9 39.4 37.6 38.6 46.9 43.1 43.6 58.6 51.2 63.7 84.9 74.6 68.1 73.3 70.6 Male Female Total Male Female Total Male Female Total Male Female Total Male Female Total 51.2 48.8 49.1 50.9 47.1 52.9 47.0 53.0 45.3 54.7 31.7 31.5 31.6 34.4 37.0 35.7 37.3 43.6 40.4 52.0 61.1 56.4 62.3 73.4 67.9
1990
1995
2000
2005
CR: Crude rate per 100 000 population ASR: Age standardized rate (per 100 000 world population)
Cancer Incidence in Sri Lanka

80 70 60 50 Crude rate 40 30 20 10 0 1985 1990 1995 Year 2000 2005
Male Female
Table 6 - Overall Cancer Incidence, 2005 by age and sex

Age Group 5-9 0-4 Cases 60 63 Male Population 884 865 Incidence 6.8 7.3 Cases 50 70 Female Population 866 836 Incidence 5.8 8.4 Cases 133 110 Total Population 1750 1701 Incidence 6.3 7.8
45-49 55-59 50-54
40-44
35-39
30-34
25-29
20-24
15-19
10-14
497 747 723
305
180
123
107
90
87
64
583 379 525
661
709
719
739
894
982
913
Total
75+
70-74
65-69
60-64
6058
724
681
766
841
9718
194
165
224
282
341.5 373.2 62.3 411.5
298.6
196.8
137.9
85.4
46.0
25.5
17.1
14.5
10.0
9.0
7.0
1109 786 934
847
633
394
255
194
138
70
59
7314
548
538
689
259 229 189
298
408
547
607
687
746
756
796
915
935
876
9950
239.7 73.4
284.1
264.9
263.4
228.2
202.2
139.9
92.1
52.7
33.7
24.5
15.1
7.5
6.7
13372
1272
1219
1455
1627
1681
1832
1344
938
574
378
301
228
157
123
1348 1072 580 787 1190
1455
1475
1535
1809
1917
1789
19668
423
354
483
300.9 67.9
343.5
300.4
280.5
213.1
170.7
113.2
69.5
39.5
25.6
19.7
12.5
8.2
6.9
Cancer Incidence 2005

400 350 300 Incidence per 100 000 250 200 150 100 50 0 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Age Group
Graph 3 - Cancer vs age 2005
75+ 70-74 65-69 60-64 55-59 50-54 45-49

Age Group
40-44 35-39 30-34 25-29 20-24 15-19 10-14 5-9 0-4 20 15 Male Percentage 10 5 0 5 10 15 Female 20
Incidence Population

Male Site Lip oral cavity and pharynx No CR
Table 7 - Leading cancer sites, 2005

Female ASR 14.1 Site Breast No 1859 CR ASR Site Breast
Rank 1
All No 1908 CR ASR 9.7 9.7
1240 12.7
18.7 18.3
Trachea bronchus 666 and lung Esophagus Colon & Rectum Lymphoma 498 388 360
6.9
7.7
Cervix Uteri
881
8.9
8.9
Lip Oral Cavity & Pharynx Esophagus Cervix Uteri Trachea Bronchus & Lungs Thyroid
1617
8.2
8.7
3 4 5
5.1 4.0 3.7
5.8 4.4 3.9
Ovary Thyroid Esophagus
596 592 524
6.0 6.0 5.3
5.9 5.6 5.5
1022 881
5.2 4.5
5.6 4.6
832 752
4.2 3.8
4.5 3.6
Larynx
324
3.3
3.7
Lip Oral Cavity & Pharynx Colon & Rectum Leukaemia Lymphoma
377
3.8
3.8
7 8 9
Leukaemia Prostate Unknown Primary Site
313 303 257
3.2 3.1 2.7
3.3 3.5 2.9
353 257 243
3.5 2.6 2.4
3.6 2.8 2.5
Colon & Rectum Lymphoma Ovary
741 604 596
3.8 3.1 3.0
3.6 3.3 3.0
10 Brain All Sites
171
1.8
1.8 68.1
Uterus All Sites
237 7314
2.4
2.4
Leukaemia All Sites
570 13372
2.9
3.0
6058 62.3
73.4 73.3
67.9 70.6
CR: Crude rate per 100,000 population
ASR: Age standardised rate per 100,000 world population
Graph 4 - Leading cancer sites, 2005 Male

Lip oral cavity and pharynx Trachea Bronchus and lung Esophagus Colon and rectum Lymphoma Larynx Leukemia Prostate Unknown primary site Brain 0.0
11.0 20.4
2.8
6.8 5.9 5.3 5.2 5.0 4.3
8.2
5.0
10.0
15.0
20.0
25.0
Percentage of all cancers
Female
Breast Cervix uteri Ovary Thyroid Esophagus Lip oral cavity and pharynx Colon and rectum Leukaemia Lymphoma Uterus 0.0
12.1 25.4
5.1 4.8 3.5 3.3 3.2
8.1 8.1 7.2
5.0
10.0
15.0
20.0
25.0
30.0
All
Breast Lip oral cavity and pharynx Esophagus Cervix uteri Trachea bronchus and lung Colon and rectum Thyroid Lymphoma Ovary Leukemia
12.1 14.3
0.0
2.0
4.0
4.5 4.4 4.3
6.6 6.2 5.7 5.6
7.6
6.0
8.0
10.0
12.0
14.0 16.0
10
Cancer Incidence Data - 2005 0-14 years
Graph 6 - Leading cancers by age group
Male 0-14 Years 187 cases

Leukaemia Lymphoma Brain 18.2 35.8
Bones joints & articular cartilage of limbs Connective subcutaneous and other soft tissues Bones joints & articular cartilage of other & unsp Thyroid gland 0 Kidney Testis
Eye and adnexa
2.7 2.1
3.2
4.3
5.3
16.0
2.7
2.1 5 10 15 20 25 30 35 40
Female 0-14 Years 179 cases

Leukaemia Brain Lymphoma Eye and adnexa 14.0 34.1
Connective subcutaneous and other soft tissues Thyroid Ovary
Bones joints & articular cartilage of limbs
3.9 3.4 5
5.0 3.9
6.1
7.8
10.6
Bones joints & articular cartilage of other & unsp 0
Adrenal gland
2.8
10
15
20
25
30
35
40
11

Lymphoma Leukaemia Brain Thyroid Testis Colon and rectum Bones joints and articular cartilage of limbs Lip oral cavity and pharynx Connective subcutaneous and other soft tissues Bronchus and lung Parotid and major salivary glands 0 2 17.7 17.7
2.9 2.0 4
5.9 5.4 5.2 4.9 4.4
10.1 9.8
10
12 14
16 18 20

Thyroid Breast Ovary Placenta Leukaemia Lymphoma Brain Cervix uteri Connective subcutaneous and other soft tissues Lip oral cavity and pharynx 0 14.1 26.1
3.8 2.3 2.1 2.3 5
9.6 8.5 7.9 7.9
10
15
20
25
30
12

Lip oral cavity and pharynx Leukaemia Bronchus and lung Lymphoma Colon and rectum Esophagus Brain Unknown primary site Thyroid Larynx Stomach 0 10.0 9.3 8.4 20.8
6.4 5.7 4.4 4.0 3.8 3.5 3.1 5
10
15
20
25

Breast Cervix uteria Thyroid Ovary Colon and rectum Esophagus Lip oral cavity and pharynx Uterus Leukaemia Lymphoma Brain 0 13.0 11.3 34.6
3.9 3.2 3.0 2.7 2.3 2.2 1.9 5
8.8
10
15
20
25
30
35
40
13
Male
50-64 Years 2312 cases

Lip oral cavity and pharynx Bronchus and Lung Esophagus Larynx Colon and rectum Unknown primary site Lymphoma Prostate Leukaemia Stomach 0 14.2 21,6
6.4 6.3 5.1 4.0 3.3 3.3 3.0 5
9.5
10
15
20
25
Female
50-64 Years 2822 cases

Breast Cervix uteria Ovary Esophagus Lip oral cavity and pharynx Thyroid Colon and rectum Uterus Leukaemia Bronchus and lung Lymphoma 0 13.8 28.6
5.4 5.0 4.9 4.5 2.8 2.6 2.6 5
8.6 8.0
10
15
20
25
30
35
14
Cancer Incidence Data - 2005 65 years and above
Male
65 years and above 2169 cases

Lip oral cavity and pharynx Bronchus and Lung Esophagus Prostate Colon and rectum Larynx Unknown primary site Lymphoma Leukaemia Multiple myeloma 0 10.8 10.2 10.1 23,6
4.4 3.6 3.1 3.0 5
7.2 6.4
10
15
20
25
Female 65 years and above 1772 cases

Breast Cervix uteri Esophagus Lip oral cavity and pharynx Colon and rectum Ovary Leukaemia Thyroid Lymphoma Multiple myeloma 0 13.2 12.9 17.4
3.6 3.4 3.2 3.0 5
8.6 7.0 6.6
10
15
20
15
Graph 7 - Age Standardised Rate, 1985-2005 ASR (W) of cancer 1985-2005 - Sri Lanka
90 80 ASR(W) per 100 000 population 70 60 50 40 30 20 10 0 1985 1990 1995 2000 2005
39.4 37.6 34.9 46.9 43.1 38.6 58.6 51.2 43.6 84.9 74.6 63.7 73.3 70.6 68.1
Male Female Total
16
Graph 8 - Percentage changes in Age Standardised Rates (ASR) for selected cancers, 1995-2005
(ASR based on World Population)
Male
Trachea bronchus and lung Colon and rectum Prostae Esophagus Lip oral cavity and phrynx Brain Thyroid Bladder Larynx Tongue -1 -0.5 0 0.5 1 1.5 2 2.5 3
Female
Breast Thyroid Colon and rectum Uterus Trachea bronchus and lung Overy Cervix uteri Esophagus Lip oral cavity and pharynx -4 -2 0 2 4 6
17
Table 8 - Cancer cases by ethnicity, sex and sub-site, 2005

ICD O-Code Lip C00.0 C00.1 C00.6 C00.8 C00.9 All Sinhala Tamil Muslim Other
Male 4 14 0 1 7 67 1 218 40 37 24 65 7 33 1 1 32 248 3
Female 1 9 1 0 0 16 0 51 14 17 12 17 4 2 0 0 9 113 0
Male 3 13 0 0 5 58 0 181 36 33 21 54 7 30 1 1 25 215 3
Female 1 5 1 0 0 10 0 41 13 10 11 10 2 2 0 0 7 70 0
Male
Female 0 4 0 0 0 6 0 7 0 6 1 5 1 0 0 0 1 34 0
Male 1 0 0 1 0 2 0 7 1 0 0 1 0 2 0 0 2 9 0
Female 0 0 0 0 0 0 0 3 1 1 0 2 1 0 0 0 1 8 0
Male
Female 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
External upper lip External lower lip Commissure of lip Overlapping lesion of lip Lip, NOS
0 1 0 0 2 7 1 30 3 4 3 10 0 1 0 0 5 24 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Base of tongue C01.9 Base of tongue, NOS Other and unspecified parts of tongue C02.2 Ventral surface of tongue, NOS C02.9 Tongue, NOS Gum C03.0 C03.1 C03.9 Upper gum Lower gum Gum, NOS
Floor of mouth C04.9 Floor of mouth, NOS Palate C05.0 C05.1 C05.2 C05.8 C05.9 Hard palate Soft palate Uvula Overlapping lesion of palate Palate, NOS
Other and unspecified parts of mouth C06.0 Cheek mucosa C06.1 Vestibule of mouth C06.2 C06.9 Retromolar area Mouth, NOS
32
29
23
24
Parotid gland C07.9 Parotid gland
37
23 5 2 15 1 4 0 14
33 8 4 97 16 19 1 16 125
19 5 1 13 0 2 0 9 14
3 0 0 6 3 1 0 2 14
3 0 1 2 1 2 0 3 9
1 0 0 1 0 0 0 2 7
1 0 0 0 0 0 0 2 0
0 0 0 1 0 0 0 0 1
0 0 0 0 0 0 0 0 0
Other and unspecified major salivary glands C08.0 Submandibular gland 8 C08.9 Major salivary gland, NOS 4 Tonsil C09.9 Tonsil, NOS 105 19 20 1 20 147
Oropharynx C10.0 Vallecula C10.9 Oropharynx Nasopharynx C11.3 Anterior wall of nasopharynx C11.9 Nasopharynx Pyriform fossa C12.9 Pyriform sinus
18

ICD O-Code Hypopharynx C13.0 Postcricoid region C13.2 Posterior wall of hypopharynx C13.9 Hypopharynx, NOS Male 23 0 4 All Female 23 1 4 Male 18 0 2 31 1 4 21 32 367 11 2 2 115 4 1 0 5 12 4 3 1 1 1 1 20 75 17 195 11 7 2 102 9 3 4 8 1 Sinhala Female 20 1 4 6 0 5 35 20 349 6 2 0 37 3 1 2 5 11 3 7 0 6 0 0 24 84 11 173 7 2 1 41 13 13 7 3 0 Male Tamil Female 2 0 0 5 0 1 8 9 84 1 0 0 13 0 0 0 1 0 0 0 0 1 0 0 4 4 2 6 0 2 0 2 0 4 2 1 0 Male 2 0 1 3 0 0 2 2 10 0 0 0 8 0 0 0 0 1 0 0 0 1 0 1 3 8 0 12 1 1 0 5 1 0 0 1 0 Muslim Female 1 0 0 1 0 0 0 1 12 0 0 0 1 0 0 0 2 0 0 1 0 1 0 0 1 2 1 10 0 0 0 3 1 1 1 0 0 Male Other Female 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
3 0 1 3 0 1 4 6 47 0 0 0 16 2 0 0 1 1 0 0 0 1 0 0 3 7 3 14 1 0 0 3 1 2 2 1 0
0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 1 0 0 1 0 0 0 0 0
Other and ill defined sites in lip oral cavity and pharynx C14.0 Pharynx, NOS 37 12 Esophagus C15.0 Cervical esophagus C15.3 Upper third of esophagus C15.4 Middle third of esophagus C15.5 Lower third of esophagus C15.9 Esophagus, NOS Stomach C16.0 Cardia. NOS C16.3 Gastric antrum C16.4 Pylorus C16.9 Stomach, NOS Small intestine C17.0 Duodenum C17.1 Jejunum C17.2 Ileum C17.9 Small intestine, NOS Colon C18.0 C18.1 C18.2 C18.3 C18.4 C18.5 C18.6 C18.7 C18.9 Caecum Appendix Ascending colon Hepatic flexure of colon Transverse colon Splenic flexure of colon Descending colon Sigmoid colon Colon, NOS 1 5 27 40 425 11 2 2 139 6 1 0 6 14 4 3 1 3 1 2 26 92 20 222 14 8 2 111 11 5 0 6 43 30 445 7 2 0 51 3 1 2 8 11 3 8 0 8 0 0 29 91 14 189 7 4 1 46 14 18 10 4 0
Rectosigmoid junction C19.9 Rectosigmoid junction Rectum C20.9 Rectum, NOS Anus and anal canal C21.0 Anus, NOS C21.1 Anal canal C21.8 Overlapping lesion of rectum, anus and anal canal Liver and intrahepatic bile ducts C22.0 Liver C22.1 Intrahepatic bile duct Gallbladder C23.9 Gallbladder
Other and unspecified parts of biliary tract C24.0 Extrahepatic bile duct 6 C24.1 Ampulla of Vater 10 C24.9 Billiary tract 1
19

ICD O-Code Pancreas C25.0 Head of pancreas C25.9 Pancreas, NOS Other and ill-defined digestive organs C26.0 Intestinal tract, NOS C26.9 Gastrointestinal tract, NOS Nasal cavity and middle ear C30.0 Nasal cavity C30.1 Middle ear Accessory sinus C31.0 Maxillary sinus C31.1 Ethmoid sinus C31.2 Frontal sinus C31.3 Sphenoid sinus C31.9 Accessary sinus , NOS Larynx C32.0 C32.1 C32.2 C32.3 C32.9 Glottis Supraglottis Subglottis Laryngeal cartilage Larynx, NOS Male 19 26 1 7 12 2 24 0 1 1 4 154 81 3 3 83 1 5 3 2 0 655 4 11 1 2 All Female 12 20 0 2 5 1 6 1 0 1 2 22 9 0 0 10 2 1 2 1 1 159 5 4 0 0 Male 17 22 1 6 11 2 20 0 1 1 3 138 69 3 3 72 1 2 3 2 0 566 3 10 1 2 Sinhala Female 11 18 0 2 4 1 3 1 0 1 1 18 7 0 0 8 2 1 2 1 0 135 5 3 0 0 Male Tamil Female 1 2 0 0 0 0 2 0 0 0 1 3 2 0 0 2 0 0 0 0 0 13 0 1 0 0 Male 2 1 0 0 0 0 2 0 0 0 0 5 1 0 0 4 0 2 0 0 0 57 0 1 0 0 Muslim Female 0 0 0 0 1 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 1 10 0 0 0 0 Male Other Female 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
0 3 0 1 1 0 2 0 0 0 1 11 12 0 0 7 0 1 0 0 0 32 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Trachea C33.9 Trachea Bronchus and lung C34.0 Main bronchus C34.1 Upper lobe, lung C34.2 Middle lobe, lung C34.3 Lower lobe, lung C34.9 Lung, NOS Thymus C37.9 Thymus Heart, mediastinum and pleura C38.3 Mediastinum, NOS C38.4 Pleura, NOS C38.8 Overlapping lesion of heart, mediastinum and pleura Other and ill defined sites within respiratory system and intrathoracic organs C39.9 Ill-defined sites within respiratory system
Bones, joints and articular cartilage of limbs C40.0 Long bones of upper limb, scapula and associated joints 3 C40.1 Short bones of upper limb, and associated joints 2 C40.2 Long bones of lower limb and associated joints 24 C40.9 Bones of limb, NOS 5
2 2 21 7
3 2 21 5
2 2 15 5
0 0 1 0
0 0 2 1
0 0 2 0
0 0 3 1
0 0 0 0
0 0 0 0
20

ICD O-Code Bones, joints and articular cartilage of other and unspecified sites C41.0 Bones of skull and face and associated joints C41.1 Mandible C41.2 Vertebral column C41.3 Rib, sternum, clavicle and associated joints C41.4 Pelvic bones, sacrum, coccyx and associated joints C41.9 Bone, NOS Haemopoetic and reticuloendothelial systems C42.1 Bone marrow C42.2 Spleen Skin C44.0 C44.1 C44.2 C44.3 C44.4 C44.5 C44.6 C44.7 C44.9 Skin of lip, NOS Eyelid External ear Skin of other and unspecified parts of face Skin of scalp and neck Skin of trunk Skin of upper limb and shoulder Skin of lower limb and hip Skin, NOS Male All Female Male Sinhala Female Male Tamil Female Male Muslim Female Male Other Female
1 2 11 2 3 5
3 2 1 3 4 6
1 0 10 2 2 5
2 2 1 2 4 5
0 2 1 0 1 0
0 0 0 1 0 1
0 0 0 0 0 0
1 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
506 3 3 4 7 8 5 14 8 53 21
417 2 2 2 5 14 5 9 5 22 14
431 3 1 4 7 7 3 9 8 48 18
368 1 2 1 5 13 5 8 5 16 12
44 0 2 0 0 1 1 5 0 5 1
27 1 0 1 0 0 0 1 0 4 1
30 0 0 0 0 0 1 0 0 0 1
21 0 0 0 0 1 0 0 0 2 1
1 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 0
Peripheral nerves and autonomic nervous system C47.0 of head C47.1 of upper limb and shoulder C47.2 of lower limb and hip C47.3 of thorax C47.5 of pelvis C47.6 of trunk, NOS C47.9 Autonomic nervous system, NOS Retroperitoneum and peritoneum C48.0 Retroperitoneum C48.2 Peritoneum, NOS Connective subcutaneous and other soft tissues C49.0 C49.1 C49.2 C49.3 C49.4 C49.5 C49.9
1 1 1 1 1 1 3 4 1 7 10 23 1 2 3 23 0 0 1 48 -
1 1 0 1 1 0 12 11 1 10 7 19 6 5 2 24 1 1 0 1857 1 23
1 1 1 1 1 1 3 4 1 7 8 21 1 2 2 19 0 0 1 38 -
1 1 0 0 1 0 11 7 1 10 6 17 5 5 1 18 1 1 0 1568 1 21
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 6 -
0 0 0 1 0 0 1 3 0 0 1 2 0 0 1 4 0 0 0 186 0 2
0 0 0 0 0 0 0 0 0 0 2 2 0 0 1 2 0 0 0 4 -
0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 2 0 0 0 98 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 0 0
of head, face, and neck of upper limb and shoulder of lower limb and hip of thorax of abdomen of pelvis NOS Nipple Upper outer quadrant of breast Axillary tail of breast Breast, NOS Labium majus Vulva, NOS
Breast C50.0 C50.4 C50.6 C50.9 Vulva C51.0 C51.9
21

ICD O-Code Vagina C52.9 Vagina, NOS Cervix uteri C53.0 Endocervix C53.9 Cervix uteri Corpus uteri C54.1 Endometrium C54.2 Myometrium C54.9 Corpus Uteri Uterus, NOS C55.9 Uterus, NOS Ovary C56.9 Ovary Male All Female 29 3 878 7 1 176 53 596 Male Sinhala Female 25 3 731 7 1 158 49 536 Male Tamil Female 2 0 128 0 0 9 2 36 Male Muslim Female 2 0 18 0 0 8 2 24 Male Other Female 0 0 1 0 0 0 0 0
Other and unspecified female genital organs C57.0 Fallopian tube C57.9 Female genital tract, NOS Placenta C58.9 Placenta Penis C60.0 C60.9 Prepuce Penis, NOS
1 73 303 14 1 42 69 1 121 0 0 4 8 1 1 1 2
5 1 77 31 0 35 1 1 1 14 1 0 2 5
1 59 272 10 0 41 59 1 104 0 0 4 6 1 1 1 2
5 1 65 24 0 32 1 1 1 13 1 0 2 4
0 10 21 2 0 1 2 0 8 0 0 0 0 0 0 0 0
0 0 5 4 0 3 0 0 0 0 0 0 0 1
0 4 10 2 1 0 8 0 9 0 0 0 2 0 0 0 0
0 0 6 3 0 0 0 0 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 1 0 0 0 0 0 0 0 0 0 0 0
Prostate gland C61.9 Prostate gland Testis C62.0 C62.1 C62.9 Undescended testes Descended testes Testis, NOS
Kidney C64.9 Kidney Renal pelvis C65.9 Renal pelvis Bladder C67.9 Bladder, NOS Other and unspecified urinary organs C68.0 Urethra C68.1 Paraurethral gland Eye and adnexa C69.0 Conjunctiva C69.2 Retina C69.3 Choroid C69.5 Lacrimal gland C69.6 Orbit, NOS C69.9 Eye, NOS
22

ICD O-Code Meninges C70.1 Spinal meninges C70.9 Meninges, NOS Brain C71.0 C71.1 C71.2 C71.3 C71.4 C71.5 C71.6 C71.7 C71.8 C71.9 Cerebrum Frontal lobe Temporal lobe Parietal lobe Occipital lobe Ventricle, NOS Cerebellum, NOS Brain stem Overlapping lesion of brain Brain , NOS Male 0 6 1 9 12 8 6 0 11 4 3 117 All Female 1 5 2 11 6 7 7 1 9 5 0 83 Male 0 6 1 8 12 7 2 0 7 4 3 104 Sinhala Female 1 5 2 9 3 6 7 1 7 5 0 75 Male Tamil Female 0 0 0 1 1 0 0 0 2 0 0 5 Male 0 0 0 0 0 0 0 0 3 0 0 6 Muslim Female 0 0 0 1 2 1 0 0 0 0 0 3 Male Other Female 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 1 0 1 4 0 1 0 0 6
0 0 0 0 0 0 0 0 0 0 0 1
Spinal cord, cranial nerves and other parts of central nervous system C72.0 Spinal cord C72.1 Cauda equine C72.2 Olfactory nerve C72.9 Nervous system, NOS Thyroid gland C73.9 Thyroid Gland Adrenal gland C74.0 Cortex of adrenal gland C74.1 Medulla of adrenal gland C74.9 Adrenal gland, NOS Other endocrine glands and related structures C75.1 Pituitary gland C75.2 Craniopharyngeal duct C75.3 Pineal gland Other and ill-defined sites C76.0 Head, face or neck, NOS C76.1 Thorax, NOS C76.2 Abdomen, NOS C76.3 Pelvis, C76.8 Overlapping lesion of ill defined sites Lymph nodes C77.0 Lymph nodes of head, face and neck C77.1 Intrathoracic lymph nodes C77.2 Intra-abdominal lymph nodes C77.3 Lymph nodes of axilla or arm C77.4 Lymph nodes of inguinal region or leg C77.5 Pelvic lymph nodes C77.9 Lymph node, NOS Unknown primary site C80.9 Unknown primary site Total
6 0 2 0 160 1 3 5
0 1 1 1 592 5 3 7
5 0 2 0 139 0 2 4
0 1 1 1 535 5 3 7
0 0 0 0 12 0 1 0
0 0 0 0 34 0 0 0
1 0 0 0 9 1 0 1
0 0 0 0 22 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 1 0 0 0
1 5 2 1 1 4 0 2
5 1 2 4 0 3 1 1
1 4 2 1 1 2 1
3 1 2 4 0 2 1 1
0 1 0 0 0 2 0
1 0 0 0 0 1 0 0
0 0 0 0 0 0 1
1 0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
9 1 0 3 2 1 335 257 6058
8 0 2 3 0 0 222 138 7314
8 1 0 3 2 0 279 226 5207
8 0 2 3 0 0 192 111 6199
1 0 0 0 0 0 28 22 523
0 0 0 0 0 0 17 20 780
0 0 0 0 0 0 26 9 315
0 0 0 0 0 0 13 7 321
0 0 0 0 0 1 2 0 13
0 0 0 0 0 0 0 0 13
23
Table 9 - Cancer cases by age group Males, 2005

ICD-O Code All Lip C00.0 C00.1 C00.8 C00.9 External upper lip External lower lip Overlapping lesion of lip Lip, NOS 4 14 1 7 67 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 1 1 2 8 1 2 1 7 1 2 1
2 1 13
1 1 6
4 1
Base of tongue C01.9 Base of tongue, NOS Other and unspecified parts of tongue C02.2 Ventral surface of tongue, NOS C02.9 Tongue, NOS Gum C03.0 C03.1 C03.9 Upper gum Lower gum Gum, NOS
8 10
1 218 40 37 24 65 7 33 1 1 32 1
1 1
5 1 1
22 1 1 2 4
19 2 2 1 10 1 5
35 4 2 2 9 2 4 4
1 28 7 4 2 5
35 3 8 4 11 1 3 1 3
20 3 5 3 13
26 26 6 11 7 7 6 4 6 2 3 9 3 1 5 1 4
Floor of mouth C04.9 Floor of mouth, NOS Palate C05.0 C05.1 C05.2 C05.8 C05.9 Hard palate Soft palate Uvula Overlapping lesion of palate Palate, NOS
1 1 1
1 1
1 1
5 4
5 4
Other and unspecified parts of mouth C06.0 Cheek mucosa C06.1 C06.2 C06.9 Vestibule of mouth Retromolar area Mouth, NOS
248 3 32 29 37 1 1 3
2 1
6 1
11 2
12 2 1 2
25 4 5 4
24 3 2 4
46 5 5 2
39 3 4 5
35 47 1 7 8 5 1 5 4 2
Parotid gland C07.9 Parotid gland Other and unspecified major salivary glands C08.0 Submandibular gland C08.9 Major salivary gland, NOS Tonsil C09.9 Tonsil, NOS
8 4 105 19 20
1 6 1
1 14 1 2
1 18 6 3 1 1 14 5 6
2 1 7 16 1 1 2 5
12 1 2
18 2 1
Oropharynx C10.0 Vallecula C10.9 Oropharynx
Nasopharynx C11.3 Anterior wall of nasopharynx 1 C11.9 Nasopharynx 20
24

ICD-O Code All Pyriform sinus C12.9 Pyriform sinus Hypopharynx C13.0 Postcricoid region C13.9 Hypopharynx, NOS Other and Ill-defined sites in Lip, Oral Cavity and Pharynx C14.0 Pharynx, NOS Oesophagus C15.0 Cervical esophagus C15.3 Upper third of esophagus C15.4 Middle third of esophagus C15.5 Lower third of esophagus C15.9 Esophagus, NOS Stomach C16.0 Cardia. NOS C16.3 Gastric antrum C16.4 Pylorus C16.9 Stomach, NOS Small intestine C17.0 Duodenum C17.1 Jejunum C17.9 Small intestine, NOS Colon C18.0 C18.1 C18.2 C18.3 C18.4 C18.5 C18.6 C18.7 C18.9 Caecum Appendix Ascending colon Hepatic flexure of colon Transverse colon Splenic flexure of colon Descending colon Sigmoid colon Colon, NOS 147 23 4 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 4 2 5 2 12 3 1 22 3 1 16 5 27 2 24 2 1 20 14 5 1 1
37 1 5 27 40 425 11 2 2 139 6 1 6 14 4 3 1 3 1 2 26 92 20 222 1 1 4 5 1
1 2 4
1 3 2 3 8 3 3 4 2 3 1 2 3 5 6 11 4 6 12 31 52 75 64 84 39 63 1 12 1 1 1 3 1 31 1 2 3 1 1 2 1 1 1 1 1 17 1 2 16 4 20 1 1 1 1 18 1 8 1
1 1 1 3 1 1 2 1 4 12
1 1 1 1 4 1 6 1 8 2 5 1 2 2 1 1 1 2 1 8 1 8 22 3 3
1 1 1 1 1 1 5 4 3 8 13 17 15 2 22 2 1 4 25 3 1 30 1 1 2 32
4 6 2
5 8 7
Recto-sigmoid junction C19.9 Rectosigmoid juntion Rectum C20.9 Rectum, NOS
32 35 1 1 3 1
Anus and anal canal C21.0 Anus, NOS 14 C21.1 Anal canal 8 C21.8 Overlapping lesion of rectum, anus and anal canal Liver and intrahepatic bileducts C22.0 Liver C22.1 Intrahepatic bile duct Gallbladder C23.9 Gallbladder 111 11 5
1 1
7 1
20
26 2 1
12 15 17 1 2 1 1 2
25

ICD-O Code Other and unspecified parts of biliary tract C24.0 Extrahepatic bile duct C24.1 Ampulla of Vater C24.9 Billiary tract Pancreas C25.0 Head of pancreas C25.9 Pancreas, NOS Other and ill defined digestive organs C26.0 Intestinal tract, NOS C26.9 Gastrointestinal tract, NOS Nasal cavity and middle ear C30.0 Nasal cavity C30.1 Middle ear Accessory sinuses C31.0 Maxillary sinus C31.2 Frontal sinus C31.3 Sphenoid sinus C31.9 Accessary sinus, NOS Larynx C32.0 C32.1 C32.2 C32.3 C32.9 Glottis Supraglottis Subglottis Laryngeal cartilage Larynx, NOS All 6 10 1 19 26 1 7 12 2 24 1 1 4 154 81 3 3 83 1 5 3 2 655 4 11 1 2 1 1 1 1 3 1 3 1 1 4 7 15 29 3 1 1 1 1 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 1 4 3 1
2 1 2 3 2 1
5 7
1 4
1 2
3 3
1 1 1
1 2
1 2
2 3 1 3 1 2 1
1 1 1
1 1 1
1 1 1 1 3 3 2
4 1
2 1
1 1 1
9 27 7 17 1 7 11
20 9 11
29 10 15
24 20 21 9 15 10 1 1 1 2 15 11 8 1 1 1 64 64
Trachea C33.9 Trachea Bronchus and lungs C34.0 Main bronchus C34.1 Upper lobe, lung C34.2 Middle lobe, lung C34.9 Lung, NOS Thymus C37.9 Thymus Heart, mediastinum, and pleura C38.3 Mediastinum, NOS C38.4 Pleura, NOS C38.8 Overlapping lesion of heart, mediastinum and pleura Other and ill defined sites within respiratory system and intra thoracic organs C39.9 Ill defined sites within respiratory system
1 45
1 97 102 122 105 2 1 1
26

ICD-O Code Bones, joints and articular cartilage of limbs C40.0 Long bones of upper limb, scapula and associated joints 3 C40.1 Short bones of upper limb, and associated joints 2 C40.2 Long bones of lower limb and associated joints 24 C40.9 Bones of limb , NOS 5 Bones, joints and articular cartilage of other and unspecified sites C41.0 Bones of skull and face and associated joints C41.1 Mandible C41.2 Vertebral column C41.3 Rib, sternum, clavicle and associated joints C41.4 Pelvic bones, sacrum, coccyx and associated joints C41.9 Bone, NOS Bone marrow C42.1 Bone marrow Spleen C42.2 Skin C44.0 C44.1 C44.2 C44.3 C44.4 C44.5 C44.6 C44.7 C44.9 Spleen All 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
2 1 1 3 1 3 10 2 5 1 1 1 1 1
1 2 11 2 3 5 506 3 24
2 1 1 24 20
2 1 1
1 1 1 2 1 1 1 1
1 23 1 15 23 16
1 31
1 1 43 43 45 2 43
1 39 47
23
47
Skin of lip, NOS 3 Eyelid 4 External ear 7 Skin of other and unspecified parts of face 8 Skin of scalp and neck 5 Skin of trunk 14 Skin of upper limb and shoulder8 Skin of lower limb and hip 53 Skin, NOS 21
1 1 1 1 1 2 1
1 1 1 2 1 7 4
1 1
1 1 2 9 3 1 6 1 2 2 7 5
2 1
2 1 4 1 3 2
1 1 1 9 2
1 8 3
4 1 5 1
Peripheral nerves and autonomic nervous System C47.0 of head C47.1 of upper limb and shoulder C47.2 of lower limb and hip C47.3 of thorax C47.5 of pelvis C47.6 of trunk, NOS C47.9 Autonomic nervous system, NOS Retroperitoneum and peritoneum C48.0 Retroperitoneum C48.2 Peritoneum, NOS C48.8 Overlapping lesion of retroperitoneum and peritoneum
1 1 1 1 1 1 3 4
1 1 1 1 1
1 1
1 1 1 2
27

ICD-O Code All Connective, subcutaneous and other soft tissues C49.0 of head, face, and neck 7 C49.1 of upper limb and shoulder 10 C49.2 of lower limb and hip 23 C49.3 of thorax 1 C49.4 of abdomen 2 C49.5 of pelvis 3 C49.9 NOS 23 Breast C50.6 C50.9 Penis C60.0 C60.9 Axillary tail of breast Breast ,NOS Prepuce Penis, NOS 1 48 1 73 303 14 1 42 69 1 121 4 8 1 1 1 2 6 1 1 3 1 7 1 2 8 1 1 1 6 7 14 1 1 1 1 2 2 1 1 14 1 22 1 4 3 1 1 1 1 2 1 1 2 3 7 2 5 2 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
2 1
1 3
1 2 2 1
1 1
1 1 1
2 1 3
1 1 2
1 3
3 2 1
1 1 2
2 1 1
1 2
1 4 11
6 1 13 28 1
10
1 1 3 4 2
2 2 1 5 3
7 5 1 3 10
16 14
4 35
6 51
10 10 75 92
Prostate gland C61.9 Prostate gland Testis C62.0 C62.1 C62.9 Undescended testes Descended testes Testis, NOS
3 10
5 11
1 10 8 1 15 1 25 15 1 5 3
Kidney C64.9 Kidney Renal pelvis C65.9 Renal pelvis Bladder C67.9 Bladder, NOS Eye and adnexa C69.0 Conjunctiva C69.2 Retina C69.3 Choroid C69.5 Lacrimal gland C69.6 Orbit, NOS C69.9 Eye, NOS Meninges C70.9 Meninges, NOS Brain C71.0 C71.1 C71.2 C71.3 C71.4 C71.6 C71.7 C71.8 C71.9
1 1
Cerebrum 1 Frontal lobe 9 Temporal lobe 12 Parietal lobe 8 Occipital lobe 6 Cerebellum, NOS 11 Brain stem 4 Overlapping lesion of brain 3 Brain , NOS 117
2 1
3 2
2 1 1
1 1
2 1
3 2
1 1 5 7
1 4 2
1 2 2 1
1 1 3
2 6 10 12
1 8 13
14
28

ICD-O Code All Spinal cord, cranial nerves and other parts of central nervous system C72.0 Spinal cord 6 C72.2 Olfactory nerve 2 Thyroid gland C73.9 Thyroid Gland Adrenal gland C74.0 Cortex of adrenal gland C74.1 Medulla of adrenal gland C74.9 Adrenal Gland Other endocrine glands and related structures C75.1 Pituitary gland C75.2 Craniopharyngeal duct C75.3 Pineal gland Other and ill defined sites C76.0 Head, face or neck, NOS C76.1 Thorax, NOS C76.2 Abdomen, NOS C76.8 Overlapping lesion of ill defined sites 160 1 3 5 2 2 2 9 14 15 7 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
2 10
20
14
13
26
12 10 1
1 5 2 1 1 4 2
1 1
1 1
1 1
1 1
Lymph nodes C77.0 Lymph nodes of head, face and neck 9 C77.1 Intrathoracic lymph nodes 1 C77.3 Lymph nodes of axilla or arm 3 C77.4 Lymph nodes of inguinal region or leg 2 C77.5 Pelvic lymph nodes 1 C77.9 Lymph node, NOS 335 Unknown Primary Site C80.9 Unknown primary site All sites 257 6058
1 1 7
1 1
1 1
1 12 11 1 20 1 87 14 19 13 1 3 24 4 21 11
1 34 24 25 42 26 40 37 34 23 41 22 27 27 28
63
60 64
90 107 123 180 305 497 723 747 841 766 681 724
29

ICD-O Code
Table 10 - Cancer cases by age group Females, 2005

Age Group All 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 1
Lip C00.0 C00.1 C00.6
External upper lip External lower lip Commissure of lip
1 9 1 16 2
2 1 5 2
Base of tongue C01.9 Base of tongue, NOS Other and unspecified parts of tongue C02.9 Tongue, NOS Gum C03.0 C03.1 C03.9 Upper gum Lower gum Gum, NOS
51 14 17 12 17 4 2 9
1 1
8 2 1
13
8 2 2 2 5
8 2 4 1 2
3 4 5 2 1
3 3 8 2 1 1 1
2 6
Floor of mouth C04.9 Floor of mouth, NOS Palate C05.0 C05.1 C05.9 Hard palate Soft palate Palate, NOS
1 2 1
1 3
Other and unspecified parts of mouth C06.0 Cheek mucosa C06.2 Retromolar area C06.9 Mouth, NOS Parotid gland C07.9 Parotid gland Other and unspecified major salivary glands C08.0 Submandibular gland C08.9 Major salivary gland, NOS Tonsil C09.9 Tonsil, NOS
113 7 7 23 1 1
12
13 1 1 2
14 1
13 1 3
13 1 1
17 23 4 1 2 2 1 2
5 2 15 1 4 14 23 23 1 4 1 3 2 1 2 1
2 3
1 1
Oropharynx C10.0 Vallecula C10.9 Oropharynx Nasopharynx C11.9 Nasopharynx Pyriform sinus C12.9 Pyriform sinus Hypopharynx C13.0 Postcricoid region C13.2 Posterior wall of hypopharynx C13.9 Hypopharynx, NOS
1 3
1 2 4 3 1 2 2 1 1 1 5 1
1 2 2 1
3 1 1 1
3 6
1 6 2
30

ICD-O Code All Other and Ill-defined sites of Lip, oral Cavity and pharynx C14.0 Pharynx, NOS Esophagus C15.3 Upper third of esophagus C15.4 Middle third of esophagus C15.5 Lower third of esophagus C15.9 Esophagus, NOS Stomach C16.0 Cardia, NOS C16.3 Gastric antrum C16.9 Stomach, NOS Small intestine C17.0 Duodenum C17.1 Jejunum C17.2 Ileum C17.9 Small intestine, NOS Colon C18.0 C18.1 C18.2 C18.4 C18.7 C18.9 Caecum Appendix Ascending colon Transverse colon Sigmoid colon Colon, NOS 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
12 6 43 30 445 7 2 51 3 1 2 8 11 3 8 8 29 91 14 189 7 4 1 46 14 18 3 1 1 1 1 3 2 1 3 1 2 13
4 1 1 6 5 9 4 63 59 2 1 6 1 1 1
1 2 5 8
1 6 5 5 29 61
1 2 8 5 9 1 1 5 68 69 68 2 2 11
1 3
7 1
10 1 1 1 1
3 2 2 1 12 1 17
2 4 1 2 4 8 5 27
1 1 1
1 2 1 3 2 1 6
1 1 13 2 15
1 3 11 2 30 2
2 2 4 6 12 10 2 23 1 1 25
2 1 1 1 3 6 10 10
Recto-sigmoid junction C19.9 Rectosigmoid junction Rectum C20.9 Rectum, NOS Anus and anal canal C21.0 Anus, NOS C21.1 Anal canal C21.8 Overlapping lesion of rectum, anus and anal canal Liver and intrahepatic bile ducts C22.0 Liver C22.1 Intrahepatic bile duct Gallbladder C23.9 Gallbladder Other and unspecified parts of biliary tract C24.0 Extrahepatic bile duct C24.1 Ampulla of Vater Pancreas C25.0 Head of pancreas C25.9 Pancreas, NOS
18 23 3 1
1 5 1 4 5 3 3 8 2 2 6 2 2 4 1 7 1 2 2 2 2
1 1
10 4 12 20
1 1
1 2
1 1 2
5 4
2 1
3 1
1 1
31

ICD-O Code All Other and ill-defined digestive organs C26.9 Gastrointestinal tract, NOS Nasal cavity and middle ear C30.0 Nasal cavity C30.1 Middle ear Accessory sinuses C31.0 Maxillary sinus C31.1 Ethmoid sinus C31.3 Sphenoid sinus C31.9 Accessary sinus , NOS Larynx C32.0 Glottis C32.1 Supraglottis C32.9 Larynx, NOS Trachea C33.9 Trachea Bronchus and lungs C34.0 Main bronchus C34.1 Upper lobe, lung C34.2 Middle lobe, lung C34.3 Lower lobe, lung C34.9 Lung, NOS Thymus C37.9 Thymus Heart, mediastinum, and pleura C38.3 Mediastinum, NOS 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
2 5 1 6 1 1 2 22 9 10 2 1 2 1 1 159 5 4 1 3 1 1 1
1 1 1 2 1
1 1 1 2 2 1
2 1 1 1 1
4 2 2
4 1
3 3 2
3 1 2
1 1 1 3 1 5 1 1
1 1 14 1 1 11
1 26 1 2 27 20 21 13 18
Bones, joints and articular cartilage of limbs C40.0 Long bones of upper limb, scapula and associated joints 2 C40.1 Short bones of upper limb, and associated joints 2 C40.2 Long bones of lower limb and associated joints 21 C40.9 Bones of limb, NOS 7 Bones, joints and articular cartilage of other and unspecified sites C41.0 Bones of skull and face and associated joints C41.1 Mandible C41.2 Vertebral column C41.3 Rib, sternum, clavicle and associated joints C41.4 Pelvic bones, sacrum, coccyx and associated joints C41.9 Bone, NOS
1 1 1 3 1 4 1 1 1 1 2 1 1 1 1 2 2 1 1 2
3 2 1 3 4 6
1 1
1 1 1 1
1 1 2 2 2 1
32

ICD-O Code Bone marrow C42.1 Bone marrow Spleen C42.2 Skin C44.0 C44.1 C44.2 C44.3 C44.4 C44.5 C44.6 C44.7 C44.9 Spleen Skin of lip, NOS Eyelid External ear Skin of other and unspecified parts of face Skin of scalp and neck Skin of trunk Skin of upper limb and shoulder Skin of lower limb and hip Skin, NOS All 417 2 2 2 5 14 5 9 5 22 14 1 1 1 1 1 1 1 1 0-4 31 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 15 15 13 8 21 13 18 23 2 1 1 1 1 1 1 1 1 3 1 2 2 1 3 3 1 2 2 4 2 2 3 2 1 4 2 1 1 1 1 5 1 3 6 2 23 45 32 40 63 20 37
Peripheral nerves and autonomic nervous System C47.0 of head 1 C47.1 of upper limb and shoulder 1 C47.3 of thorax 1 C47.5 of pelvis 1 C47.9 Autonomic nervous system, NOS 12 Retroperitoneum and peritoneum C48.0 Retroperitoneum C48.2 Peritoneum, NOS Connective subcutaneous and other soft tissues C49.0 of head, face, and neck C49.1 of upper limb and shoulder C49.2 of lower limb and hip C49.3 of thorax C49.4 of abdomen C49.5 of pelvis C49.9 NOS Breast C50.0 C50.4 C50.9 Vulva C51.0 C51.9 Nipple Upper outer quadrant of breast Breast, NOS Labium majus Vulva, NOS 11 1
1 1 3 1 2 1 1 2 1 2 1 2 1 1 1 2 1 1
10 7 19 6 5 2 24 1
1 1 1 1 2 2 1
2 1 1 3
2 1 2 2
2 1 1 1
1 2 1 1 3
1 3 1 1
1 3 1 1 3
1 2 2 1 1
3 1
1 4 22 1 67 120 217 312 338 270 200 127 1 86 94
1 1857 1 23 29 3 878
3 1 1 9 1
3 6
6 2
3 4
1 4
5 5
Vagina C52.9 Vagina, NOS Cervix Uteri C53.0 Endocervix C53.9 Cervix uteri
41
1 81 121 150 132 106
97
1 70 66
33

ICD-O Code All Corpus Uteri C54.1 Endometrium C54.2 Myometrium C54.9 Corpus Uteri Uterus, NOS C55.9 Uterus, NOS Ovary C56.9 Ovary 7 1 176 53 596 1 6 8 10 20 25 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 2 4 8 1 34 7 5 56 2 16 9 2 33 14 43 6 80 26 5 47 17 8 52 1 1 11 11 3 2
76 116
38 27
Other and unspecified female genital organs C57.0 Fallopian tube C57.9 Female genital tract, NOS Placenta C58.9 Placenta Kidney C64.9 Kidney Bladder C67.9 Bladder, NOS Other and unspecified urinary organs C68.0 Urethra C68.1 Paraurethral gland Eye and adnexa C69.0 Conjunctiva C69.2 Retina C69.3 Choroid C69.6 Orbit, NOS C69.9 Eye, NOS Meninges C70.1 Spinal meninges C70.9 Meninges, NOS Brain C71.0 C71.1 C71.2 C71.3 C71.4 C71.5 C71.6 C71.7 C71.9 Cerebrum Frontal lobe Temporal lobe Parietal lobe Occipital lobe Ventricle, NOS Cerebellum, NOS Brain stem Brain , NOS
5 1 77 31 35 2 1 3 2 16 26 11 1 10 1 3
1 1 4 4 3 6 4 1 3 4 1 8
2 3 5
3 3 1
5 3 3
1 1 1 14 1 2 5 1 5 2 11 6 7 7 1 9 5 83
1 1
12
2 2 1 1 1 1 1
1 1
1 1 1 2 1 1
1 1 1 2 1 1 7
1 1
3 1 1
1 2
2 1 1 1 7
1 2 1 8
1 1 4
2 9
2 1 5
1 1 2
2 3 2 8 3
11
Spinal cord, cranial nerves and other parts of central nervous system C72.1 Cauda equine C72.2 Olfactory nerve C72.9 Nervous system, NOS
1 1 1
1 1
34

ICD-O Code All Thyroid gland C73.9 Thyroid Gland Adrenal gland C74.0 Cortex of adrenal gland C74.1 Medulla of adrenal gland C74.9 Adrenal Gland Other endocrine glands and related structures C75.1 Pituitary gland C75.2 Craniopharyngeal duct C75.3 Pineal gland Other and ill defined sites C76.0 Head, face or neck, NOS C76.2 Abdomen, NOS C76.3 Pelvis, C76.8 Overlapping lesion of ill defined sites 592 5 3 7 1 3 2 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 6 9 55 1 48 60 69 71 1 1 71 1 1 67 1 43 32 29 15 16
5 1 2 4 3 1 1
1 1
1 1
1 1
1 1
Lymph nodes C77.0 Lymph nodes of head, face and neck 8 C77.2 Intra-abdominal lymph nodes 2 C77.3 Lymph nodes of axilla or arm 3 C77.9 Lymph node, NOS 222 Unknown Primary Site C80.9 Unknown primary site All sites 138 7314
1 2 9 7 17 17
1 1 8 2 6 4
1 2 22 17 26 11
9 7
13 11
14 10
21 19
20 18
27 19
13 11
70
50 59
70 138 194 255 394 633 847 1109 934 786 689 538 548
35
Table 11 Number of cancer cases by histological type and sub-site - 2005

Site Lip Histology Carcinoma, undifferentiated, NOS No 3 % 8.1
Base of tongue
parts of tongue
Other and unspecified
Gum
Floor of mouth
Total
Mucoepidermoid carcinoma
Squamous cell carcinoma, large cell, non-keratinising, NOS
Squamous cell carcinoma, NOS
Verrucous carcinoma, NOS
Carcinoma, undifferentiated, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
Adenosquamous carcinoma
Acinar cell carcinoma
Adenoid cystic carcinoma
Adenocarcinoma, NOS
Small cell carcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
Carcinoma, NOS
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Squamous cell carcinoma, keratinising, NOS
Carcinoma, anaplastic, NOS
Neoplasm, malignant
Total
Malignant melanoma, NOS
30 1 1
81.1 2.7 2.7
5.4
37 1 2
100 1.2 2.4
70 1 1
84.3 1.2 1.2
1.2
1.2
83 1 8
100 0.4 3.0
1.2
6.0
252 1 2
93.3 0.4 0.7
1.1
0.7
270 10 9 1
100 0.7 6.9
0.4
100 6 6
69.4 4.2 4.2
2.1
1.4
6.3
144 12 5 1
14.6 6.1 1.2
100
2.1
0.7
2.1
61 1 1
74.4 1.2 1.2
1.2
82
100
36

Site Palate Histology Carcinoma, NOS Neoplasm, malignant No 1 5 % 1.1 5.6
parts of mouth
Parotid gland
major salivary glands
Tonsil
Squamous cell carcinoma, NOS Total
Carcinoma, NOS
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Total
Malignant lymphoma, non-Hodgkin, NOS
Malignant lymphoma, NOS
Haemangiosarcoma
Carcinoma in pleomorphic adenoma
Oxyphilic adenocarcinoma
Adenocarcinoma, NOS
Pleomorphic carcinoma
Neoplasm, malignant
Total
Liposarcoma, NOS
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Sarcoma, NOS
68 2 4
76.4 2.2 4.5
2.2
1.1
4.5
30 5 5
89
100 1.1 6.8
1.1
1.1
383 5 3
87.2 1.1 0.7
1.1
439 1 1
100 1.7 1.7
0.2
0.2
0.2
0.2
0.9
22 2 6
10.0 1.7 3.3
36.7
19 3 1
31.7 5.0 1.7
60 4 8
19 1 4
21.1 100 0.8 3.3
15.8
21.1
42.1
100
3.3
1.7
1.7
112 120
93.3 100 0.8
0.8
0.8
37

Site Oropharynx Histology Carcinoma, NOS Neoplasm, malignant No 1 4 % 2.3 9.1
Nasopharynx
Pyriform Sinus
Hypopharynx
and pharynx
sites in lip oral cavity
Other and ill defined
Esophagus
Total
Leiomyosarcoma, NOS
Spindle cell sarcoma
Signet ring cell carcinoma
Mucin producing adenocarcinoma
Mucinous adenocarcinoma
Papillary adenocarcinoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
Squamous cell carcinoma, adenoid
Papillary carcinoma, NOS
Small cell Carcinoma, NOS
Neoplasm, malignant
Total
Basaloid carcinoma
Total
Total
Neoplasm, malignant
Total
Neoplasm, malignant
Total
44 3 2
31
15.9 70.5 100 8.6 5.7 2.3
25 2 1
71.4 5.7 2.9
2.9
35 1 5
100 0.6 2.9
2.9
163 170 2 1 1
95.9 100 3.6 1.8 0.6
49 2 1
89.1 3.6 1.8
55 45 1 1 2
100 91.8 2.0 2.0 4.1
51 2 5
49
100 0.5 5.0
830 12 2 1
81.2 0.1 1.2
0.1
0.2
104 2 1
10.2 0.2 0.1
0.2
1022
100
0.1
0.1
0.1
0.4
0.3
0.1
38

Site Stomach Histology Carcinoma, NOS Neoplasm, malignant No 2 8 % 0.9 3.7
Small intestine
Carciniod tumor, NOS Spindle cell sarcoma
Adenocarcinoma, NOS
Neoplasm, malignant
Malignant lymphoma, NOS Total
Gastrointestinal stromal sarcoma
Adenocarcinoma, NOS
176 2 2
16
82.2 0.9 0.9
7.5
1.4
1 214 1 2
0.5 100 3.7 7.4
1.9
13 3 1
48.1 11.1 3.7 3.7
Neuroendocrine carcinoma, NOS
Leiomyosarcoma, NOS
Colon
Rectosigmoid junction Squamous cell carcinoma, NOS Mucinous adenocarcinoma Adenocarcinoma, NOS
Total
Leiomyosarcoma, NOS
Papillary mucinous cystadenocarcinoma
Carciniod tumor, NOS
Carciniod tumor of uncertain malignant potential
Adenocarcinoma in adenomatous polyp
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Malignant lymphoma, NOS Total
Gastrointestinal stromal tumor, NOS
3 1
11.1 3.7 3.7
1 27 1 9
3.7 100 0.3 3.1
249 1 3
84.0 0.3 1.0
0.3
2.0
296 31 1 1 1
100 91.2 2.9 2.9 2.9
0.3
0.7
0.3
0.3
2.4
0.3
3.1
0.3
0.3
0.7
Total
34
100
39

Site Rectum Histology Carcinoma, undifferentiated, NOS Neoplasm, malignant No 15 1 2 % 0.5 3.6
Anus and anal canal
Total
Clear cell adenocarcinoma, NOS
Carcinoid tumour, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
369 1 1
89.8 0.2 0.2
0.2
0.7
0.2
Adenocarcinoma, NOS
Basaloid carcinoma
Neoplasm, malignant
411 1
100 2.8 5.6
0.2
0.5
0.2
1.5
0.5
1.2
0.2
15 11 1 2
41.7 30.6 2.8 5.6 5.6
Liver
Intrahepatic bile ducts
Gallbladder
parts of the biliary tract Adenocarcinoma, NOS Tubular adenocarcinoma Cholangiocarcinoma
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Transitional cell carcinoma, NOS
Neoplasm, malignant
Total
Lipobarcoma, NOS
Klatskin tumor
Cholangiocarcinoma
Neoplasm, malignant
Total
Peripheral neuroectodermal tumor
Hepatoblastoma
Hepatocellular carcinoma, NOS
Adenocarcinoma, NOS
Neoplasm, malignant
Total
36 14 1 1
100 8.9 0.6
5.6
136 3
86.6 1.9 0.6
157 22 1 1 1
100 88.0 4.0 4.0 4.0
0.6
0.6
25 1 3
13.0 4.3 4.3
100
14 23 15 1 2 2
60.9 100 48.4 3.2 6.5 8.7
8.7
13 31
41.9 100
Total
40

Site Pancreas Histology Carcinoma, undifferentiated, NOS Neoplasm, malignant No 20 2 4 % 26.0 2.6 5.2
organs
parts of digestive
Nasal cavity
Middle ear
Accessory Sinuses
Larynx
Total
Small cell sarcoma
Adenocarcinoma, NOS
Giant cell carcinoma
Neoplasm, malignant
Total
Neuroblastoma , NOS
Rhabdomyosarcoma , NOS
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Total
Malignant lymphoma, large B-cell, diffuse, NOS
Embryonal rhabdomyosarcoma, NOS
Small cell sarcoma
Sarcoma, NOS
Adenocarcinoma, NOS
Basal cell carcinoma, NOS
Total
Stromal sarcoma, NOS
Total
Acinar cell tumor
Paget disease, mammary
Islet cell carcinoma
Adenocarcinoma, NOS
38 3 1
49.4 3.9 1.3
77 1 1
10 1 1
10
70.0 58.8 5.9 5.9 100
10.0
10.0
10.0
100
1.3
1.3
3.9
5.2
17 1 1
26 1 2
33.3 10.0 65.0 2.5 5.0 2.5 100
33.3
33.3
100
5.9
5.9
5.9
5.9
5.9
21 1 6
40
100 1.6 5.8
2.5
2.5
2.5
7.5
326 3 3
89.3 0.8 0.8
0.5
0.3
365
100
0.3
0.5
41

Site Trachea Histology Squamous cell carcinoma, NOS Neoplasm, malignant No 1 2 % 33.3 14.2 1.1 0.5 100 66.6
Bronchus and lung
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Non-small cell carcinoma
Small cell carcinoma, intermediate cell
Large cell carcinoma, NOS
118 9
20 19 2 1
222 411 2
26.8 49.6 0.2 0.1 0.2
2.3
0.1
2.4
0.1
Thymus
Squamous cell carcinoma, NOS Adenocarcinoma, NOS Carcinoid tumor, NOS
Total
Hodgkin lymphoma,NOS
Alveolar adenocarcinoma
Bronchiolo-alveolar adenocarcinoma, NOS
Carcinoid tumor, NOS
Basal cell adenocarcinoma
829 1 1
11.1 11.1 11.1
100
0.1
0.1
0.2
0.5
0.1
1.0
0.2
Neuroendocrine carcinoma, NOS Thymoma, malignant, NOS
Thymoma, type B2, malignant Malignant lymphoma, NOS Total Malignant lymphoma, non-Hodgkin, NOS
22.2 11.1 11.1 11.1 100
11.1
Heart, mediastinum and pleura
Neoplasm, malignant
Carcinoma, undifferentiated, NOS Small cell carcinoma, NOS
11.1 11.1 5.6 5.6
Thymoma, malignant, NOS Teratoma, malignant , NOS
Adenocarcinoma, NOS
Fibrous mesothelioma, malignant
2 1
11.1 5.6
5.6
5.6
Other and ill defined sites in respiratory system and intrathoracic organs
Superficial spreading adenocarcinoma
Total
Hodgkin lymphoma,NOS
Mixed germ cell tumor
18 1
27.8 5.6 5.6
100
100
Total
100
42

Site Bones, joints and articular cartilage of limbs Histology Neoplasm, malignant Spindle cell sarcoma Giant cell sarcoma No 3 1 1 % 4.5 1.5 1.5
Ewing sarcoma
Giant cell tumor of bone,malignant
Chondrosarcoma, NOS
Aggressive osteosarcoma
Fibroblastic osteosarcoma
Osteosarcoma, NOS
Epithelioid sarcoma
38 1 1
57.6 1.5 1.5
1.5
Bones, joints and articular cartilage of other and unspecified sites
Plasmacytoma, NOS Bone marow Malignant lymphoma, NOS Malignant lymphoma, non-Hodgkin, NOS Malignant lymphoma, lymphoplasmacytic Precursor cell lymphoblastic lymphoma, NOS Plasmacytoma, NOS Multiple myeloma Plasma cell leukemia Monoclonal gammopathy of undetermined significance Leukemia, NOS Acute Leukemia, NOS B-cell chronic lymphocytic leukemia /small lymphocytic lymphoma Prolymphocytic leukemia, NOS Precursor cell lymphoblastic leukemia, NOS (Acute lymphoblastic leukemia) Acute myeloid leukemia, M6 type Acute myeloid leukemia, NOS Chornic myeloid leukemia, NOS Acute myelomonocytic leukemia Acute myeloid leukemia with abnormal marrow eosinophils Acute myeloid leukemia without maturation Acute myeloid leukemia with maturation Atypical chornic myeloid leukemia, BCR/ABL negative Acute panmyelosis with myelofibrosis Hairy cell leukemia Chornic myelomonocytic leukemia Juvenile myelomonocytic leukemia Polycythemia vera Myelosclerosis with myeloid metaplasia Essential thrombocythemia Lymphoproliferative disorder, NOS Myeloproliferative disease, NOS Refractory anemia with excess blasts in transformation [obs] Myelodysplastic Syndrome, NOS Total
Ewing sarcoma
Giant cell tumor of bone, malignant
Neoplasm, malignant Osteosarcoma, NOS Chondroblastic osteosarcoma Chondrosarcoma, NOS
Total
Langerhans cell histiocytosis, unifocal
Plasmacytoma, NOS
11 1
16.7 1.5 3.0
6.1
3.0
66 1 9 1 9
10 43 11
2.3 20.9 2.3 20.9 23.3 25.6 0.7 0.7 0.1 0.2 0.1 26.8 0.1 0.1 0.2 0.3 2.7 0.1 22.6 0.2 9.9 13.9 3.4 0.1 1.7 4.7 0.2 0.9 0.2 0.2 0.1 1.6 0.5 0.4 0.1 0.2 0.1 6.8 100 100 4.7
100
6 6 1 2 1 247 1 1 2 3 25 1 209 2 91 128 31 1 16 43 2 8 2 2 1 15 5 4 1 2 1 63
Total
923
43

Site Spleen Skin Histology Total Splenic marginal zone B-cell lymphoma No 5 5 % 100 0.5 1.5 100
Squamous cell carcinoma, NOS Lymphoepithelial carcinoma
Neoplasm, malignant
Squamous cell carcinoma, large cell, nonkeratinising, NOS
116 1
57.7 0.5 0.0
0.5
Peripheral nerves and autonomic nervous system Retroperitoneum and Peritoneum
Peripheral neuroectodermal tumor Neuroblastoma, NOS Malignant peripheral nerve sheath tumor Neoplasm, Malignant Carcinoma, undifferentiated, NOS Total
Total
Langerhans cell histiocytosis, multifocal
Langerhans cell histiocytosis, NOS
Cutaneous T-cell lymphoma, NOS
Mycosis fungoides
Dermatofibrosarcoma, NOS
Nodular hidradenoma,malignant
Skin appendage carcinoma
Merkel cell carcinoma
Adenoid basal carcinoma
Basosquamous carcinoma
25 2 2
12.4 1.0 1.0
0.5
33 4 3
16.4 2.0 1.5
0.5
1.5
0.5
0.5
201 7 7 11 2 1
25
28.0 28.0 44.0 11.8 5.9 100
100
0.5
0.5
Adenocarcinoma, NOS Spindle cell sarcoma Sarcoma, NOS
2 1
23.5 5.9 5.9
11.8
Leiomyosarcoma, NOS Total
Liposarcoma, NOS
Small cell sarcoma
Rhabdomyosarcoma, NOS
2 17
17.6 11.8 100 5.9
Connective subcutaneous and other soft tissues
Spindle cell sarcoma Small cell sarcoma Giant cell sarcoma
Neoplasm, Malignant Giant cell carcinoma Sarcoma, NOS
17 1
2 1 50 1
1.4 0.7 34.7 11.8 0.7 0.7
Synovial sarcoma, NOS
Leiomyosarcoma, NOS
Liposarcoma
Malignantfibrous histiocytoma
Atypical fibrous histiocytoma
Fibromyxosarcoma
Desmoplastic small round cell tumour
Epithelioid sarcoma
15 4 7
10.4 2.8 7.6 4.9
4.9
4.2
0.7
0.7
0.7
0.7
11
44

Site Histology Haemangiosarcoma Synovial sarcoma, biphasic No 5 2 % 3.5 1.4
Breast
Papillary carcinoma, NOS Adenocarcinoma, NOS
Carcinoma in situ, NOS
Neoplasm, malignant
Total
Myeloid sarcoma
Histiocytic sarcoma
Plasmacytoma, extramedullary
Haemangioblastoma
Haemangiopericytoma, malignant
Haemangiopericytoma, NOS
Epithelioid haemangiendothelioma, malignant
109 6 1
142
100 0.1 5.7
1.4
2.1
0.7
0.7
1.4
0.7
0.7
11 4
0.3 0.1 0.6
Vulva
Vagina
Total
Leiomyosarcoma, NOS
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Mature T-cell lymphoma, NOS
Haemangiosarcoma
Phyllodes tumour, malignant
Malignant myoepithelioma
Adenocarcinoma with squamous metaplasia
Lobular carcinoma, NOS
Duct carcinoma, desmoplastic type
Atypical medullary carcinoma
Intraductal papillary adenocarcinoma with invasion
Comedocarcinoma, NOS
Infiltrating duct carcinoma, NOS
Mucinous adenocarcinoma- Mucoid carcinoma
Tubular adenocarcinoma
16 1686 1 3 1
88.4 0.1 0.2
0.1
0.8
0.1
0.1
0.1
0.2
40 1 1
1908 3 1
100 12.5 4.2 4.2
0.1
0.2
0.4
0.1
0.1
0.1
0.1
2.1
0.1
0.4
17 1 1
70.8 4.2
24 18 2 4 1
100 62.1 6.9 3.4
4.2
13.8 10.3 100 3.4
29
45

Site Cervix uteri Histology Carcinoma insitu, NOS Neoplasm, malignant No 12 2 1 43 % 1.4 4.9
Corpus Uteri
Uterus, NOS
Other and unspecified female genital organs
Placenta
Total
Trophoblastic tumour, epithelioid
Choriocarcinoma, NOS
Invasive hydatidiform mole
Total
Papillary serous cystadenocarcinoma,
Adenocarcinoma, NOS Endometrioid adenocarcinoma, NOS
Total
Adenosarcoma
Smooth muscle tomour of uncertain malignant potential
Leiyomyosarcoma, NOS
Sarcoma, NOS
Endometrioid adenocarcinoma, NOS
Adenocarcinoma, NOS
Total
Mullerian mixed tumour
Endometrial stromal sarcoma, NOS
Sarcoma, NOS
Serous cystadenocarcinoma, NOS
Adenocarcinoma, NOS
Squamous cell carcinoma, large cell, non keratinising, NOS
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Carcinoma, NOS
674 40 26 1 3 1 74
76.5 4.5 8.4
0.1
0.2
0.1
881 3 2
100 1.6 1.1
0.2
0.1
0.1
0.3
3.0
0.1
75 75 1 1 6
40.8 40.8 0.5 0.5 3.3
0.5
1.6
184 21 13 13 1 2 1 1 1
100 39.6 24.5 24.5 1.9 3.8 1.9 1.9 1.9
0.5
2.2
3.8
2.2
0.5
53 4 1
24 77 1
52
16.7 67.5 1.3 100
66.7 16.7
100
31.2 100
46

Site Ovary Histology Carcinoma, undifferentiated, NOS Neoplasm, malignant No 55 1 3 % 0.5 9.2
Dysgerminoma
Small cell sarcoma
Sarcoma, NOS
Granulaosa cell tumour, juvenile
Granulaosa cell tumour, malignant
Mucinous cystic tumour of borderline malignancy
Mucinous cystadenocarcinoma, NOS
Serous surface papillary carcinoma
Papillary serous cystadenocarcinoma
Papillary cystadenocarcinoma, NOS
Clear cell cystic tumor of borderline malignancy
Cystadenocarcinoma, NOS
Adenocarcinoma, NOS
17 264 1 1 1
19
44.3 0.2 0.2
0.2
2.9
3.2
0.2
26 23 39 1 1 7 1
45 19 4 5 2
15 1 2
12
Penis
Prostate
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Bowen disease
Small cell carcinoma, keratinising, NOS
Neoplasm, malignant
Total
Mixed germ cell tumour
Teratoma, malignant, NOS
Yolk sac tumour
11 6
0.3 0.5 1.8
0.2
0.3
0.2
0.2
0.3
2.5
2.0
0.7
0.8
3.2
0.3
7.6
0.2
0.2
6.5
1.2
3.9
0.2
4.4
596 1 1
100 1.4 1.4
0.8
1.0
60 1 3
81.1 1.4 4.1
4.1
1.4
Total
Adenocarcinoma, NOS
35 2
74
10
11.6 0.7 3.3
100
4.1
1.4
237 303 1
18
78.2 100 0.3
5.9
47

Site Testis Histology Carcinoma, undifferentiated, NOS Neoplasm, malignant No 3 4 % 5.3 7.0
Kidney
Bladder
Other and unspecified urinary organs
Total
Transitional cell carcinoma, NOS Adenocarcinoma, NOS
Total
Mucin-producing adenocarcinoma
Adenocarcinoma, NOS
Papillary transitional cell carcinoma
Lymphoepithelial carcinoma
Pseudosarcomatous carcinoma
Carcinoma, anaplastic NOS
Neoplasm, malignant
Total
Clear cell sarcoma of kidney
Nephroblastoma, NOS
Malignant fibrous histiocytoma
Renal cell carcinoma, NOS
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Teratocarcinoma
Embryonal carcinoma, NOS
Germinoma
Spermatocytic seminoma
Seminoma, NOS
Leydig cell tumour, maliganant
Sertoli cell carcinoma
Adenocarcinoma, NOS
18 4 1
31.6 7.0 1.8
1.8
1.8
1.8
1.8
13 7 1
22.8 12.3 100 1.0 9.0 1.8 1.8
1.8
57 1 9
68 1 1
68.0 1.0 1.0
1.0
4.0
1.0
1.0
100 1 6
100 0.6 3.8
4.0
9.0
127 4 2
81.4 2.6 1.3
0.6
2.6
1.3
0.6
1.3
2.6
156 1 1
50.0 50.0 100
100
1.3
48

Site Eye and adnexa Histology Squamous cell carcinoma, NOS Neoplasm, malignant No 5 1 % 12.5 2.5 2.5 2.5
Meninges
Brain
Spinal Cord and Neoplasm, malignant central nervous system Chordoma, NOS and other parts of CNS Myxopapillary ependymoma Malignant lymphoma, non-Hodgkin, NOS Neuroblastoma, NOS
Total
Neurilemoma, malignant [obs]
Meningioma, malignant
Central neurocytoma
Medulloblastoma, NOS
Oligodendroglioma, NOS
Glioblastoma, NOS
Pilocytic astrocytoma
Fibrillary astrocytoma
Astrocytoma, anaplastic
Astrocytoma, NOS
Ependymoma, anaplastic
Ependymoma, NOS
Glioma, malignant
Chordoma, NOS
Haemangioblastoma
Neoplasm, malignant
Total
Meningeal sarcomatosis
Atypical meningioma
Total
Follicular lymphoma, NOS
Malignant peripheral nerve sheath tumour
Retinoblastoma
Adenocarcinoma, NOS
22 2 1
55.0 5.0 2.5
12.5
40 3 8
12 1 9
25.0 100 0.3 3.0 8.3
66.7
100
5.0
84 6 7
27.8 2.0 2.3
0.3
2.0
0.7
0.7
12 5 2
86
28.5 0.7 4.0
16 1 1
12
47
15.6 5.3 4.0
1.7
302 2 2 2
Total
11
36.4 100 9.1
18.2 18.2 18.2
100
0.3
0.3
0.3
0.3
49

Site Thyroid Histology Carcinoma, anaplastic, NOS Neoplasm, malignant No 38 1 12 % 5.1 1.6
Adrenal
Other endocrine glands and related structures
Other ill defined sites
Total
Dysgerminoma
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Pineoblastoma
Pitituary carcinoma, NOS Craniopharyngeoma Pineocytoma
Total
Neuroblastoma, NOS
Pheochromocytoma, malignant
Adrenal cortical carcinoma
Neoplasm, malignant
Total
Hodgkin lymphoma, NOS
Small cell sarcoma
Medullary carcinoma, NOS
Papillary carcinoma, follicular variant
Follicular carcinoma, minimally invasive
Follicular carcinoma, NOS
Granular cell carcinoma
Oxyphillic adenocarcinoma
Adenocarcinoma, NOS
503 1
66.9 0.1 0.1
144 34 1 5 1
19.1 4.5 0.1
0.1
0.3
752 1 5
20.8 25.0 4.2
100
0.5
0.1
0.4
0.1
0.1
0.7
24 5 6 1
25.0 31.3 37.5 6.3 6.3 100
25.0
16 1 1
18.8 100 5.9 5.9
17
29.4 5.9 5.9
17.6
5.9
17.6 100
5.9
50

Site Lymph nodes Histology Malignant lymphoma, NOS Hodgkin Lymphoma, NOS No 21 1 % 3.6 0.2
Unknown Primary site Neoplasm, malignant Epithelioma, Malignant Carcinoma, NOS
Total
Langerhans cell histiocytosis, disseminated
Langerhans cell histiocytosis , multifocal
Langerhans cell histiocytosis , unifocal
Precursor cell lymphoblastic lymphoma, NOS
Anaplastic large cell lymphoma, T cell and null cell type
Mature T cell lymphoma, NOS
Malignant lymphoma, large B clell, diffuse, NOS
Malignant lymphoma, lymphoplasmacytic
Malignant lymphoma, small B lymphocytic, NOS
Hodgkin lymphoma, nodular sclerosis, NOS
Hodgkin lymphoma, mixed cellularity, NOS
461 72 1 1
12.3 0.2 0.2
78.7
136 1 4
586
34.4 0.3 1.0
100
1.0
0.3
0.2
0.3
0.2
0.2
0.3
0.9
1.0
0.2
0.3
Total
Germinoma
Adenocarcinoma, NOS
Squamous cell carcinoma with horn formation
Non small cell carcinoma
97 127 1 5 1
24.6 32.2 0.3 1.3 0.3
1.0
0.3
0.8
0.3
1.5
0.5
395
100
0.3
0.3
0.3
0.3
0.3
0.3
51
Table 12 Lip oral cavity and pharynx

Group Female Male
Incidence data 2005
Number 1240 377
Percentage 5.2
20.5
ASR 14.1 8.7 3.8
ASR- Age standardised rate per 100 000 world population ICD-O Code C00.1 C00.0
Total
1617
12.1
C06.0 C06.2 C06.1
C05.9
C05.8
C05.2
C05.1
C05.0
C04.9
C03.9
C03.1
C03.0
C02.9
C02.2
C01.9
C00.9
C00.8
C00.6
Cheek mucosa
Palate, NOS
Overlapping lesion of palate
Uvula
Soft palate
Hard palate
Floor of mouth, NOS
Gum, NOS
Lower gum
Upper gum
Tongue, NOS
Ventral surface of tongue, NOS
Base of tongue, NOS
Lip, NOS
Overlapping lesion of lip
Commissure of lip
External lower lip
External upper lip
Male 14 1 0
Female 9 1
67 218 37 40 1
16 51 0
65 33 1 1 7
24
17 2 4
12
17
14
C14.0
C13.9
C13.2
C13.0
C12.9
C11.9
C11.3
C10.9
C10.0
C09.9
C06.9
Total
Pharynx, NOS
Hypopharynx, NOS
Posterior wall of hypopharynx
Postcricoid region
Pyriform sinus
Nasopharynx
Anterior wall of nasopharynx
Oropharynx
Vallecula
Tonsil, NOS
Mouth, NOS
Retromolar area
Vestibule of mouth
248 32 3
32
113 7 0
105 20 20 1 19
29
15 4 1
147 23 4 0
23 4 1
23
14
1240
37
377
12
52

Histology Neoplasm, malignant Male 5 57 Female 25 9 1
Total
Basaloid carcinoma
Liposarcoma, NOS
Sarcoma, NOS
Adenocarcinoma, NOS
Carcinoma, NOS
35 3 1
1079 2 5
14
310 1 3
14 2 2
10
1240
377
Lip oral cavity and pharynx

ASR(W) per 100 000 population 14 12 10 8 6 4 2 0 1985
12.3
12.3
10.3
11.4 8.7
1990
1995 Year
2000
2005
Lip oral cavity and pharynx

Age Specific rate per 100 000 150 100 50 0
0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Age Group
Male Female
53
Table 13 Lip and anterior part of oral cavity Incidence data 2005
Group Female Male
Number
ASR- Age standardised rate per 100 000 world population ICD-O Code
Total
983
253
730
Percentage 3.5
12.1 7.3
ASR 2.6 8.3
5.3
C00.0 C00.1 C00.6 C00.8 C00.9 C02.2 C02.9 C03.0 C03.1 C03.9 C04.9 C05.0 C06.0 C06.1 C06.2 C06.9
Total
External upper lip External lower lip Commissure of lip Overlapping lesion of lip Lip, NOS Ventral surface of tongue, NOS Tongue, NOS Upper gum Lower gum Gum, NOS Floor of mouth, NOS Hard palate Cheek mucosa Vestibule of mouth Retromolar area Mouth, NOS
Male
730
4 14 0 1 7 1 218 40 37 24 65 7 248 3 32 29
Female 1 9 1 0 0 0 51 14 17 12 17 4 113 0 7 7
253
Neoplasm, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Small cell carcinoma, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinising, NOS Squamous cell carcinoma, large cell, non-keratinising, NOS Adenocarcinoma, NOS Adenoid cystic carcinoma Mucoepidermoid carcinoma Acinar cell carcinoma Adenosquamous carcinoma Malignant melanoma, NOS Liposarcoma, NOS Total
Histology
Male
730
39 3 19 2 8 634 2 2 9 6 1 1 2 2 0
Female 22 0 6 0 6 200 1 1 2 6 4 1 3 0 1
253
Lip and anterior part of oral cavity

Age Specific rate per 100 000
70 60 50 40 30 20 10 0 0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Age Group Male Female
54
Table 14 Posterior part of oral cavity and pharynx

Group Male Total Female ASR- Age standardised rate per 100 000 world population ICD-O Code
Incidence data 2005
Number 512 124 634
Percentage
8.5 1.7 4.7
ASR
5.8 1.2 3.4
C01.9 C05.1 C05.2 C05.8 C05.9 C09.9 C10.0 C10.9 C11.3 C11.3 C11.9 C12.9 C13.0 C13.2 C13.9 C14.0
Total
Base of tongue, NOS Soft palate Uvula Overlapping lesion of palate Palate, NOS Tonsil, NOS Vallecula Oropharynx Anterior wall of nasopharynx Superior wall of nasopharynx Nasopharynx Pyriform sinus Postcricoid region Posterior wall of hypopharynx Hypopharynx, NOS Pharynx, NOS
Male 67 33 1 1 32 105 19 20 1 1 21 147 23 0 4 37
Female 16 2 0 0 9 15 1 4 0 0 14 23 23 1 4 12
512 Male 18 2 16 1 1 1 6 447 3 1 2 7 1 1 4 1
124 Female 3 1 3 0 1 0 0 110 2 0 1 2 1 0 0 0
Total
Neoplasm, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Small cell carcinoma, NOS Papillary carcinoma, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinising, NOS Basaloid carcinoma Adenocarcinoma, NOS Adenoid cystic carcinoma Mucoepidermoid carcinoma Acinar cell carcinoma Adenosquamous carcinoma Sarcoma, NOS
Histology
512
124
Posterior part of oral cavity and pharynx

50 40 30 20 10 0 0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Age Group
Male
Female
55
Group Female Male
Incidence data 2005
Table 15 Tongue
Number 286 67
Percentage 0.9 4.7
ASR 0.7 3.2
Total
353
2.6
1.9
C02.9
Total
Tongue, NOS
Base of tongue, NOS
Male 67 1
Female 16 0
286 Male 1 8
218
67 Female 0 2
51
Histology
Total
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
263 1 0
59 1 1
286
67
Tongue
25 20 15 10 5 0 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 0-4 5-9
Age Group Male Female
56
Group Female Male
Incidence data 2005
Table 16 Esophagus
Number 524 498
Percentage 7.2
8.2
ASR 5.5 5.7
Total
1021
7.6
5.6
Total
C15.9
C15.5
C15.4
Esophagus, NOS
Lower third of esophagus
Middle third of esophagus
Upper third of esophagus
Cervical esophagus
Male 5 1
Female 6 0
498 Male 29 1 1
425
40
27
524 Female 22 1 4
445
30
43
Histology
Total
Leiomyosarcoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
Neoplasm, malignant
388 1 5
442 0 7
63 2 1
41 0 0
498
524
ASR (W) per 100 000 population
7 6 5 4 4.1 3 2 1 0 1985
Age specific rate per 100 000
Esophagus
5.8 5.6 5.6
4.8
50 45 40 35 30 35 20 15 10 5 0
Esophagus
1990
1995
Year
2000
2005
57
0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Male Female
Incidence data 2005

Group Male Female Total ASR- Age standardised rate per 100 000 world population ICD-O Code C16.0 C16.4 C16.3 Number 154 214 60 Percentage 2.5 0.8 1.6 ASR 1.7 0.6 1.2
Table 17 Stomach
Cardia. NOS Pylorus
Male 11 2 2
Female 2 7
Gastric antrum
Total
C16.9
Stomach, NOS
154 Male 0 3
139
60 Female 2 5
51
Histology
Squamous cell carcinoma, NOS Mucinous adenocarcinoma Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
133 2 1
11
0 43 0 1 5
Total
154
60
1.4 1.2 1 0.8 0.6 0.4 0.2 0
Stomach
1 1.2
0.8
0.9
0.9
1985
1990
1995
Year
2000
2005
Age specific rate per 1000 000 population
14 12 10 8 6 4 2 0 0-4 10-14 5-9 15-19 20-24
Stomach
24-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
58
70-74
75+
Table 18 Colon and rectum Incidence data 2005
Group Male Total Female
388 353 741
Number 6.4 4.8 5.5
Percentage
4.4 3.6 4.0
ASR
C18.0 C18.1 C18.2 C18.3 C18.4 C18.5 C18.6 C18.7 C18.9 C19.9 C20.9
Total
Caecum Appendix Ascending colon Hepatic flexure of colon Transverse colon Splenic flexure of colon Descending colon Sigmoid colon Colon, NOS Rectosigmoid junction Rectum, NOS
Male 14 4 3 1 3 1 2 26 92 20 222
Female 11 3 8 0 8 0 0 29 91 14 189
388 Male 0 5 1 1 0 344 1 1 2 2 0 0 5 2 8 1 1 1 2 0 11
353 Female 1 3 0 4 1 305 2 0 1 0 1 1 10 1 6 1 1 0 1 1 13
Histology
Total
Carcinoma, NOS Carcinoma, undifferentiated, NOS Small cell carcinoma, NOS Squamous cell carcinoma, NOS Basaloid carcinoma Adenocarcinoma, NOS Adenocarcinoma in adenomatous polyp Carcinoid tumour of uncertain malignant potential Carcinoid tumour Papillary adenocarcinoma, NOS Clear cell adenocarcinoma, NOS Papillary mucinous cystadenocarcinoma Mucinous adenocarcinoma Mucin-producing adenocarcinoma Signet ring cell carcinoma Adenosquamous carcinoma Malignant melanoma, NOS Leiomyosarcoma, NOS Gastrointestinal stromal sarcoma Malignant lymphoma, non-Hodgkin, NOS
Neoplasm, malignant
388
353
40 30 20 10 0
Colon and rectum
0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Age Group Male Female
59
Group Female Male
Incidence data 2005
Table 19 Colon
Number 150 146
Percentage 2.1 2.4
ASR 1.5 1.6
ASR- Age standardised rate per 100 000 world population ICD-O Code C18.0 C18.2 C18.1
Total
296
2.2
1.6
Caecum
Male 14 3 4
Female 11 8 3
C18.9
C18.7
C18.6
C18.5
C18.4
C18.3
Total
Colon, NOS
Sigmoid colon
Descending colon
Splenic flexure of colon
Transverse colon
Hepatic flexure of colon
Ascending colon
Appendix
146 Male 0 1
92
26
150 Female 10 3 1
91
29
Histology
Total
Leiomyosarcoma, NOS
Papillary mucinous cysadenocarcinoma
Carcinoid tumour of uncertain malignant potential
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
129 1 1
120 0 2
146
150
10 8 6 4 2 0 10-14
Colon
15-19
20-24
24-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
60
65-69
70-74
75+
0-4
5-9
Table 20 Rectum anal canal and anus

Group Female Male
Incidence data 2005
Number 201 246
Percentage 2.8
4.1
ASR 2.1 2.8
Total
447
3.3
2.4
C21.8
C21.1
Total
Overlapping lesion of rectum, anus and anal canal
Anal canal
Anus, NOS
Rectum, NOS
Male 222 14 2 8
Female 189 4 7
246 Male 11 1 2
201 Female 0
Histology
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Basaloid carcinoma
12 205 1 1 1
175 0 0
246
201
Rectum and canal and anus

ASR (W) per 100 000 population Age specific rate per 1000 000 population 3 2 1 0 1.4 0.7 0.9 1990 1995 2000 2005 2.2 2.4
Rectum and canal and anus

40 20 0 0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Age Group Male Female
1985
Year
61
Group Female Male
Incidence data 2005
Table 21 Larynx
Number 324 41
Percentage 0.6
5.3
ASR 0.4 3.7
Total
365
2.7
2.1
C32.9
C32.3
C32.2
Total
Larynx, NOS
Laryngeal cartilage
Subglottis
Supraglottis
Glottis
Male 154 81 3 3
Female 22 0 9
324 Male 19 0 5
83
41 Female 1 2
10
Histology
Total
Small cell sarcoma
Adenocarcinoma, NOS
Giant cell carcinoma, NOS
Neoplasm, malignant
291 2 3
35 1 0
324
41
3 2 1 0 1985 1990 1995 Year 2000 2005 1.2 1.7 2.1 2.2 2
Larynx
Age specific rate per 1000 000 population 30 20 10 0 0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Age Group Male Female
62
Table 22 Trachea bronchus and lung

Group Male Female Total ASR- Age standardised rate per 100 000 world population ICD-O Code C34.0 C33.9
Incidence data 2005
Number 666 166 832
Percentage 11.0 2.3 6.2
ASR
7.7 1.7 4.5
Total
C34.9
C34.3
C34.2
C34.1
Lung, NOS
Lower lobe, lung
Middle lobe, lung
Upper lobe, lung
Main bronchus
Trachea
Male 5 1
Female 1 2
666 Male 100 6 3
655
166 Female 20 3 1
159
Histology
Total
Bronchio-alveolar adenocarcinoma, NOS
Adenocarcinoma, NOS
Neoplasm, malignant
16 15 2 1
191 317 1 0
32 94 1 1 0
666
166
5 4.5 4 3.5 3 2.5 2 1.5 1.8 1 0.5 0 1985
Trachea bronchus and lung

4.6 4.5
Trachea bronchus and lung

50 45 40 35 30 25 20 15 10 5 0
3.3 2.7
1990
1995
Year
2000
2005
63
0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Age Group Male Female
Table 23 Haemopoetic and reticuloendothelial system

Group Female Male
Incidence data 2005
Number 419 509
Percentage 5.7
8.4
ASR 4.4 5.6
Total
928
6.9
5.0
Total
Spleen
Bone marrow
Male 506 3
Female 417 2
509 Male 2 3 1 3 1 1 136 1 0 1 2 15 1 118 1 45 78 13 0 10 20 1 5 0 1 1 6 3 1 1 2 1 35
419 Female 4 3 0 2 1 0 111 0 1 1 1 10 0 91 1 46 50 18 1 6 23 1 3 2 1 0 9 2 3 0 0 0 28
Total
Malignant lymphoma, NOS Malignant lymphoma, non-Hodgkin, NOS Malignant lymphoma, lymphoplasmacytic Splenic marginal zone B-cell lymphoma Precursor cell lymphoblastic lymphoma, NOS Plasmacytoma, NOS Multiple myeloma Plasma cell leukaemia Monoclonal gammopathy of undetermined significance Leukemia, NOS Acute Leukemia, NOS B-cell chronic lymphocytic leukemia /small lymphocytic lymphoma Prolymphocytic leukemia, NOS Precursor cell lymphoblastic leukemia, NOS (including acute lymphoblastic leukemia) Acute myeloid leukemia, M6 type Acute myeloid leukemia, NOS Chornic myeloid leukemia, NOS Acute myelomonocytic leukemia Acute myeloid leukemia with abnormal marrow eosinophils Acute myeloid leukemia without maturation Acute myeloid leukemia with maturation Atypical chornic myeloid leukemia, BCR/ABL negative Acute panmyelosis with myelofibrosis Hairy cell leukemia Chornic myelomonocytic leukemia, NOS Juvenile myelomonocytic leukemia Polycythemia vera Myeloselerosis with myeloid metaplasia Essential thrombocythemia Lymphoproliferative disorder, NOS Myeloproliferative disease, NOS Refractory anemia with excess blasts in transformation [obs] Myelodysplastic Syndrome, NOS
Histology
509
419
Haemopoetic and reticuloendothelial system

ASR (W) per 100 000 population 6 5 4 3 2 1 0 Age specific rate per 1000 000 population
30 25 20 15 10 5 0
Haemopoetic and reticuloendothelial system
0-4
10-14
5-9
15-19
20-24
24-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
1985
1990
1995
Year
2000
2005
Male
Age Group Female
64
70-74
75+
Group Female Male
Incidence data 2005
Table 24 Skin
Number 123 78
Percentage 1.1
2.0
ASR 0.8 1.4
Total
201
1.5
1.1
Total
C44.0 C44.1 C44.2 C44.3 C44.4 C44.5 C44.6 C44.7 C44.9
Skin of lip, NOS Eyelid External ear Skin of other and unspecified parts of face Skin of scalp and neck Skin of trunk Skin of upper limb and shoulder Skin of lower limb and hip Skin, NOS
Male
123 Male 1 1 0 80 1 1 14 0 0 0 1 0 0 19 2 2 1 0 0
3 4 7 8 5 14 8 53 21
Female 2 2 5 14 5 9 5 22 14
78 Female 2 0 1 36 0 0 11 2 2 1 0 3 1 14 1 2 0 1 1
Total
Neoplasm, malignant Carcinoma, undifferentiated, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, large cell, non-keratinising, NOS Lymphoepithelial carcinoma Basal cell carcinoma, NOS Basosquamous carcinoma Adenoid basal carcinoma Adenoid cystic carcinoma Merkel cell carcinoma Skin appendage carcinoma Nodular hidradenoma, malignant Malignant melanoma, NOS Dermatofibrosarcoma, NOS Mycosis fungoides Cutaneous T-cell lymphoma, NOS Langerhans cell histiocytosis, NOS Langerhans cell histiocytosis, multifocal
Histology
123
78
Skin
1.4 1.2 1 0.8 0.6 0.8 0.4 0.2 0 1985 ASR (W) per 100 000 population Age specific rate per 1000 000 population 1.2 0.8 0.8
1.1
0-4
10-14
5-9
15-19
20-24
24-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
1990
1995
Year
2000
2005
Male
Age Group Female
65
70-74
75+
10 9 8 7 6 5 4 3 2 1 0
Skin
Group Female Male
Incidence data 2005
Table 25 Breast
Number 1859 49
Percentage 25.4 0.8
ASR 18.4 9.8 0.5
Total
1908
14.3
Total
C50.0 C50.4 C50.6 C50.9
Nipple Upper outer quadrant of breast Axillary tail of breast Breast, NOS
Male 0 0 1 48
Female 1 1 0 1857
49 Male 0 0 0 0 0 0 0 0 1 0 41 0 0 1 0 2 0 0 0 0 0 0 0 4
1859 Female 1 6 11 1 4 2 1 1 15 1 1645 3 1 6 2 38 1 1 2 1 7 3 1 105
Histology
Total
Carcinoma in situ, NOS Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Squamous cell carcinoma, NOS Adenocarcinoma, NOS Tubular adenocarcinoma Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Mucinous adenocarcinoma Signet ring cell carcinoma Infiltrating duct carcinoma, NOS Comedocarcinoma, NOS Intraductal papillary adenocarcinoma with invasion Atypical medullary carcinoma Duct carcinoma, desmoplastic type Lobular carcinoma, NOS Acinar cell carcinoma Adenocarcinoma with squamous metaplasia Stromal sarcoma, NOS Malignant myoepithelioma Phylloides tumour, malignant Haemangiosarcoma Mature T-cell lymphoma, NOS
Neoplasm, malignant
49
1859
12 ASR (W) per 100 000 population 10 8 6 4 2

4.6 5.2
Breast
80 70 60 50 40 30 20 10 0 9.3 9.7
Breast
6.8
0 1985
1990
1995
Year
2000
2005
66
0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Male
Age Group Female
Table 26 Cervix uteri

Group Total
Incidence data 2005
Female
Number 881 881
Percentage 6.6
12.0
ASR 4.6 8.9
Endocervix Total
Female 878 881 Female 43 12 1 2 674 74 40 26 3 1 1 881 2 1 1 3
Cervix uteri
Histology
Neoplasm, malignant Carcinoma, NOS
Carcinoma insitu, NOS Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Squamous cell carcinoma, NOS
Squamous cell carcinoma, keratinising, NOS Basal cell carcinoma, NOS Adenocarcinoma, NOS
Papillary adenocarcinoma, NOS Adenosquamous carcinoma Spindle cell sarcoma Total
6 5 ASR (W) per 100 000 population 4 3 2 1 0 1985

4.3
Cervix uteri
4.6 4.8 5.3 4.6
1990
1995
Year
2000
2005
40 35
Cervix uteri
30 25 20 15 10 5 0
0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Age Group
67
Table 27 Ovary and other unspecified female genital organs

Group Total
Incidence data 2005
Female
Number 602 602
Percentage 4.5 8.2
ASR 3.1 5.9
Ovary
Female 596 5 1
Fallopian tube Total
Female genital tract, NOS
602 Female 55 3 1
Histology
Neoplasm, malignant
Carcinoma, undifferentiated, NOS Small cell carcinoma, NOS Papillary carcinoma, NOS
Squamous cell carcinoma, NOS Adenocarcinoma, NOS
19 17 268 1 1 1 7 1 1 2 5 4 1
Squamous cell carcinoma, keratinising, NOS Adenoid cystic carcinoma Carcinoid tumour, NOS Papillary adenocarcinoma, NOS
Clear cell adenocarcinoma, NOS Cystadenocarcinoma, NOS
26 24 39
Endometrioid adenocarcinoma, NOS Serous cystadenocarcinoma, NOS
Clear cell cystic tumor of borderline malignancy Papillary cystadenocarcinoma, NOS Serous surface papillary carcinoma Papillary serous cystadenocarcinoma Mucinous cystadenocarcinoma, NOS
46 19
Papillary mucinous cystadenocarcinoma Mucinous adenocarcinoma
Mucinous cystic tumour of borderline malignancy Granulaosa cell tumour, malignant Granulaosa cell tumour, juvenile Sarcoma, NOS Small cell sarcoma
12 15 2 1 1 2 1 11 2 3 6 602 5
Leiyomyosarcoma, NOS Stromal sarcoma, NOS Dysgerminoma Mullerian mixed tumour Yolk sac tumour
Teratoma, malignant, NOS Mixed germ cell tumour Total
68
Ovary and other unspecified feamle genital organs

3.5 3 ASR (W) per 100 000 population 2.5 2 1.5 1 0.5 0 1985 1.2 1.5 2.5 3.2 3.1
1990
1995
Year
2000
2005
Ovary and other unspecified feamle genital organs

25 20 Age specific rate per 1000 000 population 15 10 5 0
0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Age Group
69
Group Total Male
Incidence data 2005
Table 28 Prostate
Number 303 303
Percentage 2.3 5.0
ASR 1.7 3.5
ASR- Age standardised rate per 100 000 world population ICD-O Code C61.9 Total
Prostate gland
Male 303 303 Male 35 10 18 1 2
Histology
Neoplasm, malignant
Carcinoma, undifferentiated, NOS Small cell carcinoma, NOS Adenocarcinoma, NOS Total Squamous cell carcinoma, NOS Adenosquamous carcinoma
237 303
Prostate
2.5 2 1.5 1 0.5 0 0.9 0.4 0.5 1990 1995 2000 2005 2 1.7
1985
Year
Prostate
50 45 40 35 30 25 15 10 5 0
0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Age Group
70
Group Female Male
Incidence data 2005
Table 29 Bladder
Number 121 35
Percentage 0.5
2.0
ASR 0.3 1.4
ASR- Age standardised rate per 100 000 world population ICD-O Code Total C67.9
Total
156
1.2
0.9
Bladder, NOS
Male 121 Male 1 3 121
Female 35 Female 0 3 35
Histology
Total
Adenocarcinoma, NOS
Neoplasm, malignant
103 2 1
24 2 1
121
35
Bladder
1.4 ASR (W) per 100 000 population 1.2 0.8 0.6 0.4 0.2 0 1985
0.6 1.3
1
0.8 0.9
1990
1995 Year
2000
2005
Bladder
16 14 12 10 8 6 4 2 0 0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
71
Group Female Male
Incidence data 2005
Table 30 Brain
Number 131 171
Percentage 1.8 2.8
ASR 1.3 1.8
Total
302
2.3
1.5
C71.0 C71.1 C71.2 C71.3 C71.4 C71.5 C71.6 C71.7 C71.8 C71.9 Total
Cerebrum Frontal lobe Temporal lobe Parietal lobe Occipital lobe Ventricle, NOS Cerebellum, NOS Brain stem Overlapping lesion of brain Brain , NOS
Male 1 9 12 8 6 0 11 4 3 117
Female 2 11 6 7 7 1 9 5 0 83
171 Male 5 1 1 2 3 1 50 4 2 59 5 1 1 19 8 10 0 0 0 0
131 Female 4 0 1 0 3 0 34 3 4 27 7 1 4 28 4 6 1 1 1 1
Total
Neoplasm, malignant Malignant melanoma, NOS Mixed germ cell tumour Haemangiopericytoma, malignant Haemangioblastoma Chordoma, NOS Glioma, malignant Ependymoma, NOS Ependymoma, anaplastic Astrocytoma, NOS Astrocytoma, anaplastic Fibrillary astrocytoma Pilocytic astrocytoma Glioblastoma, NOS Oligodendroglioma, NOS Medulloblastoma, NOS Central neurocytoma Meningioma, malignant Neurilemoma, malignant [obs] Malignant lymphoma, NOS
Histology
171
131
Brain
1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 0.3 0 1985 1.5 1.2 0.8 0.5 1990 1995 2000 2005
6 5 4 3 2 1 0
Brain
Year
72
0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Group Female Male
Incidence data 2005
Table 31 Thyroid
Number 592 160
Percentage 8.1 2.6
ASR 5.6 1.7
Total
752
5.6
3.7
Thyroid Gland
Male 160 Male 10 0 2 160
Female 592 Female 28 1 10 592
Histology
Papillary carcinoma, NOS Adenocarcinoma, NOS
Carcinoma, anaplastic
Neoplasm, malignant
113 1
390 0
Total
Small cell sarcoma
Follicular adenocarcinoma, NOS
22 7 0
122 27 1 2 1
160
592
Thyroid
4 3.5 3 2.5 2 1.5 1 1.2 0.5 0 1985 3.7 3.1 1.7 2
14 12 10
Thyroid
8 6 4 2 0 0-4 5-9 10-14 15-19 20-24 24-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
1990
1995
Year
2000
2005 Male
Age Group Female
73
74
Cancer Incidence Data - 2001-2005
Cancer Incidence Data
2001-2005
75

ICD-O Code Lip C00.0 C00.1 C00.3 C00.6 C00.8 C00.9
Table 32 Cancer incidence by the reporting year, sex and sub-site 2001-2005
2001-2005 2001 2002 2003 2004 Male Female 5 21 2 1 0 5 66 6 5 0 1 1 264 53 86 41 2 70 21 19 3 1 47 606 3 38 74 117 27 12 1 2 69 5 0 1 0 1 29 Male Female 2 17 0 1 0 3 105 15 3 0 0 0 151 29 35 19 3 69 17 34 4 0 33 299 2 26 29 38 12 3 6 3 70 29 0 0 0 0 34 0 5 0 0 0 1 7 4 1 0 0 0 47 16 15 9 2 17 4 8 2 0 7 121 0 7 14 25 6 4 1 0 8 1 0 0 0 1 5 Male 2 15 0 0 0 2 87 6 4 0 1 1 147 26 48 11 1 54 18 43 3 1 24 242 4 37 37 29 7 2 0 3 70 10 1 3 0 1 41 Female 2 2 1 0 0 1 17 2 2 0 0 1 47 9 20 7 0 8 4 5 0 1 7 106 1 9 24 26 7 4 0 2 9 1 0 1 0 0 6 Male Female 0 6 0 1 0 4 91 2 2 0 0 0 166 19 30 10 0 52 10 31 5 1 21 291 0 25 33 26 1 1 2 1 75 10 0 1 0 0 29 1 1 0 0 0 2 14 0 1 0 1 0 50 6 12 4 0 15 2 1 0 0 8 130 2 9 11 15 7 2 0 0 21 1 0 0 0 0 5 Male Female 3 6 0 0 0 4 81 0 0 0 0 0 228 21 23 20 0 58 8 32 2 0 40 290 0 28 32 29 6 4 3 0 72 17 0 0 1 0 39 1 4 1 0 0 1 12 0 1 0 0 0 69 8 22 9 0 13 7 3 1 0 16 136 0 6 18 28 2 0 0 0 16 1 0 0 0 0 9
2005 Male Female 4 14 0 0 1 7 67 1 9 0 1 0 0 16 0 0 0 0 0 51 14 17 12 0 17 4 2 0 0 9 113 0 7 7 23 5 2 0 0 15 1 0 0 0 0 4
External upper lip External lower lip Mucosa of upper lip Commissure of lip Overlapping lesion of lip Lip, NOS
11 58 0 2 1 20 431 23 9 1 1 1 910 135 173 84 4 298 60 173 15 3 150 1370 9 148 160 159
Base of tongue C01.9 Base of tongue, NOS Other and unspecified parts of tongue C02.0 Dorsal surface of tongue, NOS C02.1 Border of tongue C02.2 Ventral surface of tongue, NOS C02.3 Anterior 2/3 of tongue C02.4 Lingual tonsil C02.9 Tongue, NOS Gum C03.0 Upper gum C03.1 Lower gum C03.9 Gum, NOS Floor of mouth C04.0 Anterior floor of mouth C04.9 Floor of mouth, NOS Palate C05.0 C05.1 C05.2 C05.8 C05.9 Hard palate Soft palate Uvula Overlapping lesion of palate Palate, NOS
0 0 1 0 0 218 40 37 24 0 65 7 33 1 1 32 248 3 32 29 37 8 4 0 0 105 19 0 0 0 0 20
Other and unspecified parts of mouth C06.0 Cheek mucosa C06.1 Vestibule of mouth C06.2 Retromolar area C06.9 Mouth, NOS Parotid gland C07.9 Parotid gland
Other and unspecified major salivary glands C08.0 Submandibular gland 34 C08.9 Major salivary gland, NOS 14 Tonsil C09.0 Tonsillar fossa C09.1 Tonsilla pillar C09.9 Tonsil, NOS Oropharynx C10.0 Vallecula C10.2 Lateral wall of oropharynx C10.3 Posterior wall of oropharynx C10.4 Branchial cleft C10.8 Overlapping lesion of oropharynx C10.9 Oropharynx 11 7 392 85 1 4 1 1 163
76

ICD-O Code Nasopharynx C11.0 Superior wall of nasopharynx C11.3 Anterior wall of nasopharynx C11.9 Nasopharynx Pyriform fossa C12.9 Pyriform sinus Hypopharynx C13.0 Postcricoid region C13.2 Posterior wall of hypopharynx C13.9 Hypopharynx, NOS Other and ill-defined sites in lip, oral cavity and pharynx C14.0 Pharynx, NOS C14.8 Overlapping lesion of lip, oral cavity and pharynx Esophagus C15.0 Cervical esophagus C15.3 Upper third of esophagus C15.4 Middle third of esophagus C15.5 Lower third of esophagus C15.9 Esophagus, NOS Stomach C16.0 Cardia. NOS C16.3 Gastric antrum C16.4 Pylorus C16.9 Stomach, NOS Small intestine C17.0 Duodenum C17.1 Jejunum C17.2 Ileum C17.9 Small intestine, NOS Colon C18.0 C18.1 C18.2 C18.3 C18.4 C18.5 C18.6 C18.7 C18.9 Caecum Appendix Ascending colon Hepatic flexure of colon Transverse colon Splenic flexure of colon Descending colon Sigmoid colon Colon, NOS 2001-2005 Male 1 1 108 619 81 61 Female 1 0 62 102 94 1 23 2001 Male Female 0 0 21 110 15 0 25 0 0 10 23 11 0 4 2002 Male 1 0 16 126 16 0 7 Female 0 0 8 23 23 0 8 2003 Male Female 0 0 24 120 16 0 15 0 0 12 22 22 0 5 2004 Male Female 0 0 27 116 11 0 10 1 0 18 11 15 0 2 2005 Male Female 0 1 20 147 23 0 4 0 0 14 23 23 1 4
147 5
55 2
22 3 1 5 40 72 302 9 2 3 121 0 2 2 2 14 0 6 3 5 5 3 20 55 5 125 14 10 2
9 0 0 6 102 56 334 0 1 1 37 4 1 0 3 9 0 5 1 12 2 4 32 49 3 128 5 5 0
29 1 0 7 50 82 277 9 4 1 103 5 3 1 3 8 2 3 5 7 1 1 33 60 11 149 11 8 4
7 0 0 15 111 63 301 3 0 5 44 4 1 0 1 9 0 6 3 7 1 5 33 53 12 129 3 4 1
31 0 0 9 71 53 317 6 2 5 129 5 1 5 2 8 0 5 0 7 2 1 25 80 10 140 10 3 0
14 2 0 9 106 74 345 1 1 1 34 3 2 1 3 11 0 3 0 2 1 1 29 76 8 149 10 5 2
28 1 1 7 28 30 395 7 1 3 143 7 0 0 6 17 2 15 2 8 0 6 21 92 15 176 5 5 2
13 0 0 0 44 38 472 3 1 0 62 1 0 3 4 15 3 2 0 5 0 3 30 92 13 147 7 3 3
37 0 1 5 27 40 425 11 2 2 139 6 1 0 6 14 4 3 1 3 1 2 26 92 20 222 14 8 2
12 0 0 6 43 30 445 7 2 0 51 3 1 2 8 11 3 8 0 8 0 0 29 91 14 189 7 4 1
3 0 33 36 216 406 277 261 1716 1897 42 11 14 635 23 7 8 19 61 8 32 11 30 9 13 125 379 61 812 54 34 10 14 5 7 228 15 5 6 19 55 6 24 4 34 4 13 153 361 50 742 32 21 7
Rectosigmoid junction C19.9 Rectosigmoid junction Rectum C20.9 Rectum, NOS Anus and anal canal C21.0 Anus, NOS C21.1 Anal canal C21.8 Overlapping lesion of rectum, anus and anal canal
77

ICD-O Code Liver and intrahepatic bile ducts C22.0 Liver C22.1 Intrahepatic bile duct Gallbladder C23.9 Gallbladder 2001-2005 Male 452 35 42 Female 167 37 92 34 16 4 61 104 2 11 24 13 54 7 0 1 8 53 50 1 6 40 4 2 2 1 1 689 26 15 7 1 2001 Male Female 73 4 12 6 7 2 9 29 0 4 12 0 15 3 0 0 1 122 57 2 10 93 2 11 0 0 0 503 6 12 2 0 17 1 26 7 3 2 15 21 0 1 6 4 3 1 0 0 2 7 5 0 1 5 0 1 0 0 0 93 7 2 2 0 2002 Male 69 7 8 7 10 1 9 22 0 2 3 2 12 4 0 0 5 87 70 4 5 127 1 1 0 0 0 517 5 10 1 1 Female 26 16 16 3 2 0 14 20 0 5 6 0 15 2 0 0 1 3 10 0 2 9 1 0 0 0 0 114 6 6 1 0 2003 Male Female 85 7 7 12 6 0 12 36 0 1 8 2 17 1 1 0 0 107 81 0 3 71 2 1 0 0 0 597 15 11 2 0 36 3 10 11 2 1 9 15 1 1 6 2 15 3 0 0 0 11 7 1 1 6 1 0 0 0 0 161 6 3 2 0 2004 Male Female 114 6 10 4 8 0 20 24 0 3 6 0 16 1 0 0 6 123 87 6 4 70 2 0 0 0 0 633 5 8 3 1 42 3 22 3 5 1 11 28 1 2 1 6 15 0 0 0 3 10 19 0 2 10 0 0 0 0 0 162 2 0 2 1 2005 Male Female 111 11 5 6 10 1 19 26 1 7 12 2 24 0 1 1 4 154 81 3 3 83 1 5 3 2 0 655 4 11 1 2 46 14 18 10 4 0 12 20 0 2 5 1 6 1 0 1 2 22 9 0 0 10 2 1 2 1 1 159 5 4 0 0
Other and unspecified parts of biliary tract C24.0 Extrahepatic bile duct 35 C24.1 Ampulla of Vater 41 C24.9 Billiary tract 4 Pancreas C25.0 Head of pancreas C25.9 Pancreas, NOS Other and ill-defined digestive organs C26.0 Intestinal tract, NOS C26.9 Gastrointestinal tract, NOS Nasal cavity and middle ear C30.0 Nasal cavity C30.1 Middle ear Accessory sinuses C31.0 Maxillary sinus C31.1 Ethmoid sinus C31.2 Frontal sinus C31.3 Sphenoid sinus C31.9 Accessary sinus , NOS Larynx C32.0 Glottis C32.1 Supraglottis C32.2 Subglottis C32.3 Laryngeal cartilage C32.9 Larynx, NOS Trachea C33.9 Trachea Bronchus and lung C34.0 Main bronchus C34.1 Upper lobe, lung C34.2 Middle lobe, lung C34.3 Lower lobe, lung C34.9 Lung, NOS Thymus C37.9 Thymus Heart, mediastinum and pleura C38.3 Mediastinum, NOS C38.4 Pleura, NOS C38.8 Overlapping lesion of heart, mediastinum and pleura Other and ill defined sites within respiratory system and intrathoracic organs C39.9 Ill defined sites within respiratory system 69 137 1 17 41 6 84 9 2 1 16 593 376 15 25 444 8 18 3 2 0 2905 35 52 9 4
78

ICD-O Code Bones, joints and articular cartilage of limbs C40.0 Long bones of upper limb, scapula and associated joints C40.1 Short bones of upper limb, and associated joints C40.2 Long bones of lower limb and associated joints C40.3 Short bones of lower limb and associated joints C40.9 Bones of limb, NOS Bones, joints and articular cartilage of other and unspecified sites C41.0 Bones of skull and face and associated joints C41.1 Mandible C41.2 Vertebral column C41.3 Rib, sternum, clavicle and associated joints C41.4 Pelvic bones, sacrum, coccyx and associated joints C41.9 Bone, NOS Haemopoetic and reticuloendothelial system C42.0 Blood C42.1 Bone marrow C42.2 Spleen Skin C44.0 C44.1 C44.2 C44.3 C44.4 C44.5 C44.6 C44.7 C44.9 Skin of lip, NOS Eyelid External ear Skin of other and unspecified parts of face Skin of scalp and neck Skin of trunk Skin of upper limb and shoulder Skin of lower limb and hip Skin, NOS 2001-2005 Male Female 2001 Male Female 2002 Male Female 2003 Male Female 2004 Male Female 2005 Male Female
31 8 114 8 23
18 11 79 5 19
10 2 23 0 2
5 1 19 2 1
5 2 25 0 3
3 4 12 2 4
6 1 24 6 2
4 4 13 0 6
7 1 18 2 11
4 0 14 1 1
3 2 24 0 5
2 2 21 0 7
14 7 33 11 17 18
10 12 14 13 14 16
3 1 5 2 4 3
1 5 5 0 4 1
6 3 8 1 4 3
1 1 2 3 2 3
3 0 2 3 2 2
3 2 5 3 4 3
1 1 7 3 4 5
2 2 1 4 0 3
1 2 11 2 3 5
3 2 1 3 4 6
3 5 2510 2050 3 10 5 21 27 46 32 61 38 247 100 6 16 15 33 47 48 22 93 79
2 460 0 0 5 2 13 4 7 4 63 14
1 396 2 1 1 1 2 8 7 1 22 21
1 498 0 1 4 2 9 5 19 11 48 14
3 422 3 1 3 1 8 11 9 6 24 10
0 532 0 0 3 9 8 11 10 10 46 19
0 417 1 0 7 0 5 16 14 4 13 16
0 514 0 1 5 7 8 7 11 5 37 32
1 398 2 2 3 8 4 7 9 6 12 18
0 506 3 3 4 7 8 5 14 8 53 21
0 417 2 2 2 5 14 5 9 5 22 14
Peripheral nerves and autonomic nervous system C47.0 of head C47.1 of upper limb and shoulder C47.2 of lower limb and hip C47.3 of thorax C47.5 of pelvis C47.6 of trunk, NOS C47.9 Autonomic nervous system, NOS Retroperitoneum and peritoneum C48.0 Retroperitoneum C48.2 Peritoneum, NOS C48.8 Overlapping lesion of retroperitoneum and peritoneum
8 7 12 9 6 2 13 33 7 1
6 5 10 6 3 0 25 43 11 0
2 3 5 3 2 0 2 9 4 0
3 1 2 2 0 0 4 8 4 0
2 2 1 2 1 1 3 6 1 0
0 1 2 2 1 0 5 11 5 0
2 1 4 1 2 0 3 6 2 0
1 0 4 0 0 0 1 4 1 0
1 0 1 2 0 0 2 8 0 0
1 2 2 1 1 0 3 9 0 0
1 1 1 1 1 1 3 4 0 1
1 1 0 1 1 0 12 11 1 0
79

ICD-O Code Connective, subcutaneous and other soft tissues C49.0 of head, face, and neck C49.1 of upper limb and shoulder C49.2 of lower limb and hip C49.3 of thorax C49.4 of abdomen C49.5 of pelvis C49.9 NOS Breast C50.0 C50.4 C50.6 C50.9 Nipple Upper-outer quadrant of breast Axillary tail of breast Breast, NOS 2001-2005 Male 32 46 126 20 21 17 65 Female 37 32 114 33 21 20 64 2001 Male Female 7 8 25 6 4 2 10 7 5 28 7 8 5 4 2002 Male 7 13 26 5 6 3 6 Female 11 10 27 6 4 3 10 2003 Male Female 5 9 18 3 7 6 11 3 6 13 5 2 5 9 2004 Male Female 6 6 34 5 2 3 15 6 4 27 9 2 5 17 2005 Male Female 7 10 23 1 2 3 23 10 7 19 6 5 2 24
0 5 0 3 2 3 205 8353 4 124 155
0 3 0 0 1 3 42 1542 1 2 75 250 7 0 44 2 21 29 1 743 10 1 110 47 466 2 1 0 71 -
0 1 0 0 0 0 28 1579 4 1 63 297 8 1 33 0 25 31 1 752 7 0 115 55 539 0 0 1 85 -
0 0 0 0 0 0 48 1631 2 0 69 259 5 0 33 1 24 35 1 748 7 1 117 57 560 1 0 0 61 -
0 0 0 2 0 0 39 1744 1 0 44 273 15 0 35 0 31 31 0 816 8 1 138 54 627 5 1 0 80 -
0 1 0 1 1 0 48 1857 1 0 73 303 14 1 42 1 23 29 3 878 7 1 176 53 596 5 0 1 77 -
Vulva C51.0 Labium majus C51.9 Vulva, NOS Vagina C52.9 Vagina, NOS Cervix uteri C53.0 Endocervix C53.9 Cervix uteri Corpus uteri C54.1 Endometrium C54.2 Myometrium C54.9 Corpus uteri Uterus, NOS C55.9 Uterus, NOS Ovary C56.9 Ovary Other and unspecified female genital organs C57.0 Fallopian tube C57.1 Broad ligament C57.9 Female genital tract, NOS Placenta C58.9 Placenta Penis C60.0 Prepuce C60.2 Body of penis C60.9 Penis, NOS Prostate gland C61.9 Prostate gland C62.0 Undescended testes C62.1 Descended testes C62.9 Testis, NOS Other and unspecified male genital organs C63.2 Scrotum, NOS C63.9 Male genital organs, NOS
6 - 3937 39 4 656 266
- 2788 9 3 324 1382 49 2 187 13 2 2 374 -
3 2
0 0
0 1
1 1
2 0
0 0
80

ICD-O Code Kidney C64.9 Kidney Renal pelvis C65.9 Renal pelvis Ureter C66.9 Ureter Bladder C67.9 Bladder, NOS Other and unspecified urinary organs C68.0 Urethra C68.1 Paraurethral gland Eye and adnexa C69.0 Conjunctiva C69.2 Retina C69.3 Choroid C69.4 Ciliary body C69.5 Lacrimal gland C69.6 Orbit, NOS C69.9 Eye, NOS Meninges C70.0 Cerebral meninges C70.1 Spinal meninges C70.9 Meninges, NOS Brain C71.0 C71.1 C71.2 C71.3 C71.4 C71.5 C71.6 C71.7 C71.8 C71.9 Cerebrum Frontal lobe Temporal lobe Parietal lobe Occipital lobe Ventricle, NOS Cerebellum, NOS Brain stem Overlapping lesion of brain Brain , NOS 2001-2005 Male 312 3 5 526 2 0 15 31 1 2 3 8 8 4 0 18 13 62 56 99 17 10 49 29 13 417 Female 146 0 3 127 3 1 3 36 2 1 1 13 19 3 2 23 7 50 31 68 19 3 34 28 4 310 2001 Male Female 56 0 2 109 1 0 2 4 0 1 1 2 2 1 0 1 1 12 8 18 3 4 5 8 3 69 24 0 1 27 2 0 0 6 0 0 1 5 3 1 0 4 0 8 7 12 4 0 6 5 0 47 2002 Male 55 1 2 112 1 0 3 5 0 1 0 3 1 1 0 4 5 13 14 22 3 3 14 3 4 72 Female 35 0 0 30 0 0 0 9 0 0 0 0 5 1 1 2 1 14 8 13 3 0 7 8 3 62 2003 Male Female 59 0 0 84 0 0 3 8 0 0 0 1 2 1 0 4 3 20 14 31 2 2 9 7 2 73 26 0 1 15 0 0 1 2 0 1 0 4 2 1 0 4 3 9 6 20 3 0 2 7 1 49 2004 Male Female 73 1 1 100 0 0 3 6 0 0 1 1 1 1 0 3 3 8 8 20 3 1 10 7 1 86 30 0 1 20 0 0 1 5 1 0 0 2 4 0 0 8 1 8 4 16 2 2 10 3 0 69 2005 Male Female 69 1 0 121 0 0 4 8 1 0 1 1 2 0 0 6 1 9 12 8 6 0 11 4 3 117 31 0 0 35 1 1 1 14 1 0 0 2 5 0 1 5 2 11 6 7 7 1 9 5 0 83
Spinal cord, cranial nerves and other parts of central nervous system C72.0 Spinal cord C72.1 Cauda equina C72.2 Olfactory nerve C72.5 Cranial nerve, NOS C72.9 Nervous system, NOS Thyroid gland C73.9 Thyroid Gland Adrenal gland C74.0 Cortex of adrenal gland C74.1 Medulla of adrenal gland C74.9 Adrenal Gland
15 0 5 0 5
5 1 4 1 5
2 0 0 0 1 106 1 1 3 4 4 1 0
1 0 0 1 1 337 4 2 1 3 3 2 1
6 0 2 0 0 129 1 0 5 0 6 4 0
3 0 3 0 0 451 0 2 0 6 3 2 0
1 0 0 0 2 125 2 1 3 7 6 1 0
0 0 0 0 0 435 4 1 2 5 7 5 0
0 0 1 0 2 150 0 0 5 5 2 1 0
1 0 0 0 3 555 0 0 2 8 3 0 0
6 0 2 0 0 160 1 3 5 1 5 2 0
0 1 1 0 1 592 5 3 7 5 1 2 0
670 2370 5 5 21 13 8 12 27 17 11 1
Other endocrine glands and related structures C75.1 Pituitary gland 17 C75.2 Craniopharyngeal duct 23 C75.3 Pineal gland 9 C75.5 Aortic body and other paraganglia 0
81

ICD-O Code Other and ill defined sites C76.0 Head, face or neck, NOS C76.1 Thorax, NOS C76.2 Abdomen, NOS C76.3 Pelvis, NOS C76.5 Lower limb, NOS C76.8 Overlapping lesion of ill defined sites 2001-2005 Male 55 6 24 6 0 23 Female 25 2 24 18 2 21 68 15 19 28 21 2 1 751 829 2001 Male Female 33 2 7 1 0 15 17 4 6 3 15 0 0 186 282 16 0 3 0 0 5 13 0 2 7 2 1 1 98 160 2002 Male 15 0 3 1 0 0 45 7 18 11 20 0 0 184 276 Female 5 0 3 2 1 5 23 8 9 7 8 0 0 89 199 2003 Male Female 4 2 2 4 0 2 25 5 3 3 9 0 0 256 319 0 0 5 5 0 6 9 3 3 7 4 0 0 146 214 2004 Male Female 2 1 8 0 0 4 25 5 5 7 12 0 0 244 232 0 2 10 10 1 4 15 4 3 4 7 1 0 196 118 2005 Male Female 1 1 4 0 0 2 9 1 0 3 2 1 0 335 257 4 0 3 1 0 1 8 0 2 3 0 0 0 222 138
Lymph nodes C77.0 Lymph nodes of head, face and neck 121 C77.1 Intrathoracic lymph nodes 22 C77.2 Intra-abdominal lymph nodes 32 C77.3 Lymph nodes of axilla or arm 27 C77.4 Lymph nodes of inguinal region or leg 58 C77.5 Pelvic lymph nodes 1 C77.8 Lymph nodes of multiple regions 0 C77.9 Lymph node, NOS 1205 Unknown primary site C80.9 Unknown primary site Total 1366
27664 33020 5262 5901 5283 6351 5437 6445 5624 7009 6058 7314
82

ICD-O Code Lip C00.0 C00.1 C00.3 C00.6 C00.8 C00.9
Table 33 Cancer incidence by ethnicity, sex and sub-site 2001-2005

All Sinhala Tamil Muslim Male Female Male 10 50 0 2 0 17 343 17 9 0 1 1 748 110 139 74 2 245 46 137 13 3 121 Female 2 10 1 1 3 45 4 3 1 1 186 41 53 30 1 38 11 13 2 1 31 347 3 22 53 95 24 9 1 1 59 3 1 1 20 Male Female 0 6 0 0 0 3 73 6 0 1 0 0 134 19 28 10 2 45 12 25 2 0 22 211 0 27 19 20 1 1 4 2 42 14 0 0 0 0 17 2 10 1 0 2 20 2 0 0 0 61 8 27 7 1 27 9 4 0 0 12 210 0 13 19 13 3 1 0 1 8 2 0 0 9 Male Female 1 2 0 0 1 0 14 0 0 0 0 0 26 6 6 0 0 8 2 10 0 0 7 42 1 6 9 9 2 0 1 1 12 3 0 1 0 0 8 1 1 0 0 0 1 0 2 0 0 17 4 6 3 0 5 1 2 0 0 3 47 0 3 2 8 0 2 0 0 2 0 0 0 0
Other Male Female 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 2 0 0 0 1 0 0 0 0 0 0 0 0 0
External upper lip External lower lip Mucosa of upper lip Commissure of lip Overlapping lesion of lip Lip, NOS
11 58 0 2 1 20 431 23 9 1 1 1 910 135 173 84 4 298 60 173 15 3 150 1370 9 148 160 159 34 14 11 7 392 85 1 4 1 1 163
5 21 2 1 0 5 66 6 5 0 1 1 264 53 86 41 2 70 21 19 3 1 47
Base of tongue C01.9 Base of tongue, NOS Other and unspecified parts of tongue C02.0 Dorsal surface of tongue, NOS C02.1 Border of tongue C02.2 Ventral surface of tongue C02.3 Anterior 2/3 of tongue, NOS C02.4 Lingual tonsil C02.9 Tongue, NOS Gum C03.0 Upper gum C03.1 Lower gum C03.9 Gum, NOS Floor of mouth C04.0 Anterior floor of mouth C04.9 Floor of mouth, NOS Palate C05.0 C05.1 C05.2 C05.8 C05.9 Hard palate Soft palate, NOS Uvula Overlapping lesion of palate Palate, NOS
Other and unspecified parts of mouth C06.0 Cheek mucosa C06.1 Vestibule of mouth C06.2 Retromolar area C06.9 Mouth, NOS Parotid gland C07.9 Parotid gland Other and unspecified major salivary glands C08.0 Submandibular gland C08.9 Major salivary gland, NOS Tonsil C09.0 Tonsillar fossa C09.1 Tonsillar pillar C09.9 Tonsil, NOS Oropharynx C10.0 Vallecula C10.2 Lateral wall of oropharynx C10.3 Posterior wall of oropharynx C10.4 Branchial cleft C10.8 Overlapping lesion of oropharynx C10.9 Oropharynx, NOS
606 1116 3 8 38 115 74 132 117 27 12 1 2 69 5 0 1 0 1 29 130 31 13 6 4 334 68 1 3 1 1 138
83

ICD-O Code Nasopharynx C11.0 Superior wall of nasopharynx C11.3 Anterior wall of nasopharynx C11.9 Nasopharynx, NOS Pyriform fossa C12.9 Pyriform sinus Hypopharynx C13.0 Postcricoid region C13.2 Posterior wall of hypopharynx C13.9 Hypopharynx, NOS Other and ill-defined sites in lip, oral cavity and pharynx C14.0 Pharynx, NOS C14.8 Overlapping lesion of lip, oral cavity and pharynx Esophagus C15.0 Cervical esophagus C15.3 Upper third of esophagus C15.4 Middle third of esophagus C15.5 Lower third of esophagus C15.9 Esophagus, NOS Stomach C16.0 Cardia, NOS C16.3 Gastric antrum C16.4 Pylorus C16.9 Stomach, NOS Small intestine C17.0 Duodenum C17.1 Jejunum C17.2 Ileum C17.9 Small intestine, NOS Colon C18.0 C18.1 C18.2 C18.3 C18.4 C18.5 C18.6 C18.7 C18.9 Caecum Appendix Ascending colon Hepatic flexure of colon Transverse colon Splenic flexure of colon Descending colon Sigmoid colon Colon, NOS All Male Female 1 1 108 619 81 0 61 0 1 0 62 Sinhala Male 1 1 85 502 61 45 Female 1 47 68 62 1 17 Tamil Male Female 0 0 14 87 15 11 0 9 29 27 0 5 Muslim Male Female 0 0 9 26 4 4 0 6 5 5 0 1 Other Male Female 0 0 0 4 1 0 1 0 0 0 0 0 0
102 94 1 23 0 55 2
147 5
120 4
36 2
20 1 1 7 45 41 237 2 4 6 104 6 1 1 1 4 3 3 1 3 0 1 15 30 6 63 6 3 0
18 0 0 7 93 53 408 2 1 3 54 0 0 0 2 5 0 4 0 3 0 0 10 22 4 43 1 5 0
7 0 0 2 6 6 54 0 0 1 33 1 0 0 4 6 0 1 0 1 0 2 5 24 2 43 2 1 0
1 0 0 1 11 13 61 0 0 0 5 1 0 2 2 1 0 3 1 4 0 0 7 15 5 36 2 0 1
0 0 0 0 0 0 2 0 0 0 5 0 0 0 0 1 0 0 0 0 0 0 1 4 0 1 1 0 0
0 0 0 0 2 0 3 0 0 0 1 1 0 0 1 0 0 0 0 0 0 0 1 4 0 2 1 0 0
0 3 0 2 0 33 36 24 28 216 406 165 300 277 261 230 195 1716 1897 1423 1425 42 11 14 635 23 7 8 19 61 8 32 11 30 9 13 125 379 61 812 54 34 10 0 14 5 7 228 15 5 6 19 55 6 24 4 34 4 13 153 361 50 742 32 21 7 40 7 7 493 16 6 7 14 50 5 28 10 26 9 10 104 321 53 705 45 30 10 12 4 4 168 13 5 4 14 49 6 17 3 27 4 13 135 320 41 661 28 16 6
Recto-sigmoid junction C19.9 Rectosigmoid junction Rectum C20.9 Rectum, NOS Anus and anal canal C21.0 Anus, NOS C21.1 Anal canal C21.8 Overlapping lesion of rectum, anus and anal canal
84

ICD-O Code Liver and intrahepatic bile ducts C22.0 Liver C22.1 Intrahepatic bile duct Gallbladder C23.9 Gallbladder Other and unspecified parts of biliary tract C24.0 Extrahepatic bile duct C24.1 Ampulla of Vater C24.9 Biliary tract, NOS Pancreas C25.0 Head of pancreas C25.9 Pancreas, NOS Other and ill-defined digestive organs C26.0 Intestinal tract, NOS C26.9 Gastrointestinal tract, NOS Nasal cavity and middle ear C30.0 Nasal cavity C30.1 Middle ear Accessory sinuses C31.0 Maxillary sinus C31.1 Ethmoid sinus C31.2 Frontal sinus C31.3 Sphenoid sinus C31.9 Accessory sinus, NOS Larynx C32.0 Glottis C32.1 Supraglottis C32.2 Subglottis C32.3 Laryngeal cartilage C32.9 Larynx, NOS Trachea C33.9 Trachea Bronchus and lung C34.0 Main bronchus C34.1 Upper lobe, lung C34.2 Middle lobe, lung C34.3 Lower lobe, lung C34.9 Lung, NOS Thymus C37.9 Thymus Heart, mediastinum and pleura C38.3 Mediastinum, NOS C38.4 Pleura, NOS C38.8 Overlapping lesion of heart, mediastinum and pleura Other and ill-defined sites within respiratory system and intrathoracic organs C39.9 Upper respiratory tract All Male Female 452 35 42 35 41 4 69 137 1 17 41 6 84 9 2 1 16 593 376 15 25 444 8 18 3 2 0 2905 35 52 9 4 167 37 92 0 34 16 4 0 61 104 2 11 24 13 54 7 0 1 8 53 50 1 6 40 4 Sinhala Male 380 29 30 31 36 3 59 116 1 15 36 5 65 7 2 1 12 504 295 15 21 358 8 Female 141 35 72 26 14 4 49 90 1 9 19 11 36 7 1 5 45 37 1 1 28 4 2 2 1 0 585 24 14 6 1 Tamil Male Female 34 4 9 3 3 1 5 9 0 1 5 0 13 2 0 0 3 57 64 0 1 53 0 2 0 0 233 3 5 1 1 10 1 15 5 2 0 7 11 1 0 4 0 14 0 0 3 6 9 0 3 7 0 0 0 0 0 62 0 1 1 0 Muslim Male Female 36 2 3 1 2 0 5 12 0 1 0 1 6 0 0 0 1 30 17 0 3 29 0 3 0 0 256 2 3 2 1 15 1 5 3 0 0 5 3 0 2 1 2 4 0 0 0 2 4 0 2 5 0 0 0 0 1 39 2 0 0 0 Other Male Female 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 4 0 0 0 0 8 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0
2 13 2 3 1 2 1 689 2408 26 15 7 1 30 44 6 2
85

ICD-O Code Bones, joints and articular cartilage of limbs C40.0 Long bones of upper limb, scapula and associated joints C40.1 Short bones of upper limbs and associated joints C40.2 Long bones of lower limb and associated joints C40.3 Short bones of lower limb and associated joints C40.9 Bone of limb, NOS Bones, joints and articular cartilage of other and unspecified sites C41.0 Bones of skull and face and associated joints C41.1 Mandible C41.2 Vertebral column C41.3 Rib sternum, clavicle and associated joints C41.4 Pelvic bones, sacrum, coccyx and associated joints C41.9 Bone, NOS Haemopoetic and reticuloendothelial systems C42.0 Blood C42.1 Bone marrow C42.2 Spleen Skin C44.0 C44.1 C44.2 C44.3 C44.4 C44.5 C44.6 C44.7 C44.9 Skin of lip, NOS Eyelid External ear Skin of other and unspecified parts of face Skin of scalp and neck Skin of trunk Skin of upper limb and shoulder Skin of lower limb and hip Skin, NOS All Male Female Sinhala Male Female Tamil Male Female Muslim Male Female Other Male Female
31 8 114 8 23
18 11 79 5 19
23 8 96 6 21
14 11 60 4 16
7 0 9 1 2
2 0 11 1 1
1 0 9 1 0
2 0 7 0 2
0 0 0 0 0
0 0 1 0 0
14 7 33 11 17 18
10 12 14 13 14 16
13 3 27 9 12 18
8 11 12 10 9 15
0 2 3 1 3 0 0 223 0 2 2 1 4 6 14 5 22 15 0 0 2 0 1 0 3 3 1 0 3 3 12 3 2 1 5
0 1 1 2 3 1 1 189 2 1 4 0 2 6 4 2 8 7 1 1 2 1 0 0 3 5 1 0 2 1 11 1 1 3 7 1 0 1 825
1 2 3 1 2 0 0 159 0 0 3 3 0 4 1 4 14 9 1 0 0 0 0 0 0 1 1 0 8 6 7 0 4 2 8
2 0 1 0 2 0 0 107 2 2 0 0 1 2 5 2 8 4 0 0 0 0 0 0 2 3 0 0 2 1 9 3 1 0 6 1 0 0 515
0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 1
0 0 0 1 0 0 0 8 0 0 0 0 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 32
3 5 3 4 2510 2050 2122 1746 3 10 3 6 5 21 27 46 32 61 38 247 100 8 7 12 9 6 2 13 33 7 1 32 46 126 20 21 17 65 6 16 15 33 47 48 22 93 79 6 5 10 6 3 0 25 43 11 0 37 32 114 33 21 20 64 3 16 23 42 22 46 29 211 76 7 7 10 9 5 2 10 0 28 5 1 20 37 106 17 15 14 51 3 12 15 29 39 39 18 76 67 5 4 8 5 3 0 20 35 10 0 33 29 94 29 19 17 51
Peripheral nerves and autonomic nervous system C47.0 ... of head, face and neck C47.1 ... of upper limb and shoulder C47.2 ... of lower limb and hip C47.3 ... of thorax C47.5 ... of pelvis C47.6 ... of trunk, NOS C47.9 ... NOS Retroperitoneum and peritoneum C48.0 Retroperitoneum C48.2 Peritoneum, NOS C48.8 Overlapping lesion of retroperitoneum and peritoneum Connective, subcutaneous and other soft tissues C49.0 ... of head, face and neck C49.1 ... of upper limb and shoulder C49.2 ... of lower limb and hip C49.3 ... of thorax C49.4 ... of abdomen C49.5 ... of pelvis C49.9 ... NOS Breast C50.0 C50.4 C50.6 C50.9 Nipple Upper-outer quadrant of breast Axillary tail of breast Breast, NOS
0 5 0 3 2 3 205 8353
3 3 2 2 160 6981
0 27
0 16
0 2
86

ICD-O Code Vulva C51.0 Labium majus C51.9 Vulva, NOS Vagina C52.9 Vagina, NOS Cervix uteri C53.0 Endocervix C53.9 Cervix uteri Corpus uteri C54.1 Endometrium C54.2 Myometrium C54.9 Corpus uteri Uterus, NOS C55.9 Uterus, NOS Ovary C56.9 Ovary Other and unspecified female genital organs C57.0 Fallopian tube C57.1 Broad ligament C57.9 Female genital tract, NOS Placenta C58.9 Placenta Penis C60.0 Prepuce C60.2 Body of penis C60.9 Penis, NOS Prostate gland C61.9 Prostate gland Testis C62.0 Undescended testis C62.1 Descended testis C62.9 Testis, NOS Other and unspecified male genital organs C63.2 Scrotum, NOS C63.9 Male genital organs, NOS Kidney C64.9 Kidney, NOS Renal pelvis C65.9 Renal pelvis Ureter C66.9 Ureter Bladder C67.9 Bladder, NOS Other and unspecified urinary organs C68.0 Urethra C68.1 Paraurethral gland 9 3 324 1382 49 2 187 3 2 312 3 5 526 2 0 266 2788 13 2 2 374 8 3 257 All Male Female 4 124 155 6 3937 39 4 656 231 2391 12 1 2 323 116 0 3 112 3 1 1 0 60 118 4 1 14 0 0 27 0 1 39 0 0 Sinhala Male Female 4 93 129 4 3180 31 2 573 20 245 0 1 0 30 17 0 0 10 0 0 0 0 7 69 4 1 9 0 0 31 0 1 34 0 0 Tamil Male Female 0 27 23 2 634 5 2 43 14 145 1 0 0 20 12 0 0 5 0 0 0 0 0 2 0 0 0 0 0 0 0 0 3 0 0 Muslim Male Female 0 3 3 0 114 2 0 35 Other Male Female 0 1 0 0 9 1 0 5 1 7 0 0 0 1 1 0 0 0 0 0
- 1193 146 0 3 127 3 1 41 0 164 3 2 254 3 3 450 2 0
87

ICD-O Code Eye and adnexa C69.0 Conjunctiva C69.2 Retina C69.3 Choroid C69.4 Ciliary body C69.5 Lacrimal gland C69.6 Orbit, NOS C69.9 Eye, NOS Meninges C70.0 Cerebral meninges C70.1 Spinal meninges C70.9 Meninges, NOS Brain C71.0 C71.1 C71.2 C71.3 C71.4 C71.5 C71.6 C71.7 C71.8 C71.9 Cerebrum Frontal lobe Temporal lobe Parietal lobe Occipital lobe Ventricle, NOS Cerebellum, NOS Brain stem Overlapping lesion of brain Brain, NOS All Male Female 15 31 1 2 3 8 8 4 0 18 13 62 56 99 17 10 49 29 13 417 3 36 2 1 1 13 19 3 2 23 7 50 31 68 19 3 34 28 4 310 Sinhala Male 12 22 1 2 3 8 6 3 12 11 51 48 85 9 7 42 24 10 353 Female 2 30 2 1 1 11 14 3 2 21 7 39 26 63 19 3 30 24 4 274 Tamil Male Female 1 3 0 0 0 0 1 1 0 6 2 8 5 9 5 3 2 3 3 28 0 3 0 0 0 2 3 0 0 1 0 6 3 1 0 0 3 3 0 18 Muslim Male Female 2 5 0 0 0 0 1 0 0 0 0 3 3 4 3 0 5 2 0 32 1 3 0 0 0 0 2 0 0 1 0 5 2 4 0 0 1 1 0 17 Other Male Female 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
Spinal cord, cranial nerves, and other parts of central nervous system C72.0 Spinal cord C72.1 Cauda equina C72.2 Olfactory nerve C72.5 Cranial nerve, NOS C72.9 Nervous system, NOS Thyroid gland C73.9 Thyroid gland Adrenal gland C74.0 Cortex of adrenal gland C74.1 Medulla of adrenal gland C74.9 Adrenal gland, NOS Other endocrine glands and related structures C75.1 Pituitary gland C75.2 Craniopharyngeal duct C75.3 Pineal gland C75.5 Aortic body and other paraganglia Other and ill-defined sites C76.0 Head, face or neck, NOS C76.1 Thorax, NOS C76.2 Abdomen, NOS C76.3 Pelvis, NOS C76.5 Lower limb, NOS C76.8 Overlapping lesion of ill-defined sites
15 0 5 0 5
5 1 4 1 5
13 0 4 0 5
5 1 4 1 5
0 0 1 0 0 53 0 2 1 2 2 0 0 6 1 4 1 0 3
0 0 0 0 0 157 0 0 1 4 1 0 0 3 0 1 2 0 3
2 0 0 0 0 33 1 0 1 1 1 0 0 1 0 3 0 0 1
0 0 0 0 0 110 1 0 1 3 1 0 0 1 0 3 1 0 1
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 11 0 0 0 0 0 0 0 0 0 0 0 0 0
670 2370 5 5 21 17 23 9 0 55 6 24 6 0 23 13 8 12 27 17 11 1 25 2 24 18 2 21
583 2092 4 3 19 14 20 9 0 48 5 17 5 0 19 12 8 10 20 15 11 1 21 2 20 15 2 17
88

ICD-O Code Lymph nodes C77.0 Lymph nodes of head, face and neck C77.1 Intrathoracic lymph nodes C77.2 Intra-abdominal lymph nodes C77.3 Lymph nodes of axilla or arm C77.4 Lymph nodes of inguinal region or leg C77.5 Pelvic lymph nodes C77.8 Lymph nodes of multiple regions C77.9 Lymph nodes, NOS Unknown primary site C80.9 Unknown primary site Total All Male Female 121 22 32 27 58 1 0 1205 1366 68 15 19 28 21 2 1 751 Sinhala Male 95 15 25 27 48 0 0 989 Female 59 10 18 21 17 2 1 646 682 Tamil Male Female 12 3 5 0 3 0 0 131 155 4 3 0 7 3 0 0 60 100 Muslim Male Female 12 4 2 0 7 0 0 81 82 5 2 1 0 1 0 0 41 45 Other Male Female 2 0 0 0 0 1 0 4 2 79 0 0 0 0 0 0 0 4 2 116
829 1127
27664 33020 22910 27200 3118 4009
1557 1695
89
Table 34 Cancer incidence by age group and sub-site 2001-2005 Males

ICD-O Code Lip All Ext upper lip 11 2 1 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 2 2 4 1 1 1
C00.1 C00.8 C00.9 C00.6
C00.0
Ext lower lip
Overlapping lesion of lip Lip, NOS
Commissure of lip
58 1
1 1
3 1
15
11 13
20
Base of tongue C01.9
Base of tongue, NOS
431
27
39
66
50
69
65
50 52
Other and unspecified parts of tongue C02.0 C02.1 Dorsal surface of tongue, NOS 23 9 1 1 3 4 5 4 1 4
C02.2
C02.3 C02.4
Ventral surface of tongue, NOS Anterior 2/3 of tongue, NOS Lingual tonsil Tongue, NOS
Border of tongue
1 1
1 1 99 90
C02.9
910
31
84
94 151 108 138 102
Gum
C03.9
C03.1
C03.0
Gum, NOS
Lower gum
Upper gum
173 84
135
18 9
15
17 7
18
14
34
23
12
24
16
12 17
34 28
17 28
Floor of mouth C04.0 C04.9 Palate C05.1 C05.0
Anterior floor of mouth Floor of mouth, NOS
298
10
21
34
50
36
42
32
35 36
C05.8 C05.9
C05.2
Overlapping lesion of palate Palate, NOS
Uvula
Soft palate
Hard palate
173 15 3
60
12
18 2
27 3
17 1 1
31 1 2
25 2
12 23 3 2 1
13 17
150
17
16
25
20
35 16
Other and unspecified parts of mouth C06.1 C06.0 Vestibule of mouth Cheek mucosa
1370 148 9
C06.9
C06.2
Mouth, NOS
Retromolar area
160
20 4
36 5 1
61 156 164 233 214 223 255 8 26 13 2 20 1 15 29 27 2 2
23
18
26
22
30 31
Parotid gland C07.9
Parotid gland
159
14
11
16
18
15
17
16 16
Other and unspecified major salivary glands C08.9 C08.0
Major salivary gland, NOS
Submandibular gland
14
34
4 1
90

ICD-O Code Tonsil C09.1 C09.0 All Tonsillar fossa 11 392 7 1 2 2 3 11 28 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 55 3 3 50 4
C09.9
Tonsil, NOS
Tonsillar pillar
36
59
62
37 46
Oropharynx C10.0 C10.2
Vallecula
C10.3 C10.4 C10.8 C10.9
Lateral wall of oropharynx Branchial cleft
85 1 4 1 1
2 1
9 2
14
17
13
Posterior wall of oropharynx
1 1
11 11
Overlapping lesion of oropharynx Oropharynx
163
18
27
17
27
26
16 25
Nasopharynx C11.3 C11.0
C11.9
Anterior wall of nasopharynx Nasopharynx
Superior wall of nasopharynx 1 108 1 4 3 5 7 4 6 12 9
1 10 9
17
13
Pyriform sinus C12.9
Pyriform sinus
619
20
39
91
71 116 112
91 65
Hypopharynx C13.1 C13.2 C13.9 C13.0
Hypopharyngeal aspect of aryepigiottic fold Hypopharynx, NOS
Postcricoid region
81
14
14
12
10
61
10
15
11
10
Other and Ill-defined sites C14.0 Pharynx, NOS
Lip, Oral Cavity and Pharynx C14.8 Overlapping lesion of lip, oral cavity and pharynx
147 5
17
13
25
22 2
23 1
23 13 1 1
Esophagus C15.0 C15.4 C15.3
Cervical esophagus
C15.9
C15.5
Esophagus, NOS
1716
277
216
33
3 2
21
71 124 220 240 261 286 261 225
19
21
2 28 6
42
35
32
46
39
40
35
37 41
31 20
Stomach C16.2 C16.4 C16.0
C16.3
Body of stomach Pylorus Gastric antrum
Cardia. NOS
42 11 4
2 2
4 1
4 2
2 1
7 2
14
1 2 4
6 1
C16.9
Stomach, NOS
635
14
18
47
72 101
90
91 101
75 29
91

ICD-O Code Small intestine C17.1 C17.0 All 23 8 7 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 1 2 5 1 4 2 2 3 1 2 4
C17.9
C17.2
Small intestine, NOS
Ileum
Jejunum
Duodenum
2 1 4
1 3 1
1 4 1
2 3 1
19
Colon C18.1 C18.0
C18.3 C18.5 C18.6 C18.9 C18.7 C18.4
C18.2
Hepatic flexure of colon Splenic flexure of colon Descending colon Colon, NOS Sigmoid colon Transverse colon
Ascending colon
Appendix
Caecum
61 32 30 13 9 11 8
1 3 1 1
3 1
7 4
8 5
379
125
1 2 5 2
1 2
2 12
1 7
3 2 7 1 4
4 2 2
1 3 22 3 7
6 3
7 1 2 1
2 2
5 3 1 1 2 2
1 17 1
18
25
36
52
16
53
58
46
19
35 32
15 16
Recto-sigmoid junction C19.9
Rectosigmoid juntion
61
10
10
5 10
Rectum C20.9
Rectum, NOS
812
12
15
21
42
80
79 110 107 108 114 118
Anus and anal canal C21.1 C21.0 Anal canal Anus, NOS
C21.8
34 10
54
1 1
7 2
10 4
5 2
3 1
3 2
6 6 1
Liver and intrahepatic bile ducts C22.1 C22.0 Intrahepatic bile duct Liver
452 35
15
13 3
24 4
37 2
73 3
84 7
67 4
58 63 5 5
Gallbladder C23.9
Gallbladder
42
Other and unspecified parts of biliary tracts C24.1 C24.0
C24.9
Billiary tract
Ampulla of Vater
Extrahepatic bile duct
41 4
35
Pancreas C25.9 C25.0
Pancreas, NOS
Head of pancreas
137
69
11
19
11 9
26
10
18
15
10 14
Other and ill defined digestive organs C26.9 C26.0 Gastrointestinal tract, NOS Intestinal tract, NOS
17
92

ICD-O Code Nasal cavity and middle ear C30.1 C30.0 Middle ear Nasal cavity All 41 6 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 2 1 2 3 4 8 3 5 2 6 3 1 2 2
Accessory sinuses C31.1 C31.0
C31.3 C31.9
C31.2
Sphenoid sinus
Frontal sinus
Ethmoid sinus
Maxillary sinus
84 2 9
10 1 5 3
19
15
Accessary sinus , NOS
16
1 1 1
7 15
Larynx C32.1 C32.0
C32.9
C32.3
C32.2
Larynx, NOS
Laryngeal cartilage
Subglottis
Supraglottis
Glottis
376 25 15
593
18 2 1
17
32 1
36
52 3
90
54 3
89 109 66 3 3
58 3 3
95
49 40 4 5 2 7
83 64
444
15
32
60
62
73
76
72 44
Trachea C33.9
Trachea
Bronchus and lungs C34.1 C34.3 C34.2 C34.0
Upper lobe , lung Lower lobe, lung Lung , NOS
Main bronchus
18 3 2
Middle lobe, lung
1 1
5 1
C34.8 C34.9
Overlapping lesion of lung
2905
29
53 143 225 470 463 494 444 327 241
Thymus C37.9
Thymus
35
Heart, mediastinum, and pleura C38.4 C38.3 Pleura, NOS Mediastinum, NOS
52 9
C38.8
Overlapping lesion of heart, mediastinum and pleura 4
2 1
3 1 1
Other and ill defined sites within respiratory system and intra thoracic organs C39.9 Ill defined sites within respiratory system 1 1
93

ICD-O Code All Bones, joints and articular cartilage of limbs C40.0 C40.1 C40.2 C40.3 C40.9 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Bones of limb , NOS
Short bones of lower limb and associated joints
Long bones of lower limb and associated joints
Short bones of upper limb, and associated joints
Long bones of upper limb, scapula and associated joints 31 8 114 8
10
2 2
2 1 7 2 3
3 1 3 4
1 1
4 1 1 1 2
3 1 2
9 20
40 2
20 2
1 2
23
Bones, joints and articular cartilage of other and unspecified sites C41.0 C41.1 Bones of skull and face and associated joints 14 33 11 7 5 1 1 2 3 5 1 1 1 2 1 1 2 1 1 2 1 1 4 5 1 2 1 1 1 2 1
C41.3 C41.4 C41.9
C41.2
Bone, NOS
Pelvic bones, sacrum, coccyx and associated joints 17 18
Rib, sternum, clavicle and associated joints
Vertebral column
Mandible
1 3 4
2 1 1
2 2
Blood C42.0
Blood
Bone marrow C42.1
Bone marrow
2510
179 136 124 130 101
96 100
98 139 173 226 213 190 199 201 205
Spleen C42.2 Skin
Spleen
C44.3 C44.4
C44.2
C44.1
C44.0
C44.6 C44.7
C44.5
C44.9
Skin, NOS
Skin of lower limb and hip
Skin of upper limb and shoulder
Skin of trunk
Skin of scalp and neck
Skin of other and unspecified parts of face 46 61 38 32
External ear
Eyelid
Skin of lip, NOS
27
21
2 1 4 2 1 4 1
3 2 7 3
4 2
1 2
2 1
5 13 8 6 3
2 10 5 5 6
2 6
3 6 5
1 1
4 4
7 3
2 3
9 10 4 5
100
247
19 9
32 11
13
37
37 9
14
35
23 9
27 22 9 13
94

ICD-O Code Peripheral nerves and autonomic nervous System C47.1 C47.3 C47.2 C47.0 of upper limb and shoulder of thorax of lower limb and hip of head All 8 0-4 1 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 2 2 1 1 1 1 1 1 2 2 2 3 1 1 1 1 1
12 6 9
C47.9
C47.6
C47.5
Autonomic nervous system, NOS
of trunk, NOS
of pelvis
2 13
2 1
1 1
2 1
1 1 1
Retroperitoneum and peritoneum C48.2 C48.0 Peritoneum, NOS Retroperitoneum
33 7
C48.8
Overlapping lesion of retroperitoneum and peritoneum
Connective, subcutaneous and other soft tissues C49.1 C49.0
C49.9
C49.5
C49.4
C49.3
C49.2
NOS
of pelvis
of abdomen
of thorax
of lower limb and hip
of upper limb and shoulder 46 126 21 20
of head, face, and neck
32
3 1 2
65
17
3 2
4 1 2
12 2
1 3
3 3
10 2
17 1
14 1
11 3 2
4 2
9 10 1
Breast C50.6 C50.9
Axillary tail of breast Breast, NOS
205
19
16
33
29
34
15
22 26
Penis
C60.2 C60.9
C60.0
Body of penis Penis, NOS
Prepuce
9 324 3 7 7
13
1 20 43 1
3 52
2 47
3 42 33
27 33
Prostate gland C61.9 Testis
Prostate gland
1382
11
12
54
95 199 262 342 405
C62.1 C62.9
C62.0
Descended testes Testis, NOS
Undescended testes
49 187 2
1 9 1
1 3
2 9
4 23 1
7 28
4 28 1
9 24
6 20
5 11
4 7
1 11
2 8
2 2 2
1 1
Other and unspecified male genital organs C63.0 C63.9 C63.2 Epididymis Scrotum, NOS 3 1 1 1
Male genital organs
95

ICD-O Code Kidney C64.9 All Kidney 312 0-4 32 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 8 5 3 1 5 6 13 36 43 40 46 36 26 12
Renal pelvis C65.9
Renal pelvis
C66.9
Ureter
Ureter
Bladder C67.0 C67.9
Trigone of bladder Bladder, NOS
526
27
32
49
61
81
69 106 90
Other and unspecified urinary organs C68.0 Urethra
Eye and adnexa C69.2 C69.0 C69.3 Retina
Conjunctiva Choroid
31
15 1
27
1 1 1 2
3 1 1 1
C69.4 C69.5
Cillary body
C69.9
C69.6
Eye, NOS
Orbit, NOS
Lacrimal gland
2 3 1 2 1 1
1 1
Meninges C70.0 C70.1
Cerebral meninges Spinal meninges Meninges, NOS
4 18 2 4 1
1 4 1
2 2 3 1
C70.9
Brain C71.1 C71.0
C71.9
C71.8
C71.7
C71.6
C71.5
C71.4
C71.3
C71.2
Brain , NOS
Overlapping lesion of brain
Brain stem
Cerebellum, NOS
Ventricle, NOS
Occipital lobe
Parietal lobe
Temporal lobe
Frontal lobe
Cerebrum
417
13
29
49
10
17
99
56
62
13
1 1
1 2
3 13
13
8 10 6
30 15
14
2 1 3 26
4 5
1 3
5 1
4 3
30
23
34
10 2 4 2 9
13 1
10
13 1 2
11 1 3
16 4
40
39
2 1
1 2
50
37
25
1 21 10 10
Spinal cord, cranial nerves and other parts of central nervous system C72.1 C72.3 C72.0 Cauda equina Optic nerve Spinal cord
15 5
1 3
3 1
1 1
C72.2
Olfactory nerve
C72.5
C72.9
Cranial nerve, NOS
Nervous system, NOS
96

ICD-O Code Thyroid gland C73.9 All 670 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 3 5 10 42 56 64 62 60 55 62 61 63 44 50 33
Thyroid Gland
Adrenal gland C74.1 C74.0
C74.9
Medulla of adrenal gland Adrenal Gland
Cortex of adrenal gland
21
5 10
1 1
1 1
1 1
1 2 1
1 3
Other endocrine glands and related structures C75.0 C75.2 C75.1 Parathyroid gland Pituitary gland 17 9 1 1 1 1 1 3 1 2 1 1 2 3
C75.5
C75.3
Aortic body and other paraganglia
Pineal gland
Craniopharyngeal duct
23
Other and ill defined sites C76.1 C76.0 Thorax, NOS
Head, face or neck, NOS
55 24 6 6
C76.4
C76.3
C76.2
C76.5
Upper limb,
Pelvis,
Abdomen, NOS
1 1
1 2
1 2
5 4
10 1
1 9
1 2
7 2
8 1
C76.8
Lower limb,
Overlapping lesion of ill defined sites
23
Lymph nodes C77.0
C77.4 C77.5
C77.3
C77.2
C77.1
C77.8 C77.9
Pelvic lymph nodes
Lymph nodes of inguinal region or leg
Lymph nodes of axilla or arm 27 58 1
Intra-abdominal lymph nodes 32
Intrathoracic lymph nodes
Lymph nodes of head, face and neck
121 22
6 1
2 1
1 4
8 2
6 1
13 1 1
8 2
20 3 4
3 6
13 6 2
2 5
3 3
2 4
4 3
4 6
1 5
5 5
5 11
3 4
Lymph nodes of multiple regions Lymph node, NOS
1205
26
52 52
53
48
69
57
65
81
89 114 113 121
93
91 81
Unknown Primary Sites C80.9 All sites
Unknown primary site
1366 27664 373
1 311 306
2 386
18
36
76 125 190 174 220 205 151 155
413 472 567
822 1512 2107 3339 3292 3855 3517 3293 3099
97

ICD-O Code
Table 35 Cancer incidence by sub-site and age group 2001-2005 Females

Age Group All 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Lip
C00.0
C00.1 C00.3 C00.6 C00.9
Ext upper lip
Ext lower lip
Mucosa of upper lip Commissure of lip Lip, NOS
21 2 1 5
1 5 1 1
1 3
1 3
1 3
1 3 1 3
Base of tongue C01.9
Base of tongue, NOS
66
16
11
11
Other and unspecified parts of tongue C02.0 Dorsal surface of tongue, NOS Border of tongue 6 1 1 2 1 2
C02.2
C02.1
C02.3 C02.4 C02.9 Gum
Ventral surface of tongue, NOS Anterior 2/3 of tongue, NOS Lingual tonsil Tongue, NOS
1 264 1 1 2 4 10 6 23 39
1 37 1 44 40 33 25
C03.1
C03.0 C03.9
Lower gum Gum, NOS
Upper gum
86
53 41
1 1 1
1 2
11 2
4 5
20 4
16 7
12 15 7 13
Floor of mouth C04.8 C04.9 Palate C05.0 C05.1 C04.0
Overlapping lesion of floor of mouth Floor of mouth, NOS
Anterior floor of mouth
70
10
11
12
10
11
Hard palate Uvula Soft palate
21 3
C05.8 C05.9
C05.2
19 1
1 1
4 1 9
2 1 4
1 1 7
Overlapping lesion of palate Palate, NOS
47
Other and unspecified parts of mouth C06.1 C06.2 C06.9 C06.0 Vestibule of mouth Retromolar area Mouth, NOS Cheek mucosa
606 38 74 3
13 1 3
27 1 3
80 8 9
92 4 7
78 1 8 6
94 102 109 6 7 1 6 1 4
13 23
Parotid gland C07.9
Parotid gland
117
13
15
12
15
98

ICD-O Code Other and unspecified major salivary glands C08.9 C08.0 All 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Major salivary gland, NOS
Submandibular gland
12
27
1 1
1 1
1 1
5 3
5 2
2 2
2 1
Tonsil C09.0 C09.1 C09.9
Tonsillar fossa Tonsil, NOS
Tonsillar pillar
69
1 1 1 2 6 2 5 8 7 8 7
12 10
Oropharynx C10.0 C10.3
Vallecula
C10.8 C10.9
Posterior wall of oropharynx Overlapping lesion of oropharynx Oropharynx
5 1 1
29
Nasopharynx C11.0 C11.9
Superior wall of nasopharynx 1 Nasopharynx, NOS 62
Pyriform sinus C12.9
Pyriform sinus
102
13
19
17
11
14 14
Hypopharynx C13.0 C13.2 C13.9
Postcricoid region Posterior wall of hypopharynx
94 1
11
20
19
13
7 1
Hypopharynx, NOS
23
Other and Ill-defined sites C14.0 Pharynx, NOS
Lip, Oral Cavity and Pharynx C14.8 Overlapping lesion of lip, oral cavity and pharynx
55 2
4 2
10
Esophagus C15.3 C15.5 C15.4
C15.9
Esophagus, NOS
1897
261
406
36
1 7
14
41
12 11
68 134 253 266 301 313 273 227
23
28
33
49
35
68
39
69
41
59
45 28
69 43
Stomach C16.0 C16.3
Cardia. NOS Pylorus
C16.4 C16.9
Gastric antrum
14 7 5 1
2 9 16
1 1
1 2
4 4
Stomach, NOS
228
23
38
33
33
36
20 15
99

ICD-O Code Small intestine C17.0 C17.1 C17.2 C17.9 Colon C18.1 C18.0 All 15 5 6 4 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 2 1 1 1 3 5 1 2 3 2 2 4 1 3 3 1 1 1
Duodenum Jejunum Ileum
Small intestine, NOS
19
C18.2 C18.3 C18.5 C18.6 C18.9 C18.7 C18.4
Ascending colon
Appendix
Caecum
55 24 34 13 2 4 4 6 1 1 1
3 1 1
7 2
8 5 3 1 13 1 1
9 2 3 3 1 1
8 6 7 4 1
5 3 5 1 1 1
6 1 5 1 1
2 3 1 1
4 2 3 2 3
Hepatic flexure of colon Splenic flexure of colon Descending colon Colon, NOS Sigmoid colon Transverse colon
4 1 4
361
153
15
33
37
53
23
53
28
46
22
53
13
25 28
17 18
Recto-sigmoid junction C19.9
Rectosigmoid juntion
50
11
11
Rectum C20.9
Rectum, NOS
742
10
17
38
54
49 112 102
90
89
93 81
Anus and anal canal C21.0 C21.1 C21.8 Anus, NOS Anal canal
32 21 7
1 1
1 1
2 3
2 1 1
2 1 1
3 6 1
6 1 1
2 12 4 1 3
Liver and intrahepatic bileducts C22.1 C22.0 Intrahepatic bile duct Liver
167 37
17
12 2
14 2
20 6
19 6
22 3
16 5
23 12 5 5
Gallbladder C23.9
Gallbladder
92
13
10
10
16
11
12
Other and unspecified parts of biliary tracts C24.1 C24.9 Pancreas C25.9 C25.0 C24.0 Ampulla of Vater Billiary tract
Extrahepatic bile duct
16 4
34
2 1
9 2
4 1
Pancreas, NOS
Head of pancreas
104
61
14
11
14
15
12
6 14
Other and ill defined digestive organs C26.0 C26.9 Intestinal tract, NOS Gastrointestinal tract, NOS
11
100

ICD-O Code Nasal cavity and middle ear C30.0 C30.1 Nasal cavity Middle ear All 24 13 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 1 2 6 2 4 1 1 2 2 2 2 2 3 4 1
Accessory sinuses C31.0 C31.2 C31.1
Maxillary sinus Ethmoid sinus
54 7
3 1 1
5 1
10 2
4 2
1 1
C31.3
Frontal sinus
C31.9
Sphenoid sinus
Accessary sinus, NOS
Larynx C32.1 C32.0
C32.2 C32.9
C32.3
Subglottis
Supraglottis
Glottis
53 50 1 6 1
2 1
3 2 1
7 6 2
7 5 1
12
9 6 1
6 11
Larynx, NOS
Laryngeal cartilage
40
Trachea C33.9
Trachea
Bronchus and lungs C34.0 C34.1 C34.2 C34.3 C34.9 Thymus C37.9
Main bronchus
Upper lobe , lung Lower lobe, lung Lung , NOS
Middle lobe, lung
2 1 1
1 1 24 57
689
11
54
90
96
92
88
88 77
Thymus
26
Heart, mediastinum, and pleura C38.4 C38.3 Pleura, NOS Mediastinum, NOS
15 7
1 2
C38.8
Overlapping lesion of heart, mediastinum and pleura 1
Other and ill defined sites within respiratory system and intra thoracic organs C39.9 Ill defined sites within respiratory system
101

ICD-O Code Bones, joints and articular cartilage of limbs C40.0 All 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
C40.1 C40.2 C40.3 C40.9
Bones of limb, NOS
Short bones of lower limb and associated joints
Long bones of lower limb and associated joints
Short bones of upper limb, and associated joints
Long bones of upper limb, scapula and associated joints 18 11 79 5
4 1
2 1 14 1
2 1 12 2
1 1
1 2 6 1 3 1 5 1
1 1 1 1 3
2 1 1 1
3 1
6 12
19
Bones, joints and articular cartilage of other and unspecified sites C41.0 C41.1 Bones of skull and face and associated joints 10 2 1 2 4 2 1 3 1 2 1 2 1 2 1 2 1 2
C41.3 C41.4 C41.9
C41.2
Bone, NOS
Pelvic bones, sacrum, coccyx and associated joints 14 16
Rib, sternum, clavicle and associated joints
Vertebral column
Mandible
14 13
12
3 1 2
1 1 1
1 2 2 1
1 1
Blood C42.0
Blood
Bone marrow C42.1
Bone marrow
2050
156 100 77
78
61
78
70
92 123 144 221 173 190 194 158 135
Spleen C42.2 Skin
Spleen
10
C44.2 C44.3
C44.1
C44.0
External ear
Eyelid
Skin of lip, NOS
C44.6 C44.7
C44.5
C44.4
Skin of other and unspecified parts of face Skin of trunk Skin of scalp and neck
15
16
3 2
1 3
1 2
1 2
1 3
4 3
33 48 22 47
1 1 1 2 1 1 4 2
C44.9
Skin, NOS
7 2
3 1
4 5
6 1
3 3
5 2
2 4
4 10 9
79
93
15
12
14 9
12 11
12 8
13 14 11 8
102

ICD-O Code Peripheral nerves and autonomic nervous system C47.1 C47.0 of upper limb and shoulder of thorax of head All 6 5 0-4 1 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
C47.5 C47.9
C47.3
C47.2
of lower limb and hip
10 3 6
of pelvis
1 1
Autonomic nervous system, NOS
1 3 3
25
Retroperitoneum and peritoneum C48.2 C48.0 Peritoneum, NOS Retroperitoneum
43 11
4 3
Connective, subcutaneous and other soft tissues C49.1 C49.2 C49.4 C49.0 of upper limb and shoulder
of head, face, and neck
37 32
1 1
4 2
4 2
2 1 3
1 2 1
1 3 3
3 4 9 8
1 2 1
4 4 5
2 1 2 1
2 3 4
4 2 1
2 3 1
3 2 5
C49.3
of lower limb and hip of abdomen of thorax
114 21
33
1 1 2
2 1 4
3 1 3
5 1
2 1
12 1
12
12 3
11 6 4
11 3
10 1
C49.9
C49.5
NOS
of pelvis
64
20
Breast C50.4 C50.6 C50.9 Vulva C51.0 C51.9 C50.0
Upper outer quadrant of breast 3 Axillary tail of breast Breast , NOS 8353 3 2 17
Nipple
2 1
1 1
1 1
1 1
92 286 596 1101 14631516 1161 801 545 373 400
Labium majus Vulva, NOS
124
16
12
15
11
14 32
Vagina C52.9
Vagina, NOS
155
15
17
11
23
19
29 35
Cervix Uteri C53.9 C53.0
Cervix Uteri
Endocervix
3937
16
69 191 378 529 694 591 476 397 339 254
Corpus Uteri C54.1 C54.9 C54.2
Endometrium Myometrium
39 656 4
2 2 8
1 16
4 32
13 2
2 98 1
3 81
4 1
Corpus Uteri
61 151 143
35 29
Uterus, NOS C55.9
Uterus, NOS
266
25
33
55
53
36
26
11 14
103

ICD-O Code Ovary C56.9 All Ovary 2788 0-4 5 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ 5 31 70 67 109 101 142 271 378 477 344 290 222 171 105
Other and unspecified female genital organs C57.0 C57.1 C57.9 Placenta C58.9 Fallopian tube 13 2 2 1 4 1 5 1 1 1 1 1 1
Broad ligament
Placenta
374
24
80 103
63
44
25
19
10
Kidney C64.9
Kidney
146
19
10
11
21
18
10
15
11
C66.9
Ureter
Ureter
Bladder C67.0 C67.9
Trigone of bladder Bladder, NOS
127
14
14
22
22
14 22
Other and unspecified urinary organs C68.1 C68.0 Paraurethral gland Urethra
Eye and adnexa C69.0 C69.3 C69.2 Retina
Conjunctiva
C69.4
Choroid
36 2 1
33
3 1
1 1 1
2 1
C69.5
Cillary body Orbit, NOS
C69.9
C69.6
Lacrimal gland
Eye, NOS
19
13
Meninges C70.1 C70.0 C70.9
Spinal meninges Meninges, NOS
Cerebral meninges
23
2 2
1 2 2 5 2 1 2 2
C71.0 C71.1 C71.2 C71.3 C71.4 C71.5 C71.6 C71.7 C71.8 C71.9
Brain
Cerebrum 7 Frontal lobe 50 Temporal lobe 31 Parietal lobe 68 Occipital lobe 19 Ventricle, NOS 3 Cerebellum, NOS 34 Brain stem 28 Overlapping lesion of brain 4 Brain, NOS 310
1 1 5 7 17 3 3 8 3 2 1 9 8 3 1 4 3 12
6 3 1 1 1 2 11
2 2 1
8 4 8 1
5 1 5 1 1
1 9 7 5 1 2
2 7 3 10 2 1 1 34
1 5 1 11 3 1 2 1 31
7 4 4 2 2 1 27
1 1 7 4 1 23 2 15 1 5
1 1 1 1 2 1 12
2 1
21 16
13
29
1 25 16
104

ICD-O Code All Spinal cord, cranial nerves and other parts of central nervous system C72.1 C72.0 Cauda equine Spinal cord 0-4 Age Group 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
C72.5
C72.2
C72.9
Cranial nerve, NOS
Olfactory nerve
Nervous system, NOS
1 5
1 1 1 1
1 1
2 1 1 2 1 1
Thyroid gland C73.9
Thyroid Gland
2370
6 14
62 194 232 261 284 286 253 246 144 123 100
72 92
Adrenal gland C74.1 C74.0
C74.9
Adrenal Gland
Medulla of adrenal gland
Cortex of adrenal gland
13 12 8
1 5 3
1 2
1 1
Other endocrine glands and related structures C75.0 C75.2 C75.1 Parathyroid gland Pituitary gland 27 11 1 2 1 3 2 3 2 2 2 5 1 4 3 1
C75.5
C75.3
Aortic body and other paraganglia
Pineal gland
Craniopharyngeal duct
17
2 2
2 2
Other and ill defined sites C76.1 C76.0 Thorax, NOS
Head, face or neck, NOS
25 24 2 2
C76.5 C76.8
C76.3
C76.2
Lower limb
Pelvis
Abdomen, NOS
18
1 1
1 2 1
1 5
2 2
3 3
3 2
4 3
5 3 1
2 2
1 1
2 1
Overlapping lesion of ill defined sites
21
Lymph nodes C77.0
C77.4 C77.5
C77.3
C77.2
C77.1
C77.8 C77.9
Pelvic lymph nodes
Lymph nodes of inguinal region or leg
Lymph nodes of axilla or arm 28 21 2
Intra-abdominal lymph nodes 19
Intrathoracic lymph nodes
Lymph nodes of head, face and neck
15
68
1 1
3 1 1
4 1
2 1
1 1
4 2 1
1 1
11 3
1 4
1 5
14 1 1
7 2
1 2
3 2
2 2
4 1
3 1
Lymph nodes of multiple regions Lymph node, NOS
751
18
19 17
42
38
34
29
32
50
51
75
75
83
67
64 57
Unknown Primary Sites C80.9 All sites
Unknown primary site
829 33020 326
1 206 247
2 396
24
26
62
73 105 112 116
93 133 71
599 855 1182 1816 2972 3837 4927 4150 3612 3029 2574 2292
105

Site Lip
Table 36 Cancer incidence by histological type and sub-site 2001-2005

Histology Carcinoma, NOS Neoplasm, malignant No 1 7
Base of tongue
Total
Adenocarcinoma, NOS
100 2 1
80.0 1.6 0.8
4.0
4.8
0.8
5.6
124 55 4 3
11.1 0.8 0.2 2.2
100 0.6
0.8
0.8
Carcinoma, undifferentiated, NOS Small cell carcinoma, NOS Carcinoma, anaplastic, NOS
11 1
Other and unspecified parts of tongue
Total
Adenocarcinoma, NOS
Basaloid carcinoma
397 2 2
79.9 0.4 0.4
0.6
0.2
497 117 3 1
100 0.1 1.0
0.4
0.4
0.4
1.6
0.6
0.2
Total
Sarcoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
Squamous cell carcinoma, spindle cell
Squamous cell carcinoma in situ, NOS
20 2 2
994 4 3
84.7 0.3 0.3
0.2
0.5
0.2
0.2
1.7
0.1
0.3
1174
100
0.1
0.1
0.1
0.2
0.2
0.5
0.3
0.1
0.1
0.1
106

Site Gum Histology Neoplasm, malignant No 3 80 14.0 4.0 0.5 %
Total Floor of mouth
Mixed tumour, malignant, NOS
Adenocarcinoma, NOS
Carcinoma, NOS
23 2 1
409 8 1
10
71.3 1.4 0.2
1.7
0.3
0.2
16 2 8
572 37 2 1
100 9.9
0.2
0.2
0.2
0.3
0.7
0.3
1.4
2.8
Palate
Sarcoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
Basaloid squamous cell carcinoma
Carcinoma, NOS
Neoplasm, malignant
Total
Haemangiosarcoma
Sarcoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
Carcinoma, NOS
Neoplasm, malignant
297 4 1
79.4 1.1 0.3
0.5
1.9
0.5
0.3
374 78 2
15.9 3.7 0.4
100
0.3
0.3
1.3
2.1
1.9
0.3
18 5 3
347 2 2
70.5 0.4 0.4
1.0
0.6
14 1 6
0.2
0.2
0.2
0.4
0.2
1.2
2.8
0.8
0.4
107

Site Histology Malignant lymphoma, small B lymphocytic, NOS Malignant lymphoma, NOS No 1 1 % 0.2 0.2
Other and unspecified parts of mouth
Total
Malignant lymphoma, large B cell, diffuse, NOS
277 14 1
492 1
0.04 1.7 0.6
11.5
100
0.2
Parotid gland
Haemangiosarcoma
Epithelial-myoepithelial carcinoma
Acinar cell cystadenocarcinoma
Acinar cell tumour
Adenocarcinoma, NOS
Basaloid carcinoma
Carcinoma, NOS
Neoplasm, malignant
Total
Liposarcoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
Spindle cell carcinoma, NOS
41 1
1996 1 8
17
0.04 0.7 0.1
0.04
82.9 0.04 0.1 0.2 0.3
10 16 3 7 1
0.04 0.3 0.7
0.4
0.1
2408 15 3 2
0.04 100 0.7 5.4
0.04
0.04
0.1
47 33 3 1
17.0 12.0 1.1 6.9 0.4
0.4
2.2
0.4
1.1
19 1
103 1 1
37.3 0.4 0.4
0.4
0.4
10 2 1
1.8
0.7
0.4
3.6
0.4
0.4
2.2
0.7
108

Site Histology Hodgkin lymphoma, NOS Malignant lymphoma, non-Hodgkin, NOS No 1 7 % 0.4 2.5
major salivary glands
Tonsil
Oropharynx
Total
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
Fibrosarcoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
Carcinoma, NOS
Neoplasm, malignant
Total
Clear cell sarcoma, NOS
Adenocarcinoma, NOS
Carcinoma undifferentiated, NOS
Neoplasm, malignant
Total
Marginal zone B-cell lymphoma, NOS
276 1 3
100 1.1 3.4
0.7
15 1 7
17.2 1.1 8.0
3.4
22 2 4
21
25.3 2.3 4.6
24.1
35 8 1
87
100 0.2 7.3
1.1
1.1
3.4
2.3
1.1
406 2 3
84.2 0.4 0.6
0.4
0.4
0.2
1.7
14 482 38 2 1 1
13.1 0.7 0.3
100
0.2
2.9
0.2
0.2
0.8
0.2
15 1 1
229 1 1
78.7 0.3 0.3
0.3
0.3
5.2
291
100
0.3
0.3
109

Site Nasopharynx Histology Carcinoma, NOS Neoplasm, malignant No 34 1 5 % 19.7 0.6 2.9
Pyriform Sinus
Hypopharynx
Squamous cell carcinoma, NOS Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Basaloid carcinoma
Carcinoma, NOS
Neoplasm, malignant
Total
Chordoma, NOS
Adenocarcinoma, NOS
13 2 1
84 1 1
48.6 0.6 0.6
1.2
0.6
7.5
14 1 5
173 78 4 6
10.8 0.6 0.8
100
0.6
1.2
0.6
0.6
0.6
0.6
0.6
0.6
2.9
8.1
1.7
16 609 1 1 2
84.5 0.1 0.1
0.3
2.2
721 26 3 2
100 0.8 10
0.3
0.1
0.1
211 1
81.2 0.4 0.8
0.8
0.4
3.5
1.2
and pharynx
sites in lip oral cavity
Neoplasm, malignant
Total
260 20 4 1
100 0.5 9.6
1.2
172 1 2
82.3 0.5 1.0
0.5
1.9
110

Site Histology Adenocarcinoma, NOS Basaloid carcinoma No 3 1 % 1.4 0.5
Esophagus
Neoplasm, Malignant Carcinoma, NOS
Total
209 711 17 11 1 4
14.7 0.4 0.0 0.2 0.1
100
0.5
0.5
0.5
0.5
Small cell Carcinoma, NOS Papillary carcinoma, NOS
Large cell neuroendocrine carcinoma
46 11 1 1
0.9 0.0 0.2
Squamous cell carcinoma, large cell, non keratinising, NOS Basaloid carcinoma Squamous cell carcinoma, adenoid
Squamous cell carcinoma, in situ, NOS
3570 31 11 2 1
73.7 0.6 0.2
0.0
Stomach
Carcinoma, undifferentiated, NOS Small cell carcinoma, NOS Carcinoma, anaplastic, NOS
Carcinoma, NOS
Neoplasm, Malignant
Total
Leiomyosarcoma, NOS
Adenocarcinoma, NOS
384 4 2
17 1 1
15
4845 123 11 1 8
12.9 0.8 1.2
100
0.0
0.0
0.0
0.0
0.4
0.3
0.0
0.1
0.0
7.9
0.0
0.0
Linitis plastica
Adenocarcinoma, NOS
Squamous cell carcinoma,Small cell, non-keratinising
Squamous cell carcinoma,Keratinising, NOS
78 1 3
614 1 2
64.2 0.1 0.2
0.1
0.3
8.2
0.3
0.1
0.1
25 45 1 4 3
0.1
0.4
4.7
0.3
2.6
0.6
111

Site Histology Leiomyosarcoma, NOS No 1 9 0.9 %
Small intestine
Colon
Mucin- producing adenocarcinoma
Papillary Cystadenocarcinoma, NOS
Acidophil carcinoma
Villous adenocarcinoma
Adenocarcinoma in villous adenoma
Neuroendocrine carcinoma,NOS
Goblet cell carcinoid
Carciniod tumor, NOS
Carciniod tumor of uncertain malignant potential
Adenocarcinoma in adenomatous polyposis coli
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
Gastrointestinal stromal tumor, NOS
Leiomyosarcoma, NOS
Desmoplastic small round cell tumor
Sarcoma, NOS
Mucunous adenocarcinoma
Atypical carcinoid tumor
Neuroendocrine carcinoma,NOS
Carciniod tumor,NOS
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, Malignant
Total
Carcinosarcoma, NOS
956 1 6
100 1.0 5.9
0.2
0.1
0.3
0.1
0.9
0.1
10 1 1
42
41.2 1.0 9.8
2.0
10 2 1
102 92 2
100 0.2 7.0
1.0
3.9
2.0
6.9
2.0
1.0
9.8
1.0
1.0
2.0
2.9
4.9
1.0
1020 18 1 1
25
20
77.2 0.1 1.4
1.9
1.5
10
43
0.8
3.3
0.1
0.1
0.2
0.1
0.1
0.3
0.2
0.1
0.6
0.2
0.1
0.7
0.2
0.1
112

Site Histology Signet ring cell carcinoma No 4 31 3 2.3 %
Recto-sigmoid junction Neoplasm, malignant
Total
Leiomyosarcoma, NOS
1322 10 2 1
13
100 2.0 8.0
1.0
0.2
0.2
0.3
Adenocarcinoma in adenomatous polyp Papillary adenocarcinoma, NOS Tubular adenocarcinoma
Adenocarcinoma, NOS
Carcinoma , undifferentiated, NOS
81 3 1
76.0 2.0
4.0
Mucinous adenocarcinoma Signet ring cell carcinoma
Mucin-producing adenocarcinoma Total
5 1 111 1 6
2.0
Rectum
Anus and anal canal
Carcinoma , undifferentiated, NOS
Neoplasm, malignant
Total
Gastrointestinal stromal tumor , NOS
Leiomyosarcoma
Mucin -producing adenocarcinoma
Adenocarcinoma in tubulovillous adenoma
Adenocarcinoma, NOS
Basaloid carcinoma
Carcinoma, NOS
Neoplasm, malignant
143 4
100 0.1 9.2
6.0
56 1248 1 5 3
80.3 0.1 0.3
0.2
3.6
0.1
0.1
0.3
35 17 6 4 7
1554 10 1 1
100 0.6 6.3
0.1
0.1
0.1
0.1
0.1
0.4
0.3
1.1
0.5
2.3
0.1
0.1
0.3
0.4
0.3
75 1
47.5 0.6
0.6
0.6
0.6
0.6
113

Site Histology Squamous intraepithelial neoplasia, grade III Squamous cell carcinoma, large cell, non-keratinising, NOS No 1 2 % 1.3 0.0
Liver
Intrahepatic bile ducts
Gallbladder
Total
Cholangiocarcinoma
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Liposarcoma, NOS
Klatskin tumor
Cholangiocarcinoma
Neoplasm, malignant
Total
Lymphangiosarcoma
Hemangioendothelioma, malignant
Hepatoblastoma
Leiomyosarcoma, NOS
Sarcoma, NOS
Hepatocellular carcinoma, NOS
Adenocarcinoma, NOS
Carcinoma, Undifferentiated, NOS
Neoplasm, malignant
Total
Leiomyosarcoma, NOS
Malignant melanoma
Adenocarcinoma, NOS
Basaloid carcinoma
Basal cell carcinoma
39 1 1
24.7 0.6 0.6
4.4
0.6
1.3
0.6
158 34 1 1
100 0.2 5.5
3.8
2.5
1.3
514 1 4
24
83.0 0.2 0.6
3.9
0.2
24 3 3
619 67 1 3 1
100 93.1 1.4 4.2 1.4
0.5
0.2
0.5
0.5
3.9
0.2
0.2
0.5
0.2
19 1 8
72
14.2 0.7 6.0
100
71 7 4
53.0 5.2 3.0
3.7
6.7
134
100
3.0
0.7
0.7
3.0
114

Site Other and unspecified Histology Neoplasm, malignant No 1 9 % 0.7 6.7
parts of the biliary tract Papillary carcinoma, NOS Cholangiocarcinoma Adenocarcinoma, NOS
Pancreas
Squamous cell carcinoma, NOS Islet cell tumour, NOS Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
52 5 1
61
38.8 3.7 0.7
45.5
101 16 4 1 2
134
27.2 4.3 0.5
100
3.7
178 2 1
11
1.1 48.0 0.5 0.3 3.0
0.3
organs
parts of digestive
Gastrointestinal stromal sarcoma Haemangiosarcoma
Gastrointestinal stromal tumour, NOS
Adenocarcinoma, NOS
Total
Pancreatoblastoma
Leiomyosarcoma, NOS
Sarcoma, NOS
Paraganglioma, NOS
Acinar cell cystadenocarcinoma
Acinar cell tumor [obs]
Mucinous cystadenocarcinoma, non invasive
Solid pseudopapillary carcinoma
Solid pseudopapillary tumour
Islet cell carcinoma
12 1 1
17 3 3
371 12 1 1 1
100 38.7 3.2 3.2 3.2
0.5
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.8
0.8
4.6
0.3
0.5
0.3
0.3
0.3
0.3
3.2
1.1
11 1
Total
35.5 3.2 3.2
3.2
6.5
31
100
115

Site Nasal cavity Histology Neoplasm, malignant No 1 2 3.1 %
Middle ear
Larynx
Neoplasm, Malignant Carcinoma, NOS
Total
Glomus tumour, malignant
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Carcinosarcoma, NOS
Small cell sarcoma
Sarcoma, NOS
Adenocarcinoma, NOS
Carcinoma, NOS
30 2 1
46.2 3.1 1.5
1.5
3.1
1.5
1.5
65 9 1
13.8 1.5 1.5
100 47.4 5.3
1.5
1.5
3.1
1.5
1.5
1.5
4.6
1.5
115 4
19 4
21.1 10.5 100 0.2 7.2 5.3
10.5
29 1 1
14 1383 11 1 1 1
86.2 0.1 0.7
0.1
0.9
0.1
0.1
1.8
0.6
0.2
Total
Small cell sarcoma
Adenocarcinoma, NOS
Squamous cell carcinoma, small cell, nonkeratinising
10 1 2
13 1603 1
100
0.1
0.8
0.1
0.1
0.6
0.1
0.1
116

Site Trachea Histology Neoplasm, malignant No 1 2 16.7 8.3 8.3 %
Bronchus and lung
Adenocarcinoma, NOS
Basaloid carcinoma
Oat cell carcinoma
Tumourlet, NOS
Epithelioma, malignant
Carcinoma, NOS
Neoplasm, malignant
Total
998 25 1
12
58.3 100 0.7 8.3
27.5 0.0
10 1 1
34
39
108 1 1
57 1050 7 6
28.9 0.2
0.2
1.6
0.0
0.0
3.0
0.0
0.0
0.0
0.3
0.9
1.1
Total
Mucinous adenocarcinofibroma
Bronchiolo-alveolar carcinoma, non-mucinous
Bronchiolo-alveolar adenocarcinoma, NOS
1171 3
0.1 32.3 0.1 0.0 0.0
45 1 6
14 3 2
3623
100
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.4
0.0
0.2
1.2
0.0
0.2
0.1
117

Site Thymus Histology Squamous cell carcinoma, NOS Carcinoma, undifferentiated, NOS No 2 2 % 3.6 3.6
and pleura
Heart, meadiastinum,
Mesothelioma, malignant
Myxoid liposarcoma
Sarcoma, NOS
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
Malignant histiocytosis
Germinoma
Carcinoma showing thymus-like element
Thymic carcinoma, NOS
Thymoma, type B3, malignant
Thymoma, malignant, NOS
Adenocarcinoma, NOS
40 1 1
66.1 1.8 1.8
1.8
1.8
1.8
18 4 1
61
19.6 4.3 1.1
100
1.8
1.8
3.6
1.8
1.8
1.8
1.8
1.8
Other and ill defined sites in respiratory system and intrathoracic organs
Superficial spreading adenocarcinoma
Total
Neuroblastoma, NOS
Ganglioneuroblastoma
Peripheral neuroectodermal tumour
Mixed germ cell tumor
Teratoma, malignant , NOS
Germinoma
Mesothelioma, biphasic, malignant
Epithelioid mesothelioma, malignant
Fibrous mesothelioma, malignant
11 1
1.1 3.3 8.7
1.1
1.1
1.1
2.2
2.2
2.2
3.3
1.1
15 1 5
16.3 1.1 5.4
5.4
3.3
1.1
1.1
88 1
100
100
1.1
2.2
Total
100
118

Site Bones joints and articular cartilages of limbs Histology Neoplasm, malignant Sarcoma, NOS Osteosarcoma, NOS No 1 17 185 1 1 % 0.3 5.1 54.6 0.3 0.3
Chondrosarcoma, NOS
Aggressive osteoblastoma
Periosteal osteosarcoma
Fibroblastic Osteosarcoma
Chondroblastic osteosarcoma
Bones, joints and articular cartilage of other & unspecified sites
Blood Bone marow
Multiple myeloma
Plasmacytoma, NOS
Follicular lymphoma, grade 2
Splenic marginal zone B-cell lymphoma
Burkitt lymphoma, NOS
Total
Waldenstrom macroglobulinaemia
Total
Plasmacytoma, NOS
Ameloblastoma, malignant
Odontogenic tumour, malignant
Ewing sarcoma
Giant cell tumor of bone, NOS
Myxoid chondrosarcoma
Chondroblastoma, malignant
Neoplasm, malignant Osteosarcoma, NOS Chondroblastic osteosarcoma Chondrosarcoma, NOS
Total
Plasmacytoma, NOS
Odontogenic tumour, malignant
Adamantinoma of long bones
Ewing sarcoma
Giant cell tumor of bone, NOS
Chondroblastoma, malignant
11 1
0.3 0.9 3.3
0.3
54 2 1
26
16.1 0.6 0.3
7.8
0.3
0.3
316 1 45 4 26 1 1
0.6 25.1 2.2 14.5 0.6 0.6
100
0.3
2.4
35 3 3
19.6 1.7 1.7
1.7
1.1
179 8 8
40
22.3 100 75
53 4 3
38
100 1.2 0.8
Burkitt cell leukaemia
B-cell chronic lymphocytic leukemia /small lymphocytic lymphoma
Acute biphenotypic leukemia
Acute Leukemia, NOS
Leukemia, NOS
Monoclonal gammopathy of undetermined significance
Plasma cell leukemia
1133 1
24.9 0.0 0.2
0.2
0.1
0.0
0.1
0.0
0.0
0.1
0.1
27 9
0.2 2.9
0.6
0.2
132 1
0.0
119

Site Histology Adult T-cell leukaemia/lymphoma (HTLV-1 positive) No 4 1 0.0 %
Precursor cell lymphoblastic leukemia, NOS (Including lymphoblastic leukemia) ALL Precursor T-cell lymphoblastic leukemia Precursor B-cell lymphoblastic leukemia
Prolymphocytic leukemia, T-cell type
Prolymphocytic leukemia, B-cell type
Prolymphocytic leukemia, NOS
1 1121 3
0.0 24.5 0.1 0.0
0.0
0.1
Acute myeloid leukemia with maturation Acute monocytic leukaemia
Acute myeloid leukemia without maturation
Acute myeloid leukemia, minimal differentiation
Acute myeloid leukemia with abnormal marrow eosinophils
Acute basophilic leukaemia
Acute myelomonocytic leukemia
Acute promyelocytic leukaemia, t(15;17)(q22;q11-12)
Chornic myeloid leukemia, NOS
Acute myeloid leukemia, NOS
Myeloid leukaemia, NOS
Acute myeloid leukemia, M6 type
17 479 12 2 4
568 140 1
12.4 3.1 0.3
10.5
0.1
0.4
Atypical chornic myeloid leukemia, BCR/ABL negative
115 7
52 4
1.1 0.1 2.5
0.1
0.0
0.0
Spleen
Skin
Neoplasm, malignant
Total
Total
Myelodysplastic Syndrome, NOS
Therapy-related myelodysplastic syndrome, NOS
Refractory cytopenia with multilineage dysplasia
Refractory anemia with excescss blasts in transformation [obs]
Refractory anemia
Myeloproliferative disease, NOS
Lymphoproliferative disorder, NOS
Essential thrombocythemia
Myeloselerosis with myeloid metaplasia
Chronic myeloproliferative disease, NOS
Polycythemia vera
Juvenile myelomonocytic leukemia
Chornic myelomonocytic leukemia
Hairy cell leukemia
Acute panmyelosis with myelofibrosis
Myeloid sarcoma
Acute megakaryoblastic leukemia
Acute myeloid leukemia, 11q23 abnormalities
Acute myeloid leukemia, t(8;21)(q22;q22)
10 85 23 4 1 6
10
33
15 3
18 1 1
4560 10 13 2 9 1 2
363
76.9 100 0.2 1.0 7.7
15.4
100
8.0
0.0
0.0
0.0
0.4
0.1
0.1
0.3
0.5
0.0
1.9
0.1
0.2
0.2
0.7
0.1
0.1
0.0
0.0
0.2
520 2
55.7 0.2
0.1
0.4
0.2
120

Site Histology Squamous cell carcinoma, large cell, nonkeratinising, NOS No 1 1 0.1 %
system
autonomic nervous
Peripheral nerves and
and Peritoneum
Retroperitoneum
Total
Malignant peripheral nerve sheath tumor
Neuroblastoma, NOS
Small cell sarcoma
Total
Angiocentric immunoproliferative lesion
Primary cutaneous CD30+ T-cell lymphoproliferative disorder
Sezary syndrome
Mycosis fungoides
Granular cell tumour, malignant
Epithelioid haemangioendothelioma, malignant
Epithelioid haemangioendothelioma, NOS
Spindle cell melanoma, NOS
Amelanotic melanoma
Paget disease, extramammary
Eccrine adenocarcinoma
Sebaceous adenocarcinoma
Sclerosing sweat duct carcinoma
Nodular hidradenoma, malignant
Bowen disease
100 3 5
10.6 0.3 0.5
0.2
0.1
0.2
0.1
0.1
186 1 2
19.6 0.1 0.2
0.1
0.1
0.1
0.4
0.1
0.1
0.9
0.4
0.1
19 3 1
20 9 2
936 1 1
100 0.9 0.9
0.1
0.1
0.3
0.3
0.1
0.2
1.0
0.2
2.1
0.2
0.1
0.3
0.1
1.9
23 29 5 4
20.7 25.2 4.5 3.6
49 112 1
44.2 100 1.1 3.2
Adenocarcinoma, NOS
Neoplasm, malignant
5.3
4.2
1.1
1.1
1.1
121

Site Histology Spindle cell sarcoma Sarcoma, NOS No 10 2 7 % 10.5 2.1 7.4
other soft tissues
subcutaneous and
Connective
Spindle cell sarcoma Small cell sarcoma Giant cell sarcoma
Sarcoma, NOS
Carcinoma with osteoclast-like giant cells
Malignant tumour spindle cell type
Neoplasm, malignant
Total
Neuroblastoma, NOS
Cystic mesothelioma, NOS
Endometrial stromal sarcoma, low grade
Leiomyosarcoma, NOS
Pleomorphic liposarcoma
Myxoid liposarcoma
Liposarcoma, well differentiated
Liposarcoma, NOS
Fibrosarcoma, NOS
Small cell sarcoma
18 4 1
18.9 4.2 1.1
2.1
1.1
10 1 2
10.5 1.1 2.1
1.1
95 1 5
100 0.2 0.8
2.1
1.1
4.2
1.1
1.1
2.1
5.3
1.1
1.1
1.1
1.1
157 71 6 4
24.4 11.4 0.7 0.5
0.2
0.3
0.2
0.7
0.2
Leiomyosarcoma, NOS
Mixed liposarcoma
Pleomorphic liposarcoma
Myxoid liposarcoma
Liposarcoma, NOS
Myxosarcoma
Atypical fibrous histiocytoma
Abdominal fibromatosis
Infantile fibrosarcoma
Fibromyxosarcoma
Fibrosarcoma, NOS
Undifferentiated sarcoma
Epithelioid sarcoma
16 1 4
17
45 39 1 1
10 1
34
63
5.3
9.2
0.2
0.2
1.5
6.4
0.2
6.8
0.2
0.2
0.2
0.7
2.6
2.0
0.2
0.7
122

Site Histology Alveolar rhabdomyosarcoma Embryonal rhabdomyosarcoma, NOS No 16 1 5 % 0.8 2.6
Breast
Medullary carcinoma with lymphoid stroma
Intraductal micropapillary carcinoma
Noninfiltrating intraductal papillary adenocarcinoma
Comedocarcinoma, noninfiltrating
Intraductal carcinoma, noninfiltrating, NOS
Mucinous adenocarcinoma (Muciod carcinoma)
Apocrine adenocarcinoma
Cribriform carcinoma, NOS
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
Myeloid sarcoma
Histiocytic sarcoma
Alveolar soft part sarcoma
Malignant tenosynovial giant cell tumour
Malignant giant cell tomour of soft parts
Haemangioblastoma
Haemangiopericytoma, NOS
Epithelioid haemangiendothelioma, malignant
Haemangiendothelioma, malignant
Haemangiosarcoma
Synovial sarcoma, biphasic
Synovial sarcoma, spindle cell
Synovial sarcoma, NOS
Embryonal sarcoma
66 5 2
19 3 4
14 3 1
935 28 1 5
648
10.9 0.3 0.1
100
0.3
0.2
0.2
0.3
0.3
0.2
0.2
0.5
0.2
2.1
0.2
0.3
0.5
3.0
0.7
0.8
0.3
9.6
0.2
30 2
54 1 2
65
56
75 10 2 3
6854 8
80.0 0.1 0.0
0.1
0.0
0.9
0.0
0.1
0.0
0.1
0.0
0.0
0.6
0.8
0.7
0.0
0.0
0.0
0.4
34 3
0.4
0.0
0.1
0.0
0.0
0.0
0.0
123

Site Histology Lobular carcinoma, NOS 266 2 5 No 0.0 %
Vulva
Vagina
Squamous cell carcinoma, large cell, nonkeratinising, NOS3 Clear cell adenocarcinoma, NOS Adenocarcinoma, NOS
Neoplasm, malignant
Total
Yolk sac tumour
Leiomyosarcoma, NOS
Sarcoma, NOS
Adenocarcinoma, NOS
Squamous cell carcinoma, large cell, nonnkeratinising, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
Haemangiosarcoma
Phyllodes tumour, borderline
Carcinosarcoma, NOS
Small cell sarcoma, NOS
Sarcoma, NOS
Paget disease and intraductal carcinoma of breast
Paget disease and infiltrating duct carcinoma of breast
Inflammatory carcinoma
Infiltrating duct mixed with other types of carcinoma
Infiltrating duct and lobular carcinoma
48 2 5
8571 10 1 1
100.0 0.8 7.8
0.0
0.0
0.1
0.6
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
3.1
82 2 1
64.1 1.6 0.8
0.8
6.3
4.7
0.8
128 1 8
100 0.6 5.2
0.8
0.8
1.6
0.8
0.8
0.8
2.3
4.7
107 1.9 2 3
69.0 1.9
0.6
3.9
1.9
10
1.3
6.5
124

Site Histology Mucinous adenocarcinoma No 3 1 0.6 %
Cervix uteri
Corpus Uteri
Malignant tumour, clear cell type
Neoplasm, malignant
Total
Carcinosarcoma, NOS
Leiomyosarcoma, NOS
Sarcoma, NOS
Adenocarcinoma, NOS
Squamous cell carcinoma, small cell, non keratinising, NOS
Papillary squamous cell carcinoma
Carcinoma, NOS
Neoplasm, malignant
Total
Leiomyosarcoma, NOS
398 15 13 5 2 4 30
155
10.1 0.4 0.8
100
0.6
0.6
0.6
1.9
1.9
2677 297 2 4 268
67.9 7.5 6.8
0.1
0.0
0.1
0.1
0.1
0.3
0.1
175 15 6 4 1
3943 38 5 1
100.0 0.1 5.5
0.0
0.0
0.1
0.1
0.0
0.1
0.2
0.1
0.2
0.1
0.4
0.0
4.4
0.1
0.1
Adenocarcinoma, NOS
Basaloid carcinoma
24 1 1
11
0.7 3.4 1.6
317 22 6
45.5 0.9 3.2
0.1
0.1
177 4 1
25.1 0.6 0.1
0.4
125

Site Histology Mucinous adenocarcinoma Papillary serous cystadenocarcinoma No 4 3 % 0.6 0.4
Sarcoma, NOS
Uterus, NOS
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Carcinosarcoma, NOS
Mesodermal mixed tumour
Endometrial stromal sarcoma, low grade
34 19 2 2 1
11
0.4 4.9 1.6
0.7
699 19 4
100.0 1.5 7.1
0.1
0.3
0.1
0.3
0.3
2.7
0.1
12 1 1
100 11 1
37.6 0.4 4.1
0.4
0.4
4.5
Ovary
Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Small cell carcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
Carcinosarcoma, NOS
Stromal tumour, NOS
Adenosarcoma
Smooth muscle tumour of uncertain malignant potential
Sarcoma, NOS
46 2 3
17.3 0.8 1.1
46 1 2
17.3 0.4 0.8
1.5
0.4
1.1
390 11 89 1 8
266
100.0 13.9 0.3 0.4
0.4
1.5
0.4
0.4
0.4
0.4
Adenocarcinoma, NOS
58 827 2 2
29.7 0.1 0.1
0.0
2.1
3.2
0.1
196 1
0.0
7.0
126

Site Histology Clear cell adenofibroma of borderline malignancy Clear cell adenocarcinoma, NOS No 16 140 21 1 1 % 0.0 0.6
Teratoma with malignant transformation
Yolk sac tumour
Germinoma
Dysgerminoma
Brenner tumour, malignant
Brenner tumour, borderline malignancy
Carcinosarcoma, NOS
Stromal tumour, NOS
Myxoid leiomyosarcoma
Liposarcoma, NOS
Fibrosarcoma, NOS
Small cell sarcoma
Sarcoma, NOS
Paraganglioma, malignant
Steroid cell tumour, malignant
Sertoli cell tumour, NOS
Sertoli-Leydig cell tumour of poorly differentiated
Sertoli-Leydig cell tumour of intermediate differentiation
Androblastoma, malignant
Granulosa cell tumour, adult type
Thecoma, malignant
Serous papillary cystic tumour of borderline malignancy
Serous cystadenoma, borderline malignancy
Serous cystadenoma, papillary borderline maly
139 1 2
294 10 4
32
10.5 0.1 0.4
1.1
0.0
0.1
5.0
0.0
0.8
5.0
38 5 5
34
30
88
91 1 3
87 2 4
32 2
30
0.1
1.1
1.1
0.1
0.1
3.1
0.3
0.3
0.0
0.2
0.0
0.2
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
3.3
0.0
0.0
0.2
0.2
1.4
1.2
1.1
3.2
127

Site Histology Mixed germ cell tumour No 1 27 4 1.0 %
female genital organs
Leiyomyosarcoma, NOS Total
Papillary serous cystadenocarcinoma,
Adenocarcinoma, NOS
Neoplasm, malignant
Total
2788 8 1
100.0 47.1 5.9 5.9
0.0
0.1
0.0
2 17 204 1 3
17.6 5.9
11.8 100.0 54.5 0.3 0.8
5.9
Placenta
Penis
Carcinoma, NOS
Neoplasm, malignant
Total
Placental site trophoblastic tumour
Malignant teratoma, trophoblastic
Invasive hydatidiform mole
Neoplasm, malignant
143 19 374 30 3 1 4
38.2 5.1
100 0.3 8.9
1.1
Prostate
Total
Neoplasm, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Small cell carcinoma, NOS Combined small cell carcinoma Papillary carcinoma, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Basal cell carcinoma, NOS Transitional cell carcinoma, NOS Basaloid carcinoma Adenocarcinoma, NOS Trabecular adenocarcinoma Papillary adenocarcinoma, NOS Acinar cell carcinoma Adenosquamous carcinoma
Total
Adenocarcinoma, NOS
Bowen disease
261 1 7
11
0.6 77.7 0.3 2.1 3.3
1.8
0.9
1382
268 4 26 1 1 2 1 92 1 8 1 966 1 1 1 8
336
19.4 0.3 1.9 0.1 0.1 0.1 0.1 6.7 0.1 0.6 0.1 69.9 0.1 0.1 0.1 0.6 100
100
0.3
2.4
1.5
128

Site Testis Histology Neoplasm, malignant No 1 15 3 6.3 %
male genital organs
Kidney
Sarcoma, NOS
Renal cell carcinoma, sarcomatoid
Adenocarcinoma, NOS
Carcinoma, NOS
Malignant tumor, clear cell type
Neoplasm, malignant
Total
Total
Malignant teratoma, undifferentiated
Teratocarcinoma
Yolk sac tumour
Germ cell tumour, nonseminomatous
Germinoma
Spermatocytic seminoma
Seminoma, anaplastic
Seminoma, NOS
Liposarcoma, NOS
Spindle cell sarcoma, NOS
Leydig cell tumour, maliganant
Sertoli cell carcinoma
Sertoli cell tumour, NOS
Adenocarcinoma, NOS
Carcinoma, NOS
88 4 1
37.0 1.7 0.4
0.4
0.4
0.4
0.4
0.8
0.8
0.4
0.4
0.4
0.4
0.4
1.3
0.4
12 7 1
43 1 2
18
18.1 0.4 0.8
7.6
2.9
0.4
5.0
24 1 4
10.1 0.4 1.7
238 1 2
27 1 1
20.0 100 0.2 5.9
20.0
20.0
40.0
100
15 3 7
274 1 1
19
59.8 0.2 0.2
4.1
0.7
1.5
3.3
1.7
0.9
0.2
0.4
1.3
0.2
0.2
0.2
0.4
129

Site Histology Nephroblastoma, NOS No 2 69 4 15.1 0.9 0.4 %
Ureter
Bladder
Carcinoma, NOS
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Clear cell sarcoma of kidney
Malignant rhabdoid tumour
458 3 1
10 3 1
52
12.5 100 1.5 8.0
12.5
25.0
37.5
12.5
100
0.2
0.2
1.5
12 1 3
urinary organs
Eye and adenexa
Haemangioendothelioma, malignant
Haemangiosarcoma
Adenocarcinoma, NOS
Neoplasm, malignant
Total
Adenocarcinoma, NOS
Total
Adenocarcinoma, NOS
53 449 23 1 2 17 1
11
0.2 8.1 1.7
0.2
0.5
1.8
0.5
0.2
68.8 3.5 2.6
0.2
654 3 1
25 3 3
16.7 100 3.5 4.9
16.7
50.0
16.7
100
0.3
0.3
0.3
0.2
0.5
0.5
0.2
0.3
17.5 2.1 2.1
12 1 3
0.7
0.7
0.7
2.1
8.4
130

Site Histology Retinoblastoma, NOS No 1 63 1 44.1 0.7 0.7 %
Malignant lymphoma, non-Hodgkin, NOS Follicular lymphoma, NOS
Retinoblastoma, undifferentiated
11 2
2.1 0.7 7.7
Meninges
Brain
Total
Central neurocytoma
Ganglioglioma, anaplastic
Neuroblastoma, NOS
Primitive neuroectodermal tumour, NOS
Medulloblastoma, NOS
Oligodendroglioma, anaplastic
Oligodendroglioma, NOS
Gliosarcoma
Glioblastoma, NOS
Pilocytic astrocytoma
Fibrillary astrocytoma
Gemistocytic astrocytoma
Astrocytoma, anaplastic
Astrocytoma, NOS
Ependymoma, anaplastic
Ependymoma, NOS
Choroid plexus carcinoma
Mixed glioma
Glioma, malignant
Chordoma, NOS
Haemangiblastoma
Haemangiosarcoma
Germinoma
Neoplasm, malignant
Total
Meningeal sarcomatosis
Atypical meningioma
Meningioma, NOS
Neoplasm, malignant
Total
143 1 1
100 2.0 2.0
1.4
41 1 4
82.0 2.0 8.0
2.0
36 4 3
50
100 0.2 2.7
2.0
18 6 1
10
335 1 3
25.4 0.1 0.2
0.5
0.1
1.4
0.8
0.2
0.1
0.3
0.2
0.3
384 45 2 1
10
54
29.1 0.1 3.4
0.8
4.1
196 81 63 8 1 3 1
30
14.9 6.1 0.1
2.3
0.2
1319
100
0.3
0.2
0.1
0.2
0.1
0.1
0.6
0.1
4.8
0.2
131

Spinal Cord and central Neoplasm, malignant nervous system and Carcinoma, undifferentiated, NOS other parts of CNS Malignant melanoma, NOS Peripheral neuroectodermal tumour Teratoma, malignant, NOS Site Histology No 4 1 1 9.8 2.4 2.4 %
Thyroid
Neoplasm, malignant
Total
Plasmacytoma, NOS
Neuroblastoma, NOS
Primitive neuroectodermal tumour
Astrocytoma, NOS
Myxopapillary ependymoma
Ependymoma, NOS
Chordoma, NOS
12 1 1
14.6 7.3 2.4
2.4
2.4
29.3 2.4 2.4
2.4
2.4
4.9
Total
Small cell sarcoma
Mixed medullary-follicular cacinoma
Papillary carcinoma, columnar cell
Papillary carcinoma, oxyphilic cell
Papillary microcarcinoma
Insular carcinoma
Follicular carcinoma, NOS
Oxyphillic adenocarcinoma
Adenocarcinoma, NOS
112 133 1 1
41 7
100 0.2 3.7
2.4
9.8
1827 19 1 1
60.1 0.0 0.6
0.0
0.0
0.0
4.4
10 27 1 1
30 579 1 2
19.0 0.0 0.1
0.0
1.0
0.9
0.0
0.3
0.0
207 1 1
39 1 2
12 12 3040 2 1
100
0.1
0.4
0.0
0.4
0.1
0.0
0.0
0.0
0.0
0.1
1.3
0.1
0.0
0.0
0.0
6.8
132

Site Adrenal Histology Neoplasm, malignant No 1 7 10.9 4.7 1.6 %
structures
glands and related
Other endocrine
Other ill defined sites
Clear cell sarcoma
Granulosa cell tumour, malignant
Sex cord-gonadal stromal tumour, incompletely differentiated
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Total
Pineoblastoma
Pineocytoma
Pinealoma
Craniopharyngioma, adamantinomatous
Craniopharyngioma
Glomus jugulare tumour, NOS
Acidophil carcinoma
Pitituary carcinoma, NOS
Neoplasm, malignant
Total
Neuroblastoma, NOS
Small cell sarcoma
Sarcoma, NOS
Pheochromocytoma, malignant
Adrenal cortical carcinoma
Adenocarcinoma, NOS
12 1 1
17
18.8 1.6 1.6
26.6
20 64 35 1 1 3 2
31.3 100 33.3 1.0 1.0 2.9 3.1
38 2 1
36.2 1.9 1.0
1.0
1.0
1.0
1.0
1.0
15 1 1
14.3 1.0 1.0
1.0
105 31 1 1
15.0 0.5 0.5
100
1.0
41 1 1
77
19.9 0.5 0.5
37.4
2.4
1.0
1.0
1.0
1.5
0.5
0.5
1.5
0.5
1.0
0.5
0.5
0.5
1.9
0.5
1.0
133

Site Histology Embryonal carcinoma, NOS Dysgerminoma No 1 2 % 0.5 1.0
Lymph nodes
Unknown Primary site Neoplasm, malignant Carcinoma, metastatic, NOS Carcinoma, NOS
Total
Adult T-cell leukaemia/ lymphoma (HTLV-1 positive)
B-cell chronic lymphocytic leukaemia/ small lymphocytic lymphoma
Angioimmunoblastic lymphadenopathy
Heavy chain disease, NOS
Langerhans cell histiocytosis, disseminated
Multiple myeloma
Precursor B-cell lymphoblastic lymphoma
Anaplastic large cell lymphoma, T cell and Null cell type
Angioimmunoblastic T-cell lymphoma
Mature T cell lymphoma, NOS
Sezary syndrome
Malignant lymphoma, large B cell, diffuse, immunoblastic, NOS
Malignant lymphoma mixed, mixed small and large cell, diffuse [obs]
Mantle cell lymphoma
Hodgkin lymphoma, nodular sclerosis, NOS
Hodgkin lymphoma, mixed cellularity, NOS
Composite Hodgkin and non-Hodgkin lymphoma
Total
Yolk sac tumour
1734 352 1 4 1
134
206
100 73.1 14.8 0.0 0.2 0.0 5.7
0.5
0.5
1.9
4.4
1.5
27 4
1.1 0.2
0.0
0.0
0.3
0.2
15 4 1
10
16 3 1
18 1 1
2371 885 17 5 1
40.3 0.0 0.8
100
0.1
0.0
0.0
0.0
0.8
0.1
0.1
0.3
0.3
0.0
0.0
0.2
0.1
0.0
0.7
0.1
0.2
0.0
0.6
0.4
22 1 9
13
0.6
0.0
0.4
1.0
0.3
0.2
134

Site Histology Papillary carcinoma, NOS Non-small cell carcinoma No 21 1 1 % 1.0 0.0
Total
Germinoma
Carcinosarcoma, NOS
Infitrating duct carcinoma, NOS
Papillary serous cysadenocarcinoma
Adenocarcinoma, NOS
Squamous cell carcinoma with horn formation
451 3
20.5 0.1 0.0
671 1 2
30.6 0.0 0.1
0.1
0.0
30 3 1
2195
100
0.0
0.1
0.0
0.0
0.0
0.0
0.3
0.0
0.1
0.4
0.3
0.2
0.0
0.1
0.1
0.0
0.1
0.2
0.1
0.0
1.4
135
Table 37 Lip oral cavity and pharynx

Group Female Male
Incidence data 2001-2005
Number 1889 5938
Percentage 21.5 5.7
ASR- Age standardised rate per 100 000 world population ICD-O Code C00.1 C00.3 C00.6 C00.8 C00.9 C01.9 C02.0 C02.1 C02.2 C02.3 C02.4 C02.9 C03.0 C03.1 C03.9 C04.0 C04.9 C05.0 C05.1 C05.2 C05.8 C05.9 C06.0 C06.1 C06.2 C06.9 C09.0 C09.1 C09.9 C10.0 C10.2 C10.3 C10.4 C10.8 C10.9 C11.0 C11.3 C11.9 C12.9 C13.0 C13.2 C13.9 C14.0 C14.8 C00.0
Total
7827
12.9
External lower lip Mucosa of upper lip Commissure of lip Overlapping lesion of lip Lip, NOS Base of tongue, NOS Dorsal surface of tongue, NOS Border of tongue Ventral surface of tongue, NOS Anterior 2/3 of tongue Lingual tonsil Tongue, NOS Upper gum Lower gum Gum, NOS Anterior floor of mouth Floor of mouth, NOS Hard palate Soft palate Uvula Overlapping lesion of palate Palate, NOS Cheek mucosa Vestibule of mouth Retromolar area Mouth, NOS Tonsillar fossa Tonsillar pillar Tonsil, NOS Vallecula Lateral wall of oropharynx Posterior wall of oropharynx Branchial cleft Overlapping lesion of oropharynx Oropharynx Superior wall of nasopharynx Anterior wall of nasopharynx Nasopharynx Pyriform sinus Postcricoid region Posterior wall of hypopharynx Hypopharynx, NOS Pharynx, NOS Overlapping lesion of lip, oral cavity and pharynx Total
External upper lip
Male 58 0 2 1 20 431 23 9 1 1 1 910 135 173 84 4 298 60 173 15 3 150 1370 9 148 160 11 7 392 85 1 4 1 1 163 1 1 108 619 81 0 61 147 5 5938 11
Female 21 2 1 0 5 66 6 5 0 1 1 264 53 86 41 2 70 21 19 3 1 47 606 3 38 74 1 2 69 5 0 1 0 1 29 1 0 62 102 94 1 23 55 2 1889
136

Histology Neoplasm, malignant Male 663 37 149 3 2 9 7 Female 224 7 0
Total
Haemangiosarcoma
Mixed tumour malignant, NOS
Liposarcoma, NOS
Fibrosarcoma
Sarcoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
Papillary carcinoma
Carcinoma, NOS
42 0 0
15 38 4825 17 1 8 1 2
14 1464 4 9 1
34 43 14 10 5 4 4 1 0
12
21 34 21 6 3 0 1
5938
10 0 1
1889
137
Table 38 Lip and anterior part of oral cavity

Group Female Male
Incidence data 2005
Number 1305 3478
Total
4783
External upper lip Mucosa of upper lip External lower lip
Male 58 2 0 11
Female 21 1 2
C06.9
C06.2
C06.1
C06.0
C05.0
C04.9
C04.0
C03.9
C03.1
C03.0
C02.9
C02.4
C02.3
C02.2
C02.1
C02.0
C00.9
C00.8
C00.6
Total
Mouth, NOS
Retromolar area
Vestibule of mouth
Cheek mucosa
Hard palate
Floor of mouth, NOS
Anterior floor of mouth
Gum, NOS
Lower gum
Upper gum
Tongue, NOS
Lingual tonsil
Anterior 2/3 of tongue
Border of tongue
Dorsal surface of tongue, NOS
Lip, NOS
Overlapping lesion of lip
Commissure of lip
23 1 9
20
173 84 4
135
910
264 86 2 53
41 70
298 1370 148 9 60
606 38 3
21
3478 Male 382 19 76 1 1 1 3
160
1305 Female 158 4 0
74
Histology
Carcinoma, NOS
Neoplasm, malignant
27 0 0
26 2857 3 9 1
14 1026 2 4 1
138

Histology Transitional cell carcinoma, NOS Basal cell carcinoma Male 1 3 Female 1 2
Mucoepidermoid carcinoma Adenosquamous carcinoma Acinar cell carcinoma
Adenocarcinoma, NOS
Basaloid carcinoma
18 28 11 2 2 0
24 16 5 3
Total
Haemangiosarcoma
Liposarcoma, NOS
Sarcoma, NOS
3478
1305
139
Table 39 Posterior part of oral cavity and pharynx

Group Female Male
Incidence data 2005
Number 2460 584
Percentage 1.8 8.9
Total
3044
5.0
C09.0 C09.9 C09.1
C05.9
C05.8
C05.2
Tonsillar fossa Tonsil, NOS Tonsilla pillar
Palate, NOS
Overlapping lesion of palate
Uvula
Soft palate
Base of tongue, NOS
Male 173 15 3 431
Female 19 1 3 66
150 11 7
47 2 1
C14.8
C14.0
C13.9
C13.2
C13.0
C12.9
C11.9
C11.3
C11.0
C10.9
C10.8
C10.4
C10.3
C10.2
C10.0
Total
Overlapping lesion of lip, oral cavity and pharynx
Pharynx, NOS
Hypopharynx, NOS
Postcricoid region
Pyriform sinus
Nasopharynx
Anterior wall of nasopharynx
Superior wall of nasopharynx
Oropharynx
Overlapping lesion of oropharynx
Branchial cleft
Posterior wall of oropharynx
Lateral wall of oropharynx
Vallecula
392 85 4 1
69 0 5
163 1 1
29 0 1
619 81 0
108
102 94 1
62
147 2460 Male 281 18 73 0 1 8 2 8 4 5
61
55 584 Female 66 3 0 2
23
Histology
Pleomorphic carcinoma 2
Carcinoma, NOS
Neoplasm, malignant
15 0
Adenocarcinoma, NOS
Basaloid carcinoma
1967 5 8
12
438 2 5
16
15
140

Histology Papillary adenocarcinoma, NOS Adenoid cystic carcinoma Male 15 3 1 Female 10 5 0
Total
Sarcoma, NOS
Fibrosarcoma, NOS
2460
10 1 1
584
141
Group Female Male
Incidence data 2005
Table 40 Tongue
Number 1376 343
Percentage 1.0 5.0
Total
1719
2.8
C02.9
C02.4
C02.3
C02.2
C02.1
Total
Tongue, NOS
Lingual tonsil
Anterior 2/3 of tongue
Border of tongue
Dorsal surface of tongue, NOS
Base of tongue, NOS
Male 431 23 1 9
Female 66 5 6
1376 Male 147 7 4
910
343 Female 31 0 0
264
Histology
Carcinoma, NOS
Neoplasm, malignant
28 4 1
Sarcoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
1135 4
293 2 2
13 2 3
Total
1376
343
142
Group Female Male
Incidence data 2005
Table 41 Esophagus
Number 2600 2245
Percentage 7.9 8.1
Total
4845
8.0
C15.9
C15.5
C15.4
Total
Esophagus, NOS
Cervical esophagus
Male 33 3
Female 36 0
2245 Male 330 9 2
1716
277
216
2600 Female 380 8 2
1897
261
406
Histology
Adenocarcinoma, NOS
Basaloid carcinoma
Squamous cell carcinoma, large cell nonkeratinising, NOS
Large cell neuroendocrine carcinoma
Carcinoma, NOS
Neoplasm, malignant
14 1 8
32 0 3
1573 15 1 3
1997 16 0 8
3254 3 2
130 1 0
Total
Leiomyosarcoma, NOS
Leydig cell tumour, malignant
11 0
0 8 4
2245
2600
143
Group Female Male
Incidence data 2005
Table 42 Stomach
Number 254 702
Percentage 0.8 2.5
ASR- Age standardised rate per 100 000 world population ICD-O Code C16.3 C16.9 C16.4 C16.0
Total
956
1.6
Gastric antrum Stomach, NOS Pylorus
Cardia. NOS
Male 42 11
Female 14 7 5
Total
702 Male 5
635
14
254
228
Histology
Total
Carcinosarcoma, NOS
Leiomyosarcoma, NOS
Linitis plastica
Adenocarcinoma, NOS
Squamous cell carcinoma, small cell, non-keratinising
Carcinoma, NOS
Neoplasm, malignant
95 9
Female 28 2 3
47 1 1
31 0 2
458 1 2
156 0 0
16 39 1 3 3
702
254
144
Table 43 Colon and rectum

Group Female Male
Incidence data 2005
Number 1446 1541
Percentage 4.4 5.6
Total
2987
4.9
Total
C18.0 C18.1 C18.2 C18.3 C18.4 C18.5 C18.6 C18.7 C18.9 C19.9 C20.9
Caecum Appendix Ascending colon Hepatic flexure of colon Transverse colon Splenic flexure of colon Descending colon Sigmoid colon Colon, NOS Rectosigmoid junction Rectum, NOS
Male 61 8 32 11 30 9 13 125 379 61 812
Female 55 6 24 4 34 4 13 153 361 50 742
1541 Male 125 1 12 1 1 46 1 1212 12 2 0 2 10 1 2 4 1 3 0 3 1 0 1 0 0 47 9 29 3 4 1 3 0 0 2 3 1541
1446 Female 121 2 13 0 0 37 2 1136 14
Neoplasm, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Small cell carcinoma, NOS Papillary carcinoma, NOS Squamous cell carcinoma, NOS Basaloid carcinoma Adenocarcinoma, NOS Adenocarcinoma in adenomatous polyp Tubular adenocarcinoma 1 Adenocarcinoma in adenomatous polyposis coli Carcinoid tumour of uncertain malignant potential Carcinoid tumour, NOS Goblet cell carcinoid Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Adenocarcinoma in villous adenoma Villous adenocarcinoma Adenocarcinoma in tubulovillous adenoma Acidophil carcinoma Clear cell adenocarcinoma, NOS Cystadenocarcinoma, NOS Papillary cystadenocarcinoma, NOS Mucinous cystadenocarcinoma, NOS Papillary mucinous cystadenocarcinoma Mucinous adenocarcinoma Mucin-producing adenocarcinoma Signet ring cell carcinoma Adenosquamous carcinoma Malignant melanoma, NOS Spindle cell sarcoma Leiomyosarcoma, NOS Stromal sarcoma, NOS Gastrointestinal stromal tumour Gastrointestinal stromal sarcoma Malignant lymphoma, non-Hodgkin, NOS Total
Histology
1 1 3 0 0 11 0 3 1 1 1 1 2 1 1 36 9 25 5 2 0 1 1 1 2 10 1446
145
Group Female Male
Incidence data 2005
Table 44 Colon
Number 654 668
Percentage 2.0 2.4
Total
1322
2.2
C18.3 C18.5 C18.4
C18.2
Hepatic flexure of colon Splenic flexure of colon Transverse colon
Ascending colon
Appendix
Caecum
Male 61 8
Female 55 6
32 30 13 9 11
24 34 13 4 4
Total
C18.9
C18.7
C18.6
Colon, NOS
Sigmoid colon
Descending colon
668 Male 40 9 1
379
125
654 Female 52 11 492 11 1 11 1
361
153
Histology
Carcinoma, undifferentiated, NOS Squamous cell carcinoma, NOS Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Adenocarcinoma in adenomatous polyp Tubular adenocarcinoma 0 Adenocarcinoma in adenomatous polyposis coli
528 7 1 2 0
14
Total
Leiomyosarcoma, NOS
Acidophil carcinoma
Adenocarcinoma in villous adenoma
Goblet cell carcinoid
Carcinoid tumour of uncertain malignant potential
23 16 2 1 4
20 15 1 3 6
668
654
10
146
Table 45 Rectum anal canal and anus

Group Female Male
Incidence data 2005
Number 802 910
Percentage 2.4 3.3
Total
1712
2.8
Total
C21.8
C21.1
Anal canal
Anus, NOS
Rectum, NOS
Male 812 34 54
Female 742 21 802 Female 67 1 1 7 32
910 Male 86 0 0
10
Histology
Total
Gastrointestinal stromal tumour, NOS
Stromal sarcoma
Leiomyosarcoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
Squamous intraepithelial neoplasia
Carcinoma, NOS
Neoplasm, malignant
83 1 0
48 1 1
666 1 2
621 0 3
20 10 8 4 4
17 7 3
910
802
147
Group Female Male
Incidence data 2005
Table 46 Larynx
Number 1453 150
Percentage 0.5 5.3
Total
1603
2.6
Total
C32.9
C32.3
C32.2
Larynx, NOS
Laryngeal cartilage
Subglottis
Supraglottis
Glottis
Male 376 25 15 593
Female 50 6 1 53
1453 Male 100 2 4
444
150 Female 14 2 0
40
Histology
Adenosquamous carcinoma Total Small cell sarcoma
Adenocarcinoma, NOS
Squamous cell carcinoma, small cell, nonkeratinising
Giant cell carcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
28 0 1
13 1258 10 1 1 1
126 1 1
11 1453
0 0 2
150
148
Table 47 Trachea bronchus and lung

Group Female Male
Incidence data 2005
Number 2936 699
Total
3635
Total
C34.9
C34.3
C34.2
C34.1
Lung, NOS
Lower lobe, lung
Middle lobe, lung
Upper lobe, lung
Main bronchus
Trachea
Male 18 2 3 8
Female 2 4
2936 Male 831 20 0
2905
699 Female 169 1 5
689
Histology
Carcinoma, undifferentiated, NOS Spindle cell carcinoma, NOS Carcinoma, anaplastic, NOS
Carcinoma, NOS
Neoplasm, malignant
23 1 8
39
11 0 2
Bronchio-alveolar adenocarcinoma, non-mucinous
Bronchio-alveolar adenocarcinoma, NOS
Adenocarcinoma, NOS
Basaloid carcinoma
Oat cell carcinoma
Tumourlet, NOS
98 1 1
10 0 0
49 1 3
919 2 7
138 0 0
861 1 0
310 2 1
32 0 5
13 1 1
149

Histology Desmoplastic small round cell tumour Spindle cell sarcoma Male 1 0 Female 0 2
Total
Mucinous adenofibroma, NOS
2936
699
150
Table 48 Haemopoetic and reticuloendothelial system

Group Male Female Total
Incidence data 2005
2516 2065
Number 9.1 6.3
Percentage
4581
7.5
Total
C42.2
Spleen
Bone marrow
Blood
Male 2510 2516 Male 38 4 2 23 3 3
Female 2050 2065 Female 17 0 1 15 10 5
Histology
Acute Leukemia, NOS
Leukemia, NOS
Monoclonal gammopathy of undetermined significance
Waldenstrom macroglobulinaemia
Plasma cell leukaemia
Multiple myeloma
Plasmacytoma, NOS
589 3 6
10 0 1
544 5 2
Acute myeloid leukemia without maturation
Acute myeloid leukemia, minimal differentiation
Acute myeloid leukemia with abnormal marrow eosinophils
Acute basophilic leukaemia
Acute myelomonocytic leukemia
Acute promyelocytic leukemia
Chornic myeloid leukemia, NOS
Acute myeloid leukemia, NOS
Myeloid leukaemia, NOS
Acute myeloid leukemia, M6 type
Precursor T-cell lymphoblastic leukemia
Precursor B-cell lymphoblastic leukemia
Precursor cell lymphoblastic leukemia, NOS (including acute lymphoblastic leukemia)
Prolymphocytic leukemia, T-cell type
Prolymphocytic leukemia, B-cell type
Prolymphocytic leukemia, NOS
Adult T-cell leukaemia/ lymphoma (HTLV-1 positive)
Burkitt cell leukaemia
B-cell chronic lymphocytic leukemia /small lymphocytic lymphoma
Acute biphenotypic leukemia
16 81 0 0 3
11 51 1 1 6
675 2 1
446 1 0
321 59 0 1 6
249
10 230 6 2
247 81 1 1
25
27
151

Histology Atypical chornic myeloid leukemia, BCR/ABL negative Acute myeloid leukemia with maturation Male 50 4 2 Female 65 3 2
Myeloselerosis with myeloid metaplasia Lymphoproliferative disorder, NOS Essential thrombocythemia
Chronic myeloproliferative disease, NOS
Polycythemia vera
Juvenile myelomonocytic leukemia
Chornic myelomonocytic leukemia, NOS
Hairy cell leukemia
Acute panmyelosis with myelofibrosis
Myeloid sarcoma
Acute megakaryoblastic leukaemia
Acute myeloid leukemia, 11 q23 abnormalities
Acute myeloid leukemia t(8;21)(q22;q22)
Acute monocytic leukaemia
20 5 5
13 5 5
58 11 2 1
27 12 2 8 0
Total
Myelodysplastic syndrome, NOS
Therapy related myelodysplastic syndrome, NOS
Refractory cytopenia with multilineage dysplasia
Refractory anemia with excescss blasts in transformation [obs]
Refractory anemia
Myeloproliferative disease, NOS
10 1 1
2516
182
2065
181
152
Group Female Male
Incidence data 2005
Table 49 Skin
Number 359 577
Percentage 1.1 2.1
Total
936
1.5
Total
C44.9
C44.7
C44.6
C44.5
C44.4
C44.3
C44.2
Skin, NOS
Skin of trunk
Skin of scalp and neck
Skin of other and unspecified parts of face
External ear
Eyelid
Skin of lip, NOS
Male 21 5
Female 16 6
577 Male 1 6
100
247
38
61
32
46
27
359 Female 1 3
79
93
22
48
47
33
15
Histology
Malignant melanoma, NOS Spindle cell melanoma, NOS Amelanotic melanoma
Paget disease, extramammary
Eccrine adenocarcinoma
Sebaceous adenocarcinoma
Sclerosing sweat duct carcinoma
Nodular hidradenoma, malignant
Bowen disease
Neoplasm, malignant
345 1 0
175 0 2
49 0 0
51 3 5
115 1
69 0 1
Leiomyosarcoma, NOS
10 1
153

Histology Epithelioid haemangiondothelioma, NOS Male 1 1 1 Female 0 0 2
Total
Angiocentric immunoproliferative lesion
Primary cutaneous CD3+ T-cell lymphoproliferative disorder
Sezary syndrome
Mycosis fungoides
Epithelioid haemangiondothelioma, malignant
13 4 0
577
359
154
Group Female Male
Incidence data 2005
Table 50 Breast
Number 8364 207
Percentage 25.3 0.7
Total
8571
14.1
Total
C50.9
C50.6
Breast, NOS
Axillary tail of breast
Upper outer quadrant of breast
Nipple
Male 0 0
Female 3 5
207 Male 25 0 0
205
8364 Female 910 28 1 5
8353
Histology
Paget disease and intraductal carcinoma of breast
Paget disease and infiltrating duct carcinoma of breast
Inflammatory carcinoma
Infiltrating duct mixed with other types of carcinoma
Infiltrating duct and lobular carcinoma
Medullary carcinoma with lymphoid stroma
Intraductal micropapillary carcinoma
Noninfiltrating intraductal papillary adenocarcinoma
Comedocarcinoma, noninfiltrating
Intraductal carcinoma, noninfiltrating, NOS
Mucinous adenocarcinoma (Muciod carcinoma)
Cribriform carcinoma, NOS
Adenocarcinoma, NOS
Carcinoma, NOS
Neopllasm, malignant
13 1 5
30 2
49 1 1
52
53
150 0 0
70 10 2 3
6704 8
33 262 2 5 3
155

Histology Acinar cell carcinoma Male 0 0 Female 2 1
Total
Haemangiosarcoma
Phyllodes tumour, borderline
Carcinosarcoma, NOS
Small cell sarcoma, NOS
Sarcoma, NOS
207
48 2 5
8364
156
Table 51 Cervix uteri

Group Total
Incidence data 2005
Female
Number 3943 3943
Percentage 11.9 6.5
Total
Cervix uteri
Endocervix
Female 3937 6
3943
Histology
Total
Carcinosarcoma, NOS
Leiomyosarcoma, NOS
Sarcoma, NOS
Adenocarcinoma, NOS
Squamous cell carcinoma, small cell, non keratinising, NOS
Papillary squamous cell carcinoma
Carcinoma, NOS
Neoplasm, malignant
Female 398 15 13 5 2 4 30
2677 297 2 4 268
175 15 6 4 1
3943
157
Table 52 Ovary and other unspecified female genital organs

Group Total
Incidence data 2005
Female
Number 2805 2805
Percentage 4.6 8.5
C57.9
C57.1
Total
Broad ligament
Fallopian tube
Ovary
Female 2788 13 2 2
2805 391 11 89 1 2 8
Histology Carcinoma, NOS Neoplasm, malignant
Female
Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Small cell carcinoma, NOS
Sertoli-Leydig cell tumour of poorly differentiated
Sertoli-Leydig cell tumour of intermediate differentiation
Androblastoma, malignant
Granulosa cell tumour, adult type
Thecoma, malignant
Serous papillary cystic tumour of borderline malignancy
Serous cystadenoma, borderline malignancy
Serous cystadenoma, NOS, papillary borderline malignancy
Clear cell adenofibroma of borderline malignancy
Adenocarcinoma, NOS
58 835 2 2
199 16 141 21 1 1 1
139 1 2
295 10 4
32
38 5 5
34
30
88
91 1 3
158

Histology Steroid cell tumour, malignant Sertoli cell tumour, NOS Female 1 1
Total
Teratoma with malignant transformation
Yolk sac tumour
Germinoma
Dysgerminoma
Brenner tumour, malignant
Brenner tumour, borderline malignancy
Carcinosarcoma, NOS
Stromal tumour, NOS
Myxoid leiomyosarcoma
Liposarcoma, NOS
Fibrosarcoma, NOS
Small cell sarcoma
Sarcoma, NOS
87 2 4
32 27 4 1 2
30
2805
159
Group Total Male
Incidence data 2005
Table 53 Prostate
Number 1382 1382
Percentage 2.3 5.0
Prostate gland
Male 1382 Male 268 26 1 1 4 1382
Histology
Total
Trabecular adenocarcinoma
Adenocarcinoma, NOS
Basaloid carcinoma
Combined small cell carcinoma
Carcinoma, NOS
Neoplasm, malignant
92 8 1
966 1 1
1382
160
Group Female Male
Incidence data 2005
Table 54 Bladder
Number 127 526
Percentage 0.4 1.9
Total
653
1.1
Bladder, NOS
Male 526 Male 37 0 7 526
Female 127 Female 14 1 3 127
Histology
Carcinoma, NOS
Neoplasm, malignant
10 1 3
Papillary transitional cell carcinoma Papillary adenocarcinoma, NOS Adenocarcinoma, NOS
43 371 16 1 1 11 1
11
0 10 78 7 6 0 0
Total
526
127
161
Group Female Male
Incidence data 2005
Table 55 Brain
Number 554 765
Percentage 1.7 2.8
Total
1319
2.2
C71.0 C71.1 C71.2 C71.3 C71.4 C71.5 C71.6 C71.7 C71.8 C71.9
Total
Cerebrum Frontal lobe Temporal lobe Parietal lobe Occipital lobe Ventricle, NOS Cerebellum, NOS Brain stem Overlapping lesion of brain Brain , NOS
Male 13 62 56 99 17 10 49 29 13 417
Female 7 50 31 68 19 3 34 28 4 310
765 Male 21 2 2 1 1 1 1 5 10 0 2 187 1 1 33 2 245 24 0 1 15 110 1 52 1 40 0 2 0 0 0 0 1 3 765
554 Female 15 1 2 1 3 0 2 5 8 1 4 148 2 0 21 8 139 21 1 1 15 86 0 29 2 23 1 6 1 1 3 1 2 1 554
Neoplasm, malignant Carcinoma, anaplastic, NOS Malignant melanoma, NOS Germinoma Mixed germ cell tumour Haemangiosarcoma Haemangioendothelioma, malignant Haemangiopericytoma, malignant Haemangioblastoma Peripheral neuroectodermal tumour Chordoma, NOS Glioma, malignant Mixed glioma Choroid plexus carcinoma Ependymoma, NOS Ependymoma, anaplastic Astrocytoma, NOS Astrocytoma, anaplastic Gemistocytic astrocytoma Fibrillary astrocytoma Pilocytic astrocytoma Glioblastoma, NOS Gliosarcoma Oligodendroglioma, NOS Oligodendroglioma, anaplastic Medulloblastoma, NOS Primitive neuroectodermal tumour, NOS Neuroblastoma, NOS Ganglioglioma, anaplastic Central neurocytoma Meningioma, malignant Neurilemoma, malignant [obs] Malignant lymphoma, NOS Malignant lymphoma, non-Hodgkin, NOS Total
Histology
162
Group Female Male
Incidence data 2005
Table 56 Thyroid
Number 2370 670
Percentage 7.2 2.4
Total
3040
5.0
Thyroid Gland
Male 670 Male 28 2 670
Female 2370 Female 84 5 2370
Histology
Follicular lymphoma, NOS Total
Small cell sarcoma
Mixed medullary follicular carcinoma
Papillary carcinoma, columnar cell
Papillary carcinoma, oxyphilic cell
Papillary microcarcinoma
Insular carcinoma
Adenocarcinoma, NOS
Carcinoma, anaplastic
Neoplasm, malignant
45 0 0
88 1 1
399 0 5
1429 14 1 1
108 1 0
21 471 0 2 0
22
36 0 0
170 1 1
15 0 1
24 1 0
1 670 1
11 2370 1
163

Treatment
Table 57 Cancer Treatment 2005
Total
Treatment unknown
Symptomatic treatment
Radiotherapy
Surgery (S)
Hormone therapy (H)
Chemotherapy (C)
C+H
R+H
R+C
S+H 74
S+R 2409
S+C 321
R+C+H
S+R+H
S+C+H
S+C+R
S+C+R+H
Number 106 587
Percentage 0.8 4.4
495 18.0 540 3244 20 24 0.6 2.4
278
562
24.09 4.0 7.4
3.21
3.7
2.1
4.2
1632 329
12.2 2.5 0.1
24.3
0.2
13372
904
956
891
100
6.8
7.1
6.7
Cancer treatment 2005

Treatment unknown R S
Symptomatic treatment
H C+H R+H R+C S+H S+R S+C C
R+C+H S+R+H S+C+H S+C+R+H 0 500 1000 1500 2000 2500 3000 3500 S+C+H
Number of cases treated
164
Table 58 Cancer incidence by geography 2005

Province District No Central Kandy Matale Nuwara Eliya Ampara Batticoloa Trincomalee Jaffna Kilinochchi Mannar Mullatitvu Vavuniya Anuradhapura Polonnaruwa Kurunegala Puttalam Kegalle Rathnapura Galle Hambanthota Matara Badulla Monaragala Colombo Gampaha Kalutara Not available Total 822 619 110 93 166 85 42 39 90 46 9 5 4 26 217 159 58 465 300 165 421 197 224 570 257 91 222 332 246 86 1972 1006 656 310 1003 6058 Male Sex % 13.5 10.2 1.8 1.5 2.7 1.4 0.7 0.6 1.5 0.8 0.1 0.1 0.1 0.4 3.6 2.6 1.0 7.7 5.0 2.7 7.0 3.3 3.7 9.4 4.2 1.5 3.7 5.5 4.1 1.4 32.5 16.6 10.8 5.1 16.6 100 Female No % 962 680 129 153 146 88 40 18 138 99 2 8 0 29 281 218 63 577 386 191 487 219 268 662 297 115 250 353 270 83 2674 1350 881 443 1034 7314 13.2 9.3 1.8 2.1 1.9 1.2 0.5 0.2 1.9 1.4 0.0 0.1 0.0 0.4 3.9 3.0 0.9 7.9 5.3 2.6 6.7 3.0 3.7 9.1 4.1 1.6 3.4 4.8 3.7 1.1 36.6 18.5 12.0 6.1 14.1 100 Total No 1784 1299 239 246 312 173 82 57 228 145 11 13 4 55 498 377 121 1042 686 356 908 416 492 1232 554 206 472 685 516 169 4646 2356 1537 753 2037 13372 % 13.3 9.7 1.8 1.8 2.3 1.3 0.6 0.4 1.7 1.1 0.1 0.1 0.0 0.4 3.7 2.8 0.9 7.8 5.1 2.7 6.8 3.1 3.7 9.1 4.1 1.5 3.5 5.2 3.9 1.3 34.7 17.6 11.5 5.6 15.2 100
Eastern
Northern
North Central
North Western
Sabaragamuwa
Southern
Uva
Western
165
Table 59 Survival status by sex, age group and ethnicity 2005

Date of death known < 1 year Male Female Age Group 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75 and above Ethnicity Sinhala Tamil Muslim Other 452 3 4 4 13 9 10 8 7 31 49 57 61 56 60 32 48 399 33 19 1 289 3 1 2 2 9 6 5 17 21 27 45 39 38 28 19 27 254 21 14 0 Alive at 1 year Male Female 80 1 2 0 1 3 1 1 2 6 7 10 9 9 19 4 5 73 5 2 0 63 2 1 0 0 1 1 2 5 5 11 15 5 6 4 2 3 56 4 3 0 Alive at 2 years Male Female 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 Censored at the last date of contact < 1 year Male Female Alive at 1 year Male Female Alive at 2 years Male Female 42 0 2 0 1 1 2 2 2 1 7 5 4 6 4 1 4 38 2 2 0 Male Female 1586 30 22 22 20 33 39 62 85 126 174 234 179 174 155 123 108 1353 166 67 0 94 1446 1 2 2 0 1 1 1 5 14 12 21 11 9 5 5 4 25 21 16 17 24 23 34 55 72 131 181 187 195 152 168 145 No data
6 3010 3231 1027 2045 0 0 0 0 0 0 1 1 1 0 1 0 0 1 0 1 18 16 28 34 42 53 51 73 138 214 348 356 425 423 387 404 23 15 19 28 48 83 106 156 248 348 473 424 352 336 273 299 16 15 16 21 11 18 27 41 57 88 122 130 150 108 89 118 11 9 14 20 46 64 78 125 218 275 320 276 207 160 116 106
3 2564 2629 2 278 435 1 161 160 0 7 7
900 1823 66 142 57 74 4 6
82 1232 10 139 2 74 0 1
166
APPENDIX I: Statistical Terminology

Incidence The term incidence is defined as the ratio of number of patients developing a particular disease and the average population at risk for a specific time period. Normally this is expressed as per 100,000 population. Mortality The term mortality is defined as the ration of number of deaths due to the particular disease and the average population for a specific time period in a given geographical area. Normally this is expressed as per 1,000 population. Standardisation The basic idea in use of standardisation is that allowing the adjustment for discrepancies in age structures between the standard population and a special population. This volume considers two standard populations, the World Population and the Population of Developing Countries. Lifetime Risk The lifetime risk is defined as the probability of developing a particular disease during the life time of a person living in a specific community. The measure of lifetime risk included in this volume are subject to assumption of life expectation at birth of Sri Lankan population is 70 years. Calculation The methods of some important calculations included in this volume are, 1. Crude rate Is calculated by dividing the total number of cases encountered in the year with the estimated mid year population at risk. Age Specific Incidence rate Is calculated by dividing the number of cases in each five year age groups with the estimated mid year population at risk of the corresponding age groups. Age Specific Death rate Is calculated by dividing the number of deaths reported in a specific age group with the total number of deaths of the population reported in the corresponding age group. Standardised incidence rate Can be regarded as a weight mean of age-specific incidence of Sri Lanka population, using the percentage of each age interval of the age structure of the standard population. Life Time Risk (Percentage Cumulative Incidence Rate) Cumulative Incidence Rate (CIR) is the sum of the incidences of each and every single age group. When it is expressed as percentage, CIR can be used as a good estimate for lifetime risk. In this publication CIR is calculated among those belonging to the age group of 0-70 years. Selection of the 0-70 age interval was based on Sri Lankas actuarial life expectancy, which is close to 70 years in both males and females. Beyond this interval, detection of cancers on the extremely older cases is often found incidentally or after death.
2.
3.
4.
5.
167
List of Reference
Department of Census and Statistics. Estimated mid-year population by age and sex 2003-2008 Available at http://www.statistics.gov.lk/PopHouSat/Mid%20Year%20Population/Table%202.pdf Department of Census and Statistics. Number of death by cause of age and sex 2003 Available at http://www.statistics.gov.lk/PopHouSat/VitalStatistics/Index.asp United Nations Population Division. World Population prospects population database,2008 revision. Available at http://eas.un.org/unpp/index.asp Cancer registrationn Principles and Methods IARC scientific Publication world Health Organisation 2000, International Classification of Diseases of Oncology, 3rd Edition, Geneva. Cancer registry-previous publications-1985,1990,1995&2000
168

9

Cargado por

Información del documento

Derechos de autor

Formatos disponibles

Compartir este documento

Compartir o incrustar documentos

Opciones para compartir

¿Le pareció útil este documento?

¿Este contenido es inapropiado?

Copyright:

Formatos disponibles

9

Cargado por

Copyright:

Formatos disponibles

Cancer Incidence Data: Sri Lanka Year 2001-2005

National Cancer Control Programe - 2009 7th Publication

Printed By: Gunaratne Offset Ltd Wellampitiya

Cancer Incidence Data - 2005

Message by the Minister of Healthcare & Nutrition

Message by the Secretary/ Ministry of Healthcare & Nutrition

Dr. H.A.P.Kahandaliyanage Secretary Ministry of Healthcare & Nutrition

Message by the Director General of Health Services

Dr U A Mendis Director General of Health Services

Dr M A Y Ariyaratne MBBS, MD Director/ NCCP

Graph Graph Table Table Table

Appendices Appendix i : Statistical Terminology Appendix ii : List of References

Cancer Incidence Data - 2005

Cancer Incidence Data

Cancer Incidence Data - 2005

Graph 01 General population of Sri Lanka by 5-year age groups 2001

Cancer Incidence Data - 2005

Table 1 General Population: Sex Distribution

1981 6,497 6,265 103.7

1991 8,792 8,455 104.0

2001 9,267 9,465 97.9

2005 9,718 9,950 97.7

Number of males per 100 females

Source: Department of Census and Statistics

Denominators used for calculations in Cancer Registry

1985 8,076 7,766 15,842

1990 8,661 8,332 6,993

2000 9,870 9,489 19,359

2005 9,718 9,950 19,668

Source: Registrar Generals Department and Department of Census and Statistics

Table 2 Statistics on doctors, hospitals and hospital beds

Source: Medical Statistics Unit, Ministry of Health

Cancer Incidence Data - 2005

Table 3 - Cancer mortality data 1985-2003

1985 1990 1995 2001 2002 2003

Sources: Department of Census and Statistics Registrar Generals Department

Graph 2 - Crude hospital death rates 1996-2003

Crude Rate per 100 000 population

Cerebrovascular disease All causes

Source: Medical Statistics Unit, Ministry of Health

Cancer Incidence Data - 2005

Table 04 - Cancer mortality rates, 2001

ASR 3.4 3.5

1-030 1-031 1-032

2.2 0.5 1.5

3.2 0.8 2.2

2.3 0.5 0.9

3.6 0.8 1.4

Malignant neoplasm of skin

Malignant neoplasm of cervix uteri

Remainder of malignant neoplasm

Remainder of neoplasm Neoplasm

Cancer Incidence Data - 2005 Year 1985

Table 5 - Cancer incidence in Sri Lanka, 1985-2005

Cancer Incidence in Sri Lanka

Cancer Incidence Data - 2005

Table 6 - Overall Cancer Incidence, 2005 by age and sex

45-49 55-59 50-54

497 747 723

583 379 525

341.5 373.2 62.3 411.5

1109 786 934

259 229 189

1348 1072 580 787 1190